guitarrawlings

Piribo: meeting the needs for improved diagnostic and prognostic tools for rheumatoid arthritis

2011-06-07T16:36:00.000-07:00

Piribo: Meeting the Needs for Improved Diagnostic and Prognostic Tools for Rheumatoid Arthritis

Piribo, (www. piribo. com) the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report entitled “Improved Diagnostic and Prognostic Tools for Rheumatoid Arthritis - Unmet Needs in a Changing Market”.

(PRWEB) April 13, 2006

According to recent clinical studies, the key to achieving optimal outcomes in rheumatoid arthritis (RA) is to diagnose and treat it as early as possible. The need to develop more-sensitive and more-specific markers for early-stage disease is urgent.

While developments in disease-modifying drugs and biologic agents have revolutionized the treatment of RA, enabling physicians to slow disease progression and prevent some joint destruction, diagnostics has lagged behind. Therefore, the challenge in this area of medicine lies almost exclusively in the diagnosis of early-stage RA, which can be accomplished only with novel serological tests, imaging techniques, or RA biomarkers. This report profiles the efforts under way by a variety of companies in this area of great unmet need.

“Improved Diagnostic and Prognostic Tools for Rheumatoid Arthritis - Unmet Needs in a Changing Market” is priced at £1055 and is available in PDF format from Piribo. For more information go to: http://www. piribo. com/search/results. html? k=dec018 (http://www. piribo. com/search/results. html? k=dec018)

About Piribo.

Piribo is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,500 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. Piribo’s other site www. reportbuyer. com covers other global industries. The company was established in 2004.

###

New insights into the global pain market-post vioxx

2011-06-07T14:04:00.000-07:00

New Insights into the Global Pain Market-Post Vioxx

The dynamics of the pain market have been altered greatly over the past year. The troubles surrounding the multi-billion dollar Cox-II class has created a void in the marketplace. Pain Therapeutics 2005 not only analyzes this market but also the global markets for opioids, anticonvulsants, triptans, and traditional NSAIDs (http://www. arrowheadpublishers. com/PainTherapeutics. html)

Minneapolis, MN (PRWEB) May 11, 2005

Pain Therapeutics 2005: Market Dynamics and Outlook has just been released by Arrowhead Publishers. This brand new report published in May 2005 provides detailed analysis and information concerning the global market for pain therapeutics, R&D pipelines and company involvement in this field.

About one and a half billion people suffer from moderate to severe chronic pain worldwide and approximately 50 million Americans suffer with pain. The value of the pharmaceutical market for pain relief reflects this seeming worldwide epidemic of pain, with the overall value reaching nearly $23 billion in 2004.

In this new report, key pain management therapeutics such as Cox-II inhibitors, opioids, triptans, anticonvulsants and traditional NSAIDs are discussed in terms of their past, present and future value and the role they are playing in the effective management of pain.

The dynamics of this market have been altered greatly over the past year. The troubles surrounding the multi-billion dollar Cox-II class has created a void in the marketplace. Pain Therapeutics 2005 explains just what the Cox-II crisis means for the future of pain management and what kinds of opportunities their failure may present for other classes of pain management medications.

This 251-page report includes the following features:

93 tables/graphs which provide the reader with valuable illustrated insight into trends and issues affecting this growing market. Thorough financial breakdown of the leading products and companies making an impact on the pain market Identification and discussion of trends and issues that are pushing the market into the future Profiles of key companies involved in the development and marketing of pain therapeutics Forecasts of key products/classes

# # #

Hospital performance improvement: healthcare management council partner's internal collaboration focuses on pre-sedation pain and cuts costs by decreasing use of propofol

2011-06-07T10:42:00.000-07:00

Hospital Performance Improvement: Healthcare Management Council Partner's Internal Collaboration Focuses on Pre-Sedation Pain and Cuts Costs By Decreasing Use of Propofol

Dixie Regional Medical Center cut costs and improved patient care by standardizing pain control and sedation in the ICU. Hospitals around the country are under tremendous pressure to cut costs as reimbursements and contributions decline. The Healthcare Management Council's KnowledgeWeb (http://www. HMC-Benchmarks. com/hospital/tools_kw. shtml) shares cost-cutting ideas generated at Partner facilities to help hospital managers keep their facilities competitive.

(PRWEB) January 22, 2004

Dixie Regional Medical Center in St. George, Utah found that increased use of Propofol in the Intensive Care Unit was due to the absence of a standard scale for assessing pain or sedation. Dixie hypothesized that they could sedate patients more effectively (and at lower cost) by focusing on pain issues prior to sedation.

In a joint effort between nursing, pharmacy, respiratory therapy and the ICU medical staff, Dixie created a pain protocol that objectively measures pain prior to sedation. Pain is assessed and treated first so that a patient who is in pain is treated instead of being sedated. Patients that are sedated also get a "sedation holiday" every 24 hours.

Since the adoption of this protocol the use of Propofol has declined dramatically, and the use of less-expensive Fentanyl increased. There was

Some concern that ICU length of stay for the patient may increase, but after 1 year of analysis, the length of stay in ICU was the same. The success of this protocol comes from interdisciplinary involvement. The process to develop the protocol took about 4 months.

This idea is part of HMC's collection of "Successes and Good Ideas,"

Articles highlighting successful performance improvement measures in health care. For more information on these articles and other HMC hospital networking events visit http://www. HMC-Benchmarks. com/hospital/ccs. shtml (http://www. HMC-Benchmarks. com/hospital/ccs. shtml).

Contact: Shelley Burns (SHBurns@HMCOnline. net)

The Healthcare Management Council, Inc.

Area: Hospital Performance Improvement

Web site: http://www. HMC-Benchmarks. com (http://www. HMC-Benchmarks. com)
Phone: (262) 242-9471

###

Cyco software announces inaugural european user & reseller conference

2011-06-07T03:06:00.000-07:00

Cyco Software Announces Inaugural European User & Reseller Conference

Cyco Software organizes European User & Reseller Conference 2007 in Albufeira, Portugal, January 14-16.

Atlanta, GA (PRWEB) January 15, 2007

Cyco Software, a leading global software company offering Engineering Data Management (EDM) solutions, announced today that it will kick off the new year with its first-ever European User & Reseller Conference at the Sheraton Algarve Hotel in Albufeira, Portugal from January 14-16.

The year 2006 has been a very successful year for the Cyco organization. Cyco Software has seen significant revenue growth and commercial success with their new strategic focus of "Taking EDM to the Enterprise" in asset management-related markets.

The year 2007 promises further growth, many more exciting developments and new solution offerings that are currently in the pipeline. There will be a major focus on intensifying relationships with customers and business partners - Cyco Software is therefore commencing the year with its first European User & Reseller Conference in Albufeira this month, following the great success of its User & Reseller Conference held in Atlanta, USA last June.

"This is an exciting time for Cyco Software. With our rapid growth and expansion in the global EDM market, it is one of our highest priorities to listen to our customers and be in tune with their needs," says Martijn Janmaat, Cyco Software CEO. "The conference will not only be an event where customers will gain valuable knowledge, but will also provide a forum for our customers to air any questions, issues and what they wish to see in our product roadmap."

To be held at the prestigious Sheraton Algarve Hotel, a venue near the city of Faro that is part of Starwood's coveted Luxury Pine Cliffs Collection, the conference will present a mix of technical and strategic information.

The theme of the conference is "Taking EDM to the Enterprise". This slogan refers to Cyco Software's mission to provide best-of-class technology, integration, applications and services that will help organizations to leverage engineering information throughout the enterprise.

It will be an event where Cyco Software customers will meet and mingle to learn how best to exploit their Cyco AutoManager solutions, how to get the most enterprise-wide benefits from engineering data management for their companies, hear case-studies from their peers, gain invaluable technical insight and get a sneak preview of what to expect from Cyco Software's future product development.

"We are looking forward to a great, action-packed event and to hosting our valued customers and business partners in beautiful Albufeira," says Mr Janmaat. Cyco Software will hold another conference in Miami, USA this June.

About Cyco Software

Cyco Software provides Engineering Data Management and Application Integration solutions for multiple vertical industries including energy, oil & gas, (petro) chemical, government, pharmaceutical, and discrete and process manufacturing. Cyco Software has almost two decades of industry experience with over 275,000 users in 50+ countries worldwide. The company has offices in the USA, UK, Russia, Germany and The Netherlands, together with an extensive global network of established partners. Cyco Software ensures a high level of service and support on a truly worldwide scale for its leading software solutions, Cyco AutoManager Meridian and Cyco AutoManager TeamWork. For more information, please visit http://www. cyco. com (http://www. cyco. com), or call (800) 323 2926 ext 111 (Americas) or +31 (0)70 413 3700 (EMEA).

Cyco Software, Cyco and AutoManager are registered trademarks of Cyco Software BV. All other brand names, product names, or trademarks belong to their respective holders. © 2007 Cyco Software, Inc. All rights reserved.

# # #

New medical sales salary calculator helps job seekers narrow their search

2011-06-06T18:33:00.000-07:00

New Medical Sales Salary Calculator Helps Job Seekers Narrow Their Search

The new Medical Sales Salary Calculator from MedReps. com gives job seekers an effective way to evaluate the potential compensation associated with various types of medical sales jobs.

Alpharetta, GA (PRWEB) July 30, 2010

Medical sales jobs (http://www. medreps. com/Medical-Jobs/Sales/) and pharmaceutical sales jobs are known for their relatively high salaries, but compensation varies greatly depending on the type of product that a med rep or a pharma rep sells. Products with higher average sales prices will earn a higher commissions; therefore it is fair to assume those selling high dollar medical devices will earn more income than those selling disposables, but precise figures can be difficult to estimate.

A new tool from the leading site for pharmaceutical and medical sales, marketing, and management jobs eliminates the need to make assumptions about medical sales incomes. Now medical sales job seekers who would like more specific information regarding the average compensation associated with various types of medical sales jobs can look to the Medical Sales Salary Calculator (http://www. medreps. com/medical-sales-careers/salary-survey. aspx) from MedReps. com. The calculator provides real-time information on the compensation associated with various types of medical sales jobs.

“Income information is extremely important in a job search, but it’s not always easy to find,” says Robyn Melhuish, Communications Manager for MedReps. com. “We’ve made this information public as a way to further assist those seeking medical sales jobs.”

Users can select a category (such as Medical Device Sales or Capital Equipment Sales) from the dropdown box and instantly view the average compensation for sales reps offering that type of product. They can also view the top five average salaries by category as well as by state. The average salaries are calculated in real-time using the compensation figures listed in the 100 most recent MedReps. com job postings for that category or state. The Medical Sales Salary Calculator is a widget found in the MedReps. com Career Center (http://www. medreps. com/medical-sales-careers/). Users of the Salary Calculator are invited to copy the code and place the widget on their own blog or other website.

MedReps. com gives members access to the most sought after medical sales jobs and pharmaceutical jobs on the web. Members have access to more than 5,000 jobs and are able to apply directly to the recruiters and hiring managers who post them. With the launch of the new Medical Sales Salary Calculator, MedReps. com proves once again why, after ten years, MedReps. com is still the industry's favorite job board.

For more information on the leading site for pharmaceutical and medical sales, marketing, and management careers please visit MedReps. com.

MedReps. com is owned and operated by Healthcare Job Boards, the leading provider of niche career sites in the healthcare market. The HJB portfolio of premier job boards includes niche sites for physician jobs (http://www. mdsearch. com), therapy jobs (http://www. therapyjobs. com), nursing jobs (http://www. rnsearch. com), and medical sales jobs (http://www. medreps. com). For more information call 866.619.1630

# # #

Cbdm. T®, the market and business intelligence company reviews the enzyme market

2011-06-06T00:36:00.000-07:00

CBDM. T®, The Market and Business Intelligence Company Reviews The Enzyme Market

According to CBDM. T®, The market and business intelligence company, the enzyme market is significant and estimated at €3.4 billion with an annual growth of about 6.5 to 10%. Enzymes are sold in many different industry segments. These segments are Detergents, Food, Feed, Technical, Pharmaceutical, Microorganisms and Biofuels.

Paris (PRWEB) July 8, 2008

According to CBDM. T®, The market and business intelligence company, the enzyme market is significant and estimated at € 3.4 billion with an annual growth of about 6.5 to 10%. Products such as Maltogenase (amylase) and Lipolase (lipase) were first biotech enzymes marketed in the 80's. While enzymes are present everywhere and come in thousands of different forms, there are still only about 25 of them which have actually been industrialised and commercialised. They include Amylase, Protease, Lipase, Cellulase, Glycomylase, Glucose Isomerase, Chymosin, Lactase, Pullulanase and Xylanase.

Some countries have a better developed enzyme industry than others, so descriptions of these countries and the nature of the environment they provide for upcoming businesses is given in this market review. In some countries, the industry was developed with support from the state from as early as the 1980's. These are countries such as Denmark, USA and Brazil. The real breakthrough in the industry happened during the 1970s. A new technology was developed, recombinant biotechnology, and this permitted biochemists to create and modify molecules at an unprecedented level.

Enzymes are sold in many different industry segments. These segments are Detergents, Food, Feed, Technical, Pharmaceutical, Microorganisms and Biofuel. For example in the feed industry, enzymes help pigs or chickens digest their food better, which in the end helps producing better meat, while using smaller amounts of fodder. These segments are thoroughly described in this enzyme market review, looking at market sizes, growth and, while looking at global and key market drivers for each segment are also identified and analyzed.

Biofuel is dealt with in particular depth, since it is a potentially large segment for the future. The global Biofuel market (biodiesel derived from vegetable oil and ethanol derived from sugar or starch) was estimated to be worth €25 billion in 2007.

Biocatalysis is also more frequently applied by chemical companies, since it is the pertinent technology for the manufacturing of chiral drugs and sometimes for oil-based chemistry substitution. Enzymes are a key element in performing biocatalysis (biocatalysts are in fact enzymes). This means that biocatalysis will probably be a significant segment in the future enzyme market. This promising market segment is difficult to estimate. But we know that this market segment will affect the market of catalysts estimated by CBDM. T® at more than $7 billion."This explains why some enzyme producers such as Novozymes are investing more and more in the development of this field" says Philippe Tramoy, managing partner.

Key players are: Novozymes, Danisco, Genencor, Verenium, Syngenta, Monsanto, Dyadic, Codexis, Cargill, Diversa, ADM, Dow, IEP, DSM, Genzyme, BASF, Altus, Biocon, Henkel, Roche, Sanofi, Solvay, Direvo, Maxygen...

If you need more information about CBDM. T® Enzyme Market Review, please contact us at contact @ cbdmt. com.

CBDM. T® - Market and Business Intelligence (http://www. cbdmt. com) - is a market and business intelligence company with offices in France and in Israel. As an advisory services company, CBDM. T® boosts companies to develop revenue and growth by providing business and marketing services in the life science and biotech markets (market survey, market scouting, business development and strategic supports).

For more information:
CBDM. T® Market and Business Intelligence
88-90 rue de la Mare
Fr-75020 Paris - France
Tel : +33 1 4474 7957
Email : contact @ cbdmt. com
Web site : CBDM. T® (http://www. cbdmt. com)

CBDM. T® - Israel
POBox 6235
Netanya - 42490 - Israel
Tel: +972 52 3316190

###

Visicom corp. Adds new board of advisors members

2011-06-04T22:55:00.000-07:00

Visicom Corp. Adds New Board of Advisors Members

Visicom Corp announces the addition of 5 new members to its Board of Advisors team. The new Board members bring deep skills and a breadth of experience spanning finance, strategy, operations, technology, and rapid growth to the Visicom Corp. leadership team.

Madison, WI (PRWEB) July 24, 2007

Visicom Corp announced today the addition of 5 new members to its Board of Advisors team.

The new Board members bring deep skills and a breadth of experience spanning finance, strategy, operations, technology, and rapid growth to the Visicom Corp. leadership team.

The new Board of Advisors members include:

Laurie Benson, CEO, Inacom Information Systems (Inacom Information Systems (http://www. inacom. com)). Laurie has been CEO for over 20 years, growing Inacom from startup to over $70M in sales and 140 employees in 3 offices. She has served on boards including the Ingram Micro VTN Advisory Board, Microsoft VAR Leadership Council, and the HP Advisory Council. Laurie was inducted into the Ingram VentureTech Network Hall of Fame. She earned a degree from UW-Madison.

Kimberly Hodgkinson, Director of Finance and Operations, Aurora Health Care Ventures, Inc (Aurora Health Care (http://www. aurora. org)). Kim's responsibilities span over 130 retail pharmacies, 20 retail clinics, 10 vision centers, an institutional pharmacy, and mobile imaging for $3B Aurora Health Care. Kim has 15 years of executive leadership experience, and previously served as a senior finance executive with health systems in Fond du Lac, Wisconsin and Grand Rapids, Michigan. She holds both a MBA Administration in Finance and MA in Nuclear Physics from Western Michigan University.

James McCann, CFO, Dedicated Computing (Dedicated Computing (http://www. dedicatedcomputing. com)). Jim has been CFO for Dedicated Computing LLC, a $140M technology hardware manufacturer since 2002. Prior to Dedicated Computing, Jim was the CFO of a consumer products manufacturer, and Controller at a specialty chemical manufacturer. Jim spent 7 years with Arthur Andersen in the audit advisory division. Jim earned his Accounting degree from UW-Madison, and is a licensed CPA.

Gregory L. Sliwicki, President, Berbee Information Networks Corporation (Berbee (http://www. berbee. com)). Greg is currently President of Berbee, and has served in various leadership roles over the last 9 years where he helped lead company growth from $20 million in revenue to over $500 million. Berbee was recently acquired for $183M by $7B CDW Corporation. Prior to joining Berbee, Sliwicki spent 14 years with IBM Corporation. Sliwicki will be responsible for new expansion of Berbee's advanced technology solutions and customer business growth in the current 6 state market they serve. He earned a degree from UW-Madison School of Business.

Peter Zaballos, Vice President, Frazier Technology Ventures (Frazier Technology (http://www. fraziertechnology. com)). Prior to FTV, Peter was Senior Director of Marketing at digital audio and video pioneer RealNetworks, was VP of Marketing at Vivo Software, and held key executive and management roles in sales and marketing spanning more than ten years at FTP Software, C-Cube Microsystems, and LSI Logic. He earned a BS in Electrical Engineering and Computer Science from UC Berkeley, and a MBA from MIT.

Nancy L. Peckham, President, CEO and founder of Visicom Corp. said, "We are extremely pleased to bring on board such a stellar group of individuals. Each and every one of our new Advisory Board members has had a significant and direct impact on the impressive growth of their companies. We are looking forward to learning from the knowledge and experience of this fine group of people to launch us to the next level of growth at Visicom."

Richard D. Janezic, Vice President, Sales & Marketing stated, "We're thrilled and honored to have such an influential advisory team. It's a significant asset to have this level of quality and experience on our board. We welcome them, and look forward to their ideas, wisdom and energy to help propel us in our growth and development. Their vision in strategy, sales, finance, product development and new ventures will benefit both our company and our clients."

J. Jeffrey Poirior, Vice President of Operations, added, "This is an exciting time for our business and our clients. Creating a solid foundation to build our future on will be key to our success. We look forward to the guidance and challenges this board will provide as we continue to grow."

About Visicom Corp.
Visicom Corp., a leader in Enterprise Spend Management (ESM) and Telecom Expense Management (TEM) solutions, helps corporations streamline operations, improve profitability and reduce risk. Visicom's end-to-end solutions provide corporations with a unified method to manage and improve the financial and operational value of wireless, wireline, data, conferencing and network assets from a trusted provider with a single, integrated processing and reporting platform.

In concert with Inview® and now Clearview®, its 3rd generation software solution, Visicom delivers improved cost, control and compliance, deep financial intelligence and sophisticated reporting, and leaner operations. Since 1991, Visicom's services and solutions have earned the trust of more than 600 Fortune™ 2000 clients to achieve greater effectiveness and reduced risk.

From its headquarters in Madison, WI - a Forbes™ top ranked tech corridor - privately held Visicom Corp. serves clients through direct sales and select channel partners. For more information, please visit Visicom Corp (http://www. visicomcorp. com)

For More Information
Richard D. Janezic, VP Sales and Marketing
Visicom Corp.
5940 Seminole Centre Court, Suite 300
Madison, WI 53711
Rjanezic @ visicomcorp. com
608.227.0636

###

Dr’s secret to beauty online store

2011-06-02T17:32:00.000-07:00

DR’s Secret to Beauty Online Store

DR's Secret is the latest anti aging and acne treatment natural skin care product. It was created based on principle of dermatological and nutritional science. DR’s Secret online store bring the beauty closer to you.

Singapore (PRWEB) May 19, 2006

DR's Secret is the latest anti aging and acne treatment natural skin care product. Infused with natural vitamins and minerals, DR’s Secret addresses All skin problems to deliver a younger and healthier look in weeks.

DR's Secret was created based on the principles of dermatological and nutritional science DR's Secret is a Pharmaceutical Grade natural product made in USA based on the principle of 3S concept. It is Simple to use, Safe for all skin types and Speedy to see result. Unlike many other products, result is the main focus of this product, all our customers will see skin improvement after 1 months of application.

DR’s Secret was launched in 2002 and it has more than 100,000 satisfied customer so far in the region. Building on the success of this product, we are expanding our business into global arena. This allows us to build stronger brand and also to bring the best benefit of our product to more consumers.

An online store, DRSecret2U. com, has been launched to bring this great product closer to you.

We believe, DR’s Secret bring natural beauty closer to you.

About DRSecret2U:

We are a direct sale company specialize in beauty care located in Singapore. We are the distributor of our parent company, bwL, which is a public listed company on Singapore Exchange. Our product adheres to stringent quality test and regulation. We won the Singapore Promising Brand Award in 2004.

Contact:

Kok Pin Yang, Founder

DRSecret2U. com

Http://www. drsecret2u. com (http://www. drsecret2u. com)

###

Tpg capital selects metricstream grc platform to boost its internal controls and compliance

2011-06-02T07:03:00.000-07:00

TPG Capital Selects MetricStream GRC Platform to Boost its Internal Controls and Compliance

The comprehensive solution will support compliance and risk management centered on internal and financial controls.

Palo Alto, CA (PRWEB) May 21, 2010

MetricStream, Inc., the market leader in enterprise-wide Governance, Risk and Compliance (GRC) solutions announced today that TPG Capital, a leading private investment firm, has selected the MetricStream GRC platform and solution for internal controls, compliance (http://www. metricstream. com/products/compliance_management. htm) and risk management (http://www. metricstream. com/products/risk_management. htm).

Implementing MetricStream will provide TPG with a well-structured internal control system (http://www. metricstream. com/solution_briefs/Automated_Testing_Internal_%20Controls. htm) to support corporate governance by systematically monitoring and enhancing the efficiency and effectiveness of operational processes, financial reporting, business risks and compliance.

Gaurav Kapoor, CFO and General Manager at MetricStream, says: “We are immensely pleased to have TPG Capital as a customer in the private investment space. The financial services sector is going through major reforms for strengthening governance to ensuring operational efficiency and integrity. MetricStream GRC solutions play a critical role in simplifying compliance with the regulations, reducing business risk while improving business performance.”

About MetricStream
MetricStream is a market leader in Enterprise-wide Governance, Risk, Compliance (GRC) and Quality Solutions for global corporations. MetricStream solutions are used by leading corporations such as Pfizer, Philips, NASDAQ, UBS, SanDisk, BP, Subway, Fairchild Semiconductor, Hitachi and TaylorMade-Adidas Golf in diverse industries such as Pharmaceuticals, Medical Devices, Automotive, Food, High Tech Manufacturing, Energy and Financial Services to manage their quality processes, regulatory and industry-mandated compliance and corporate governance initiatives, as well as by over a million compliance professionals worldwide via the www. ComplianceOnline. com portal. MetricStream is headquartered in Palo Alto, California and can be reached at www. metricstream. com (http://www. metricstream. com).

Media contact: pr(at)metricstream(dot)com

# # #

Hr® pharmaceuticals, inc. To showcase hr® lubricating jelly and hr® clini-clean at the 25th annual american academy of nurse practitioners conference in phoenix, arizona

2011-06-01T05:50:00.000-07:00

HR® Pharmaceuticals, Inc. to Showcase HR® Lubricating Jelly and HR® Clini-Clean at the 25th Annual American Academy of Nurse Practitioners Conference in Phoenix, Arizona

HR® Pharmaceuticals, Inc will meet with Nurse Practitioners & Distributors to present and discuss the newly Kosher Certified; HR® Lubricating Jelly and HR® Clini-Clean.

York, PA (Vocus) June 24, 2010

HR Pharmaceuticals, Inc. will be showcasing its product line at the American Academy of Nurse Practitioners (AANP) Conference from June 25-27, 2010. Nurse practitioners and distributors visiting from around the world can visit HR Pharmaceuticals at booth #1228 at the Phoenix Convention Center in Phoenix, Arizona.

"We are thrilled to be a part of the American Academy of Nurse Practitioners Silver Anniversary Conference. Nurse Practitioners are vital partners to the medical industry; performing high quality primary, acute and specialty healthcare services. We are priveledged to showcase our product to such an esteemed group," said Jon P. Wiesman, CEO of HR Pharmaceuticals, Inc.

AANP was formed in 1985 to provide Nurse Practitioners is the oldest and largest national professional membership organization for nurse practitioners of all specialties. AANP represents the interests of the more than 135,000 Nurse Practitioners currently practicing in the U. S. and continually advocates at local, state, and federal levels for the recognition of Nurse Practitioners as providers of high-quality, cost-effective, and personalized healthcare.

About HR Pharmaceuticals, Inc.

Headquartered in York, PA, HR Pharmaceuticals Inc. manufactures and distributes HR Lubricating Jelly and HR Clini-Clean Hand Sanitizer. Since 1925, HR Lubricating Jelly has been used in a variety of medical applications from surgical & reproductive therapies to the development of the transcutaneous electrical nerve stimulator in the 1950's. HR Lubricating Jelly was first used as the primary echogenic medium for ultrasonic procedures dating back to the early 1960's. HR Lubricating Jelly provides a superior echogenic medium for imaging soft tissues such as muscles and/or tendons achieving exceptional results. HR Clini-Clean Hand Sanitizer is an alcohol free, dye free, hypo-allergenic and non-toxic hand sanitizer making it more effective and less harmful than alcohol based sanitizers. The active ingredient benzalkonium chloride (BZK) is an alcohol-free antimicrobial compound that has been widely used in hospitals for more that 60 years. BZK offers a broad-spectrum kill against bacteria, viruses and fungi. Laboratory studies have proven that BZK antimicrobial intensity is superior while leaving natural skin oils and micro-flora intact. All HR(r) branded products are manufactured in the USA under the scrutiny of the FDA; we are an ISO 9001:2008 and ISO 13485:2003 compliant company, dedicated to meeting the most stringent of quality assurance. We source the best pharmaceutical grade ingredients followed by a production profile in accordance with the requirements of 21 CFR Part 820, Good Manufacturing Practices - cGMP & Quality Systems Requirements (QRS) for Medical Devices.

For more information about HR Pharmaceuticals, Inc. visit http://www. hrpharma. com

# # #

Search engine marketing firm iprospect taps kaminski for c-level spot

2011-05-31T03:08:00.000-07:00

Search Engine Marketing Firm iProspect Taps Kaminski for C-Level Spot

IProspect elevates long-time company veteran to COO and hires new MD for San Francisco office

Boston, MA (PRWEB) March 30, 2010

iProspect, the Original Search Engine Marketing Firm, announced today that it has promoted Brian Kaminski (http://www. iprospect. com/corporate/brian-kaminski. htm) to Chief Operating Officer, and has hired Melanie Lowe (http://www. iprospect. com/corporate/melanie-lowe. htm) to be Managing Director of iProspect San Francisco. Both moves are in response to the company's continued strong growth.

An iProspect veteran for over a decade, Kaminski has significantly contributed to the organization's growth and has steadily moved up the ranks during his tenure. Starting in 2000 as a Campaign Analyst, Kaminski quickly distinguished himself and was promoted to Client Services Manager. Given his ability to consistently deliver impressive results for clients, Kaminski went on to become Client Services Director. Throughout his career at the company, he has been adept at building teams and developing policies and procedures to ensure that it continues to innovate and achieve superior results. In 2006 he was tapped to establish a West Coast office, and as Managing Director of iProspect San Francisco, Kaminski has been the driving force behind its impressive growth over the past four years. In 2008, he was named Executive Vice President.

In his new role as Chief Operating Officer, Kaminski will oversee client services and technology for iProspect's entire U. S. operation. A key member of the Executive Committee, Kaminski will also play a role in driving corporate strategy.

"From the very beginning, Brian set himself apart from the pack," said Robert Murray, CEO, iProspect. "In fact, not only was Brian our very first manager, he was so good, that we actually modeled our hiring profile to mirror the qualities he possessed." Murray continued, "Without question, Brian has had a significant impact on the development of the company and continues to do so today. Over the years he has proven himself time and again, and this promotion is a fitting recognition for all that he has accomplished. I know he is ready for the challenges of his new role, and I am confident he will more than deliver."

To build upon the success that Kaminski started on the West Coast, iProspect has hired Melanie Lowe as the new Managing Director of the San Francisco office. A seasoned digital executive with 20 years of experience, Lowe has worked in marketing and management roles in Asia, Europe, Canada, and the U. S. in various sectors, including technology, real estate, pharmaceutical, retail, entertainment, and tourism. She comes to iProspect from sister agency Molecular (http://www. molecular. com/), which is also part of the Aegis Media (http://www. aemedia. com/aegis-group-plc. php) network of best of breed digital agencies. At Molecular since 2007, Lowe most recently held the position of Vice President and Managing Director of its San Francisco operation. Previously, she held various management roles at Ion Global for eight years where she was responsible for leading multi-disciplinary teams to develop digital solutions for clients. Ion Global was acquired by Aegis in 2007.

In her new role as Managing Director of iProspect San Francisco, Lowe will oversee the company's West Coast operation, ensure that client campaigns are strategically led and successfully integrated across marketing channels, and keep client services teams focused on innovation and successful execution. She will also participate in the Executive Committee.

"Melanie is a seasoned digital executive who brings a wealth of knowledge and talent to the table," said Murray. "Given her years of experience in client-facing positions and managing Molecular's San Francisco office, she is well suited to take on the challenges of the MD role. We are delighted to have her onboard, and I know our clients will greatly benefit from her extensive digital marketing experience."

About iProspect
IProspect is the Original Search Engine Marketing Firm. The company helps many of the world's most successful brands maximize their online marketing ROI through natural search engine optimization (http://www. iprospect. com/services/search-engine-optimization-service. htm), pay per click advertising management (http://www. iprospect. com/services/pay-per-click-management-service. htm), online display advertising management (http://www. iprospect. com/services/online-display-advertising-service. htm), shopping feed management (http://www. iprospect. com/services/feed-management-service. htm), search leveraged public relations (http://www. iprospect. com/services/search-leveraged-public-relations-service. htm), and numerous other related services. By dramatically increasing business results for clients, iProspect helps to create search marketing heroes every day. With U. S. offices in Boston, San Francisco, Chicago and Dallas-Ft. Worth, as well as global search engine marketing offices (http://global. iprospect. com/), iProspect can be contacted at 1-800-522-1152, interest@iprospect. com, or by visiting www. iprospect. com.

Questions regarding this release should be directed to iProspect Director of Communications, Colleen Reed, at 1-800-522-1152 x4172 or colleen. reed@iprospect. com.

###

Efolder's jan spring recognized by everything channel's crn magazine as one of the top 100 women in the channel

2011-05-30T11:57:00.000-07:00

EFolder's Jan Spring Recognized by Everything Channel's CRN Magazine as One of the Top 100 Women in the Channel

Everything Channel's CRN Magazine has selected eFolder's Jan Spring, VP Channel Development, as one of the Top 100 Women in the Channel. The Top 100 Women in the Channel were chosen by the editors of the magazine based on their achievements as executives and the amount of influence they wield over the technology channel.

Atlanta, GA (PRWEB) September 9, 2009

eFolder, Inc, today announced that Jan Spring, VP Channel Development, has been recognized by Everything Channel's CRN Magazine as one of the Top 100 Women in the Channel. The Top 100 Women in the Channel were chosen by the editors of the magazine based on their achievements as executives and the amount of influence they wield over the technology channel. The Top 100 Women in the Channel represent a changing trend in a traditionally all male industry.

Jan Spring is VP of Channel Development for eFolder, Inc. and is responsible for building the solution provider channel for the company's award winning online backup (http://www. efolder. net/overview), local backup, and email archiving services. Since her arrival in 2006, eFolder has captured numerous channel accolades, including CompTIA conference awards, CRN's 2007 50 Emerging Vendors, Emerging Tech Dynamo and most recently, "25 Coolest Emerging Vendors of 2009."

Jan has extensive experience in IT solutions sales and technology channel building with several organizations. She founded The Chaparral Group in 1992, was VP of Sales at SafeNET, Inc, and previously served as VP of Sales for Computone Systems.

"We are very pleased to see women executives reaching the highest levels in a wide range of dynamic companies. It is with great pleasure that we honor the women that have made a significant impact in the technology marketplace. We offer our congratulations to Jan for her significant contributions to our industry," said Robert C. DeMarzo, senior vice president and editorial director, Everything Channel.

William E. Gross, CPA, Treasurer and Co-Founder of eFolder, Inc., said, "Jan is consistently the most productive salesperson I have ever worked with!" According to Kevin Hoffman, CTO of eFolder Inc., "Jan is passionate in everything that she does and has an extraordinary work ethic. She brings experience and energy to both eFolder and the channel at large--we are excited to have her on our team."

A special feature of the Top 100 Women of the Channel was included in the August issue of CRN Magazine. Expanded coverage is available online at channelweb. com.

About eFolder, Inc. (efolder. net)
EFolder offers brandable backup (http://www. efolder. net/) and email archiving services exclusively through the channel via software-as-a-service (SaaS), and has been in the data protection business for almost eight years. eFolder has developed and owns the intellectual property of backup technologies that many refer to as "The Gold Standard" in the backup business, providing superior efficiency, reliability, and silent data corruption protection. The award winning software is an easy fit into Managed Services practices, with its centralized web-based monitoring and instant provisioning capabilities, and the exclusive partner program model provides a 30% to 80% monthly recurring profit margin. eFolder offers customized training programs and unlimited partner support. eFolder is committed to its partners, viewing each partnership more like a business partnership where success is mutually dependent, rather than following the traditional vendor--reseller relationship model.

Everything Channel (everythingchannel. com, channelweb. com)
Everything Channel is the one-stop shop for managing and accelerating technology sales. From branding and recruiting to marketing and sales, Everything Channel offers technology marketers the unmatched breadth and depth of global brands and market intelligence combined with unparalleled audience loyalty and credibility serving all technology sales channels through an extensive database. Everything Channel provides innovative field sales and marketing solutions to arm the sellers of technology with the resources they need to achieve measurable and significant results.

About United Business Media Limited (unitedbusinessmedia. com)
UBM (UBM. L) focuses on two principal activities: worldwide information distribution, targeting and monitoring; and, the development and monetization of B2B communities and markets. UBM's businesses inform markets and serve professional commercial communities - from doctors to game developers, from journalists to jewelry traders, from farmers to pharmacists - with integrated events, online, print and business information products. Our 6,500 staff in more than 30 countries are organized into specialist teams that serve these communities, bringing buyers and sellers together, helping them to do business and their markets to work effectively and efficiently.

###

Spanning 18 countries and 41 industries, the 2006 rebrand 100™ award winners show the world how rebranding is done

2011-05-27T21:28:00.000-07:00

Spanning 18 Countries and 41 Industries, the 2006 ReBrand 100™ Award Winners Show the World How Rebranding is Done

View the complete winners list at www. rebrand. com: • Aspreva Pharmaceuticals re-articulated its global brand • Autodesk built its brand promise into every customer interaction • Croatian National Tourist Board’s rebrand boosted tourism • Four Seasons Hotels and Resorts’ rebranded website is preferred by 90% of users researched • Yum! Brands KFC's rebranded store drove sales up 50% • The New School’s rebrand boosted enrollments in New York • Prostate Cancer Foundation grew its donor base 35% • Swiss Life’s global rebrand was a key factor in its successful turnaround

Providence, RI (PRWEB) May 15, 2006

One hundred of the world’s most dynamic and refreshing rebrands are winners in the 2006 ReBrand 100™ Global Awards announced today. Representing 18 countries and 41 industries as diverse as pharmaceuticals, financial services, technology and tourism, the 2006 winners exemplify the best in rebranding strategy and design execution across the globe. An international panel converged in Providence, Rhode Island, to jury the second annual competition.

“ReBrand 100 recognizes the incredibly complex and successful rebranding efforts that drive businesses forward,” said Anaezi Modu, Director, ReBrand. “Differentiating and articulating brand experiences in today’s global economy is no easy task. We all stand to learn from the customer-centric approaches, methods, insights and best practices of the 2006 ReBrand 100 winners.”

Winning rebrands serve as inspiration and learning tools by becoming part of an online repository at www. rebrand. com, the only source for case studies and programs focused on effective rebrands.

“A critical success factor in rebranding is the clear distillation and understanding of the core brand equity, and building on it in a fresh, unexpected manner,” said Lorrie Browning, General Manager, Infant/Preschool Brands at Hasbro and 2006 ReBrand 100 juror. “The 2006 winning organizations all demonstrated this insight, and through creative and innovative design met the challenge for successful rebranding.”

The jury reviewed the “before” and “after” scenarios of each brand transformation -- a process unique among marketing, design and business award competitions. They then assessed them against the following criteria to ensure that winning rebrands:

had a clear transformation for the better in meeting strategic objectives; exceeded expectations and/or incorporated an element of surprise; spurred an emotional connection in the target audience; and were intelligently executed and capable of implementation organization-wide.

Eligible projects consisted of rebranded products, services, companies, non-profit organizations, individuals, cities, countries, buildings and interior environments launched anywhere in the world between January 2003 and September 2005. Winning rebrands range from a single brand component such as a website or packaging, to enterprise-wide initiatives.

About ReBrand 100™

The ReBrand 100™ Global Awards recognize the world’s most effective rebrands: the repositioning, revitalizing and redesign of existing brand assets to meet strategic goals. Organized by ReBrand™, the only source for case studies and programs focused on effective rebrands, ReBrand 100 is directed by Anaezi Modu and juried each year by an international panel. The Center for Design & Business is a founding sponsor of ReBrand 100. The 2007 ReBrand 100 entry deadline is September 27, 2006.

For entry and sponsorship information, and to learn best practices from winning case studies, visit www. rebrand. com.

All trademarks, service marks and company names are the property of their respective owners.

Contact:

Karin Pespisa

978-897-3994

# # #

New capsure™ cleanroom wiper from berkshire corporation captures and retains 42 times more contaminant particles

2011-05-25T19:47:00.000-07:00

New CapSure™ Cleanroom Wiper from Berkshire Corporation Captures and Retains 42 Times More Contaminant Particles

Berkshire Corporation, a leading global manufacturer of contamination control products, introduces CapSure™ Technology, advancing the performance of cleanroom wipers on particle capture and retention.

Great Barrington, MA (PRWEB) October 6, 2009

Berkshire Corporation, a manufacturer of contamination control products for cleanroom and critical environments, introduces CapSure™, a patent pending technology that enhances the cleaning performance of critical environment wipers.

The CapSure™ Technology (http://www. berkshire. com/capsure_cleanroom_wiper. shtml) features an innovative process that enables wipers to capture and retain more contaminant particles to provide a more effective wipe and reduce the risk of recontamination. A breakthrough in wiper technology, a clean CapSure™ wiper maintains the environment by releasing 80% fewer airborne particles than other wipers. The wipe captures up to 42 times more surface contaminant particles and will retain up to 93% of these particles.

CapSure™ polyester wipers are designed for use in ISO Class 3-5 (Cleanroom Class 1-100) and are recommended for pharmaceutical, biotech, medical device, laboratory, electronics, semiconductor, and other life science applications.

About Berkshire Corporation

Berkshire is the global leader in the engineering and manufacturing of contamination control products for cleanrooms and critical environments worldwide. Global technical specialists assess specific process needs and bring qualified solutions to the most critical application. For more information, visit the company's website at www. berkshire. com.

Contact: Berkshire Corporation
Phone:
1.800.242.7000
1.413.528.2602
Fax:
1.336.446.0156
E-mail: csr(at)berkshire. com

###

Ephedrine affordable to all: asthma sufferers breathe easier

2011-05-24T19:39:00.000-07:00

Ephedrine Affordable to All: Asthma Sufferers Breathe Easier

Asthma Sufferers Breathe Easier

Greensboro, NC (PRWEB) December 18, 2007

The over-the-counter drug ephedrine is now available at a cheaper and more affordable price to those who are suffering from asthma. Biotek Pharmaceuticals, an online FDA and DEA regulated company selling over-the-counter drugs and dietary supplements, is one of the first to offer maximum strength ephedrine at $11.99.

Ephedrine, which is made of the active ingredients ephedrine hydrochloride and guaifenesin, is a common over-the-counter drug treating the symptoms of asthma. Shortness of breath, phlegm, wheezing and chest tightness will all disappear when those diagnosed with asthma take maximum strength ephedrine.

Ephedrine should be used only for people who have asthma and who want to stop suffering from the symptoms of asthma. It should be used only if the a doctor has approved the use of the substance.

"If you're looking for fast-acting relief from wheezing, shortness of breath, chest tightness and phlegm, then maximum strength ephedrine is the product for you," says Biotekpharm. com. "With its dual action formula of ephedrine and guaifenesin, maximum strength ephedrine has just the right ingredients to make breathing easier and to relieve asthma. Maximum strength ephedrine will help you breathe easier faster!"

About Biotek Pharmaceuticals:

Biotek Pharmaceuticals, Inc. specializes in over-the-counter drugs and dietary supplements focusing on the health conscious consumer. They offer a wide selection of both over-the-counter drugs and dietary supplements of the highest quality. Biotek is a FDA and DEA regulated company.

For more information about Biotek Pharmaceuticals please visit BiotekPharm. com.

###

World diabetes day 2003 type 1 diabetes in children Â same diagnosis, different prognosis

2011-05-24T08:09:00.000-07:00

World Diabetes Day 2003 Type 1 diabetes in children Â same diagnosis, different prognosis

The International Insulin Foundation (IIF) would like to draw attention to the plight of people, especially children, in the developing world with insulin requiring diabetes.

(PRWEB) November 7, 2003

London, United Kingdom.(PRWEB) 5 November 2003 Â The International Insulin Foundation (IIF) would like to draw attention to the plight of people, especially children, in the developing world with insulin requiring diabetes.

November 14th 2003 marks the fourteenth annual World Diabetes Day. Diabetes is a chronic condition that affects people of all ages in all areas of the world. Inadequate care can lead to serious health complications such as blindness, kidney failure, neuropathy (degeneration of nerves and nervous system), amputation, heart attacks and death.

Type 1 diabetes is caused by a process which destroys insulin producing cells in the pancreas. Insulin is vital for the survival of patients suffering from Type 1 diabetes and must be administered daily throughout the life of the patient by injection. The International Diabetes Federation estimates that there are 5.3 million people world-wide who suffer from Type 1 diabetes, and thus require insulin every day.

The first patient to be treated with insulin was a Canadian child by the name of Leonard Thompson in 1922. Over 80 years after the first patient received this life saving treatment many people with diabetes in the developing world still have difficulties accessing insulin. This leads to a life expectancy which can be as low as 12 months for a child in rural sub-Saharan Africa compared to over 50-60 years for a child in Europe.

The stories below highlight the contrasting challenges that two children face:

My name is Mary and I live in the capital city of Zambia. I am 15 years old now. When I was 11 years old, I was admitted to a local health centre and was diagnosed as having malaria. After a few days I wasnÂt getting any better so I was sent to the main teaching hospital. After a long time there a doctor diagnosed diabetes.

My family has an income of about Â£91 per month. Sometimes my family need to spend as much as Â£42 if I have to go into hospital.

I now attend a free diabetes clinic held once a week at the main teaching hospital. I tend to go about once a month for a check up and to get my insulin. They also test my blood sugar, as I do not have a machine or testing strips at home as these are too expensive. When I go I need to miss school as the clinic takes place during school hours and it takes me over an hour to get there. I need to take a bus there. It costs about Â£1.00 to get from my home to the clinic and back. Sometimes when money is a problem I canÂt go to the clinic. But I am lucky living in the capital. If I lived in the rural areas I might have to travel up to 100km to a hospital and I would not be able to afford this more than once a year. And I know that these hospitals are often out of insulin.

I was able to attend a Youth Camp organised by the Diabetes Association in my country. I learnt a lot about my disease, how to inject myself, the foods I should and shouldnÂt eat. And also had a chance to meet other children with the same condition as me.

I am lucky to get my insulin for free at the pharmacy, but sometimes it is out of stock so then I have to buy it at a private pharmacy and this can cost as much as Â£12 for a bottle Â which lasts about a month. The hospital pharmacy hardly ever has any special insulin syringes so if I am lucky I get them free from nurses and doctors working in the intensive care unit. Most of the time though I have to pay Â£1.40 for a monthÂs supply of syringes. Even though these are meant to be used just once, I use them for a week or two depending on how much money my family has. My family does not have a fridge so my insulin is kept in a clay pot with water under my bed.

The hardest part of my treatment is injecting myself every day and not being able to enjoy the same foods as my family and friends. I worry if we donÂt have enough money for insulin. We are 8 at home and a lot of money is spent on my care and they also worry about me too much.

My name is Tom and I am 14. I have had diabetes for 2 years now and live on the outskirts of London. My GP referred me to the Hospital after I was found to be drinking a lot, passing a lot of urine and losing weight. He did a blood test in the surgery and it was then that I found out I had diabetes.

Every 3 months I attend a consultation with a diabetes specialist nurse and we go through any problems I have. If ever I have any problems I can phone her and get an appointment or she can sort things out on the phone. The nurse has also spoken to my teacher and the school nurse so they understand my diabetes and what I need at school. I am lucky as the NHS provides all my care for free and the Hospital is just a bus ride away or my Mum takes me there by car.

Last year I went to the Diabetes Care camp and had a great time doing lots of adventure stuff with other kids with diabetes. I really learnt how to monitor my blood and change my insulin.

I get my insulin and pen for injections for free. I also have a machine for testing my blood sugar so I can change the amount of insulin I need if I have a big meal or do sports.

Besides remembering to do regular blood tests, not being able to eat all the foods I like all the time and that my mum worries about me too much, I lead a normal life.

About the IIF:

The IIF is a UK Registered Charity (Registered Charity No. 10999032), established by leading academics and physicians in the field of diabetes with the aim of prolonging the life and promoting the health of people with diabetes in developing countries by improving the supply of insulin and education in its use.

To achieve this the Foundation has carried out fieldwork in both Mozambique and Zambia, where it is currently collaborating with the national diabetes associations and governments to improve the conditions faced by people with diabetes.

###

If you would like the discuss the opportunity of interviewing a child with type 1 diabetes in Zambia and in the UK, or for more information, please contact:

David Beran

International Insulin Foundation

Diabetes and Cardiovascular Disease Academic Unit

Royal Free and University College Medical School

The Archway Campus

Holborn Union Building

2-10 Highgate Hill

London N19 5LW

United Kingdom

Tel: +44 (0)207 288 3382

Fax: +44 (0)207 288 3382

E-mail: david. beran@access2insulin. org

Website: www. access2insulin. org

Wireless patriot polling system now available to u. S. Markets

2011-05-24T05:04:00.000-07:00

Wireless Patriot Polling System Now Available to U. S. Markets

TEMPE, ARIZONA (PRWEB) September 8, 2005

Named the ÂWireless Patriot Polling System,Â a new wireless voting system is now being marketed to government agencies for public hearing, school districts, public safety, and town-hall meetings.

This type of system has been used in New York for a 5000 person vote to help rebuild the grounds of the World Trade Center after the 9/11 attacks. Now, a live event producer has designed a system that will allow anonymous voters and a live audience the ability to view images, videos and even PDF documentation during the voting process, making the process uncomplicated for an individual to clearly understand what they are voting for.

This product is important in that it collects polling data while simultaneously allowing a live audience to see the data being accurately collected. Pharmaceutical companies have been using this data collection method at continuing medical education meetings, symposia events, and new product launches to help them determine research and marketing strategies for their products.

###

Palo: business intelligence for openoffice. Org

2011-05-23T07:04:00.000-07:00

Palo: Business Intelligence for OpenOffice. org

The Open-Source companies Jedox GmbH and Tensegrity GmbH, the Chemnitz University of Technology and the Australian company De Bortoli Wines started a cooperation for the development of a Business Intelligence Add-In for OpenOffice. org. They now seek additional sponsors to start the project.

Wildorado, TX (PRWEB) January 31, 2007

A combination of Spreadsheet-Software plus a capable server for Business Intelligence and OLAP becomes more and more popular. While Microsoft offers the combination of MS Office and Office PerformancePoint Server as a comprehensive BI solution, there is a sophisticated and free alternative: the Open Source based Palo Server. For Palo version 1.5 there already is a free Add-In available which helps convert Excel 200, XP, 2003 and 2007 into a server based solution for analysis and planning.

More and more companies are realizing the value of using Open Source software in the enterprise. Since Palo was launched around a year ago, this Open Source product has not only been embraced by a large number of individual users, but also various larger organizations, such as the German Chamber of Commerce (Deutscher Industrie - und Handelskammertag), ALTANA Pharma Germany and now also De Bortoli Wines, one of Australia's larger privately owned companies.

De Bortoli Wines are now going a step further. After IT head Bill Robertson learned that German software producer Jedox is ready to develop an Add-In for the OpenOffice. org spreadsheet module Calc, De Bortoli opted to be the first company on the list of sponsors to support this project. De Bortoli makes wide use of Open Source software and have previously sponsored a small number of select Open Source projects. As strong believers in Open Standards, De Bortoli Wines standardisation on the Open Document File format (ISO/IEC 26300) for Office Applications has been a strategic reason behind their adoption of OpenOffice.

The Palo Add-In for OpenCalc will be finalized as soon as a few more sponsors have committed to contribute to the new project. Further information about sponsoring options can be found under www. palo. net.

About Jedox: The Freiburg (Germany) based software manufacturer is the leading supplier for Enterprise Spreadsheet solutions (www. jedox. com). Their commercial product Worksheet-Server allows to convert Excel spreadsheets into web based browser applications on a mouse click.

Note: Office, Excel, Microsoft, Office PerformancePoint Server are trademarks or registered trademarks of Microsoft Corporation.

###

Kistler-morse has just signed a contract with falcon-software's falcongrafx division for the redesign of their corporate company websites

2011-05-22T22:50:00.000-07:00

Kistler-Morse has just signed a contract with Falcon-Software's FalconGrafx division for the redesign of their corporate company websites

Victoria, BC Canada (PRWEB) December 20, 2003

Falcon-Software Company's FalconGrafx division today announced a contract agreement for the development of a new business website for Kistler-Morse, headquartered in Bothell, Washington. The project will include product catalog development, workgroup secure area systems, dynamic content management with sales & distribution application tools.

Kistler-Morse (www. kmcorp. com) has been designing and manufacturing premier weight, level and batching measurement solutions for Bulk and In-Process industries around the world. Kistler-Morse's work is found throughout the food, personal care, pharmaceutical/biotech and chemical industries, in virtually every kind of bin, silo, blender and tank.

Falcon-Software Company is a leading web design and animation firm specializing in web based solutions for companies across North America. Falcon-Software delivers a powerfully effective range of strategic and creative services, including award-winning design, e-Business applications and multimedia animation production.

###

For Additional Information: Natalie Frank

Public Relations

Tel: 250-480-1311

Email: Natalie Evans

Pharmaceutical companies are implementing new pathway-based technologies and strategies in their r&d programs

2011-05-18T20:19:00.000-07:00

Pharmaceutical Companies are Implementing New Pathway-Based Technologies and Strategies in Their R&D Programs

Research and Markets (researchandmarkets. com/reports/c38484) has announced the addition of the new report from Decision Resources, Inc “Can Pathway-Based Approaches Overcome the Problems of Target-Based Drug Discovery?” to their offering.

Dublin (PRWEB) June 22, 2006

Research and Markets (http://www. researchandmarkets. com/reports/c38484 (http://www. researchandmarkets. com/reports/c38484)) has announced the addition of the new report from Decision Resources, Inc “Can Pathway-Based Approaches Overcome the Problems of Target-Based Drug Discovery?” to their offering.

After the human genome was sequenced, pharmaceutical and biotechnology companies hoped that their enormous investment in drug discovery and development programs--$51.3 billion in 2005--would yield higher R&D productivity. However, the industry’s target-based research approach has failed to generate many drugs that work via novel mechanisms of action, and drugs that fail late in clinical trials significantly drive up the overall cost of drug development. Companies are now re-evaluating their drug discovery research strategies, implementing or considering a shift to a pathway-based approach in the hopes of unlocking the promise of genomics-based drug discovery. By studying the routes by which drugs act on a system (i. e., a signalling pathway or network) rather than simply scrutinizing a specific target, companies hope to better understand how a disease progresses, which they hope will in turn lead to better-designed and more effective therapeutic strategies.

In this report, Decision Resources Inc discuss recent progress in pathway-based drug discovery. They review studies aimed at expanding researchers’ knowledge of key pathways and those that use whole-pathway screening methods. Decision Resources Inc also highlight the application of pathway-based methods to drug discovery and translational medicine and discuss the impact of pathway-based strategies on pharmaceutical R&D.

Business Implications

In the post-genomic era, target-based drug discovery has been less productive than the pharmaceutical industry companies had hoped. In contrast, discovery based on the study of intracellular signalling pathways, mostly based on academic research, has been a successful post-genomic drug discovery strategy. This approach has yielded, for example, a proliferation of kinase inhibitors for cancer treatment.

Drug companies are interested in expanding their knowledge of pathways to identify large numbers of proprietary, validated targets and in assessing the impact of drugs on pathways. These needs have fuelled the development of novel pathway expansion and whole-pathway cellular assay technologies. Companies active in these areas include BioImage, Bionaut Pharmaceuticals, BioSeek, Cellzome, and Hybrigenics.

Pharmaceutical companies are implementing new pathway-based technologies and strategies in their R&D programs. Novartis is leading the way in this arena and has restructured its entire R&D program around pathways. Although no other big pharma has so thoroughly reoriented its research strategy around pathways, interest in these approaches is spreading throughout the industry.

Drug candidates arising from new pathway studies are still in the research and preclinical stages. Until companies obtain proof-of-concept of these drugs in human clinical trials, the success of the new pathway-based paradigms of drug discovery remains unknown. Nevertheless, Decision Resources Inc expects that new pathway-based technologies and strategies will penetrate the pharmaceutical industry in the next several years.

Key Topics Covered Include:

The Success of Traditional Pathway Studies The Need for New Pathway-Based Knowledge and Approaches Tandem Affinity Purification Hybrigenics’ Study of Signal Transduction Pathways in Drosophila Pathway-Based Drug Screening Technologies and Strategies Outlook for Pathway-Based Drug Discovery

For more information visit http://www. researchandmarkets. com/reports/c38484 (http://www. researchandmarkets. com/reports/c38484)
Source: Decision Resources, Inc

Laura Wood

Senior Manager

Research and Markets

Fax: +353 1 4100 980

###

Are we poisoning our seniors?

2011-05-17T03:19:00.000-07:00

Are We Poisoning Our Seniors?

Accidental poisoning of seniors is a silent epidemic plaguing our generation of elderly. It is important to know the hazards and safety practices involved with medications.

(PRWEB) March 12, 2004

Accidental poisoning of seniors is a silent epidemic plaguing our generation of elderly. Many medications, which are beneficial to others, are inappropriate for seniors and can be deadly if taken in combination with other remedies. Over-the-counter medications, vitamins, herbs, sedatives, antidepressants, pain medication and even prescription medications can cause adverse drug reactions and side effects resulting in fatal or life-threatening injuries.

Frequently, the reactions to these medications include dizziness, instability with walking, falling, and disorientation or confusion. These signs are often dismissed simply as the consequences of growing older, or as symptoms of another disease which may result in additional medications being prescribed. The following are measures that seniors and their families can take to avoid a potential problem:

1. Make sure the individual can read the medication labels. Often they attempt to do so without their glasses or in the dark, causing mistakes in taking the correct medication or dose of medication.

2. A record of all medications, along with the dose and time they are supposed to be taken, should be kept and updated frequently. Include all over-the-counter drugs and all prescribed medications from each physician the individual sees for care. This record should be taken to each doctorÂs visit to assist with the coordination of care.

3. Store all medications in the original containers and in the same area. Seniors often reach for a medication in a Âfamiliar locationÂ and if it has been moved from its usual place, they may accidentally pick something else up by mistake. This will also eliminate the potential for outdated drugs to accumulate and inadvertently be taken.

4. Choose an individual to coordinate and manage the care of the senior with all of the doctors that they see and the medications they take and select a single pharmacy to fill all prescriptions. Often times a family member or reliable friend can assist in this process, or you can hire a consulting pharmacist or a geriatric care manager to assist.

5. Search the web for general information on medications and drug interactions or expected geriatric reactions. Some examples of websites that can help include: www. ccgp. org, www. drugdigest. org, www. webmd. com and www. seniorcarepharmacist. com.

Make certain the senior understands that misusing medications is a leading cause of death in their age group. Taking a variety of different prescriptions may be necessary in a handful of patients. However, for the majority of seniors, a good diet and daily exercise can play key roles in helping to keep them healthy.

Sue Ellen Engelman has been assisting area families throughout the Wilkes-Barre/Scranton area since the beginning of 2001 as the owner of Comfort Keepers in Luzerne/Lackawanna counties. Comfort Keepers offers companionship and other non-medical services for aging adults, new mothers and others needing assistance. In-home services include companionship, meal preparation, light housekeeping, grocery shopping, transportation and more. Comfort Keepers does not utilize independent contractors. All caregivers are hired employees who are carefully screened, bonded and insured.

If you are in need of assistance or are interested in learning more about Comfort Keepers, please call (570) 474-9100 or visit www. comfortkeepers. com.

By: Sue Ellen Engelman

Proactive strategic intelligence of greece and cyprus joins the global intelligence alliance, already a network of 60 professional ci companies

2011-05-15T09:28:00.000-07:00

Proactive Strategic Intelligence of Greece and Cyprus Joins the Global Intelligence Alliance, Already a Network of 60 Professional CI Companies

The Global Intelligence Alliance (GIA, globalintelligence. com) is pleased to announce that the leading Athens-based Competitive Intelligence (CI) company Proactive Strategic Intelligence Ltd., (psiworldwide. biz) is the latest addition to the group of GIA Member companies, a global network of professional CI and business research providers.

(PRWEB) February 24, 2005

Harry Stavrinides, a Partner of Proactive Strategic Intelligence Ltd., says: ÂWe welcome this partnership and view it as a challenge in utilising our profound expertise in specific industries, such as IT & Telecommunications, FMCG, Industrial Technologies, Transportation, and Energy and Utilities, to provide high quality services in our region to current and prospective GIA clients around the globe. At the same time, we empower our own clients with an access to the extensive global presence and valuable services of the GIA network. As Corporate Research, Competitive Intelligence and Strategic Planning Business Advisors, we are focusing on the geographical regions of Central & Eastern Europe, Caspian, Black Sea and Middle East countries, through our local hubs in Athens, Greece and Nicosia, Cyprus.Â

Hans Hedin, the GIA Coordinator says: "We are very happy to welcome PSI to the rapidly expanding network of GIA Member companies. With PSIÂs GIA Membership, our clients already have ten local access points around the globe to the services of our network of 60 professional CI and business research companies.Â

Since the 1st of September 2004, Proactive Strategic Intelligence Ltd., is also a regional distributor of the Viva Intelligence PortalÂ, a CI software tool of Novintel, the founding Member of the Global Intelligence Alliance.

For more information, please contact

Hans Hedin (hans. hedin@globalintelligence. com)

Tel: + 46 735 340 173

Harry Stavrinides (hstavrinides@psiworldwide. biz)

Tel. +30 69 48 50 27 14

About the Global Intelligence Alliance

The Global Intelligence Alliance (GIA, www. globalintelligence. com) is a global network of professional Competitive Intelligence companies. Leveraging its world-wide reach, the GIA provides multi-national organizations with a single source for all CI requirements including: process consulting; intelligence services; training; and leading technology solutions.

About Proactive Strategic Intelligence Ltd.

PSI Proactive Strategic Intelligence Ltd (www. psiworldwide. biz)., is a premier Business Advisory professional firm and expert Technology Assessor and Solutions Provider, focusing on the geographical regions of Central & Eastern Europe, Caspian and Black Sea and Middle East counties. Currently, our network of advisors and subject matter experts covers more than 20 countries and involves more than 40 specialised associates. As Business Advisors, we specialise on Strategic Planning, Corporate Research, Competitive Intelligence and Knowledge Management Services & Solutions. PSI Partners and senior Executives are experts in Communication, Information Technology and Strategic Business Development, with extensive, hands on experience in multinational organisations and large regional corporations, in the industries of Telecommunications, Information Technology, Electronics, Mass Media, FMCG, Pharmaceutical and Healthcare, Energy and Utilities.

###

Unique split-architecture device coupler system doubles number of intrinsically safe (is) devices for hazardous environments

2011-05-14T11:02:00.000-07:00

Unique Split-Architecture Device Coupler System Doubles Number Of Intrinsically Safe (IS) Devices For Hazardous Environments

Expanded fieldbus process control comes to the pharmaceutical industry.

North Hills, CA (PRWEB) December 15, 2005

For two decades, distributed control systems (DCS) have enabled pharmaceutical plants to exercise precise control over their processes, especially given the more efficient communication protocols such as FOUNDATION fieldbus. However, limitations in installing multiple sensor and other control devices in hazardous environments have traditionally stymied pharmaceutical engineers and DCS integrators in their efforts to maintain tight control.

Now, a new split architecture approach developed by engineers at MooreHawke -- a division of Moore Industries-International, in North Hills, California--goes beyond traditional FISCO (Foundation Intrinsically Safe Concept) operating parameters with a full 350mA per segment; enough to drive up to 16 devices -- while still being intrinsically safe for hydrogen at the individual spur connection. Subsequently approved by the FM (US) and SIRA (ATEX) certifying organizations, this approach uses a field-mounted device coupler (http://www. miinet. com), and associated power supply with a safe-area interface.

“To get the most bang for the buck during our last expansion we utilized the MooreHawke RouteMaster system of power supplies and device couplers within our DeltaV DCS,” says John Hutto, Instrumentation & Control engineer for Boehringer Ingelheim Fine Chemicals in Petersburg, Virginia -- part of the Boehringer Ingelheim group of companies, one of the world’s leading pharmaceutical corporations.

“Our plant has a fair amount of drums that hold flammables and open manways on reactors, and while we try to keep everything closed, there are certain instances where you need to manually have a flammable open to the air for a short time -- that makes the area a Class 1, Division 1 area,” says Hutto.

The RoutemasterTM system “enabled us to get in the neighborhood of up to eight devices per segment,” he says. We could have gotten even more, but we like to limit our devices to those that are part of the same control loop or system, per segment. With ordinary FISCO, we could have only used about five, and that would be the max'."

The split-architecture power supply steps around the complexity associated with FISCO circuits by the use of a conventional wire-wound resistor. The ROUTEMASTER also incorporates full AC/DC power conversion, simple linear power supply, and full galvanic isolation, with built in redundant supplies. Fewer components translate into greater reliability.

The high current made possible by split architecture device coupler (http://www. miinet. com) s and power supplies enables the connection of devices over cable lengths almost double that of FISCO -- 1900meters for trunk lines and 120meters per spur.

"Within the building the longest trunk run was 400 feet, and out in the field the longest cable run we got into was 500 feet." says Hutto. "This helps because we always have one of these device couplers available that we can easily tie an instrument into within 30-40 feet of any given place in the plant. We can get right up there in the bay and minimize conduit and wiring runs to short distances eliminating clutter verses traditional wiring techniques."

For pharmaceutical plants, it appears that recent technological improvements have finally enabled IS segment capacity virtually indistinguishable from non-hazardous fieldbus implementations. For those who believe that "the product is the process," this improvement in device coupler (http://www. miinet. com) s will allow devotees to stay competitive well into the future.

# # #

Dan atwood honored as oracle ace

2011-05-14T08:17:00.000-07:00

Dan Atwood Honored as Oracle ACE

Industry veteran to educate Oracle community and share best practices to extend the value of Oracle BPM

Plano, TX (PRWEB) November 18, 2010

Avio Consulting, a leading BPM consulting firm, today announced that Oracle has awarded Dan Atwood, senior BPM architect at Avio Consulting, with the elite honor of Oracle ACE.

According to Oracle, ACEs are known for their strong credentials as Oracle community enthusiasts and advocates. All candidates have been nominated by Oracle Technology and Application communities.

With more than twenty-five years of IT experience and eleven years of BPM experience, Dan Atwood brings leadership and development skills in all phases of the Oracle BPM development lifecycle.

Dan Atwood demonstrates his abilities through a proven track record of technical excellence in working with diverse Oracle clients. Having headed BPM training and courseware development at both Fuego and BEA Systems, Dan has trained and mentored over 2,000 customers in all facets of BPM. He developed and now teaches classes for developers, business analysts and decision makers using the latest version of Oracle BPM.

“I am extremely excited to be recognized among a very select group of Oracle ACE award recipients that will continue to be tracked by Oracle and its BPM customer community,” said Dan Atwood, senior BPM architect, Avio Consulting. “This is a testament to Avio Consulting’s focus on Oracle BPM best practices and customer successes and Oracle’s growing market momentum as a leading BPM solution.”

“Dan Atwood’s knowledge of BPM is well respected throughout the industry and he is often asked to assist companies with their BPM strategies. He is also one of Avio’s leading BPM consultants focused on delivering record results for many of Oracle’s leading BPM customers, " said Avio Consulting president and CEO, Monnie Soto. " Dan’s ACE appointment reinforces our commitment to have the most talented Oracle BPM team. Our number one goal is to provide resources that help make it easier for organizations to use and implement Oracle BPM. Dan is playing an important role by adding value and best practice perspectives to the Oracle community.”

Dan Atwood is by far the most active participant on the Oracle Technical Network’s BPM forum and is the only person having reached “Guru” status.

About Avio Consulting
Avio Consulting is an innovative technology professional services firm focused on enabling enterprise agility and business process transformation through the adoption of emerging technologies such as Business Process Management (BPM) and Service Oriented Architecture (SOA). Avio Consulting bridges the gap between business and IT by using proven methodologies combined with industry expertise and best practices to solve complex business processes. Avio Consulting helps companies evaluate and select BPM and SOA software, manage the implementation of the software, and facilitate all related organizational changes to assure that each of its clients realize the full business benefits of their implementation. Avio Customers include: Best Buy, Citigroup, Intercall, New York University, Procter and Gamble, United Healthcare, Watson Pharmaceuticals. Avio Consulting is headquartered in Plano, Texas. For more information please visit http://www. avioconsulting. com.

###

Adieu aux salles de bains encombrÃ©es!

2011-05-13T19:20:00.000-07:00

Adieu aux salles de bains encombrÃ©es!

MAAX dÃ©voile EvolutionÂ® InspirationÂ® et BalanceÂ® : Des solutions de rangement qui MAAXimisent lÂespace

Montreal, QC (PRWEB) September 21, 2005

MONTRÃAL, CANADA -- (le 2 aoÃ»t 2005) - MAAX, chef de file nord-amÃ©ricain de la conception, de la fabrication et de la distribution de produits innovateurs pour la salle de bains, la cuisine et le spa, Ã©largit sa ligne AdvantaÂ® en y ajoutant les armoires Ã pharmacie Evolution, Inspiration et Balance. Ces solutions de rangement reflÃ¨tent Ã merveille les derniÃ¨res tendances en matiÃ¨re de style et de fabrication tout en demeurant abordables.

De plus, ces modules de rangement se dÃ©clinent en diffÃ©rentes formes, grandeurs (de 15 Ã 48 pouces de largeur) et finis. Elles sont munies dÂÃ©lÃ©gants miroirs biseautÃ©s ou polis ronds sans aucune distorsion, de portes simples, doubles ou triples et sont disponibles avec ou sans cadre pour un style plus en vogue. Leur design contemporain se conjugue trÃ¨s bien Ã diffÃ©rentes ambiances en plus dÂoptimiser lÂespace disponible dans la salle de bains.

De nos jours, de plus en plus de produits et de petits appareils sont disposÃ©s dans la salle de bains, lÂespace de rangement y joue alors un rÃ´le crucial. GrÃ¢ce Ã une utilisation judicieuse de lÂespace, celle-ci peut sembler plus grande et plus attrayante pour lÂoeil. DÂailleurs, Pat HÃ©naire, Vice-prÃ©sident corporatif du marketing et des ventes, mentionne : Â« Comme la salle de bains nÂest pas toujours spacieuse, des solutions de rangement aussi efficaces quÂesthÃ©tiques sÂavÃ¨rent un investissement judicieux. En lanÃ§ant ces trois nouvelles sÃ©ries dÂarmoires Ã pharmacie, MAAX rÃ©pond Ã une demande grandissante pour des solutions novatrices au manque dÂespace de rangement dans la salle de bainsÂ».

Evolution

La sÃ©rie Evolution conjugue style et raffinement avec son agencement dÂaluminium, de bois, de miroir et de verre. Elle peut transformer une salle de bains encombrÃ©e en un espace distinctif et spacieux grÃ¢ce Ã sa conception ingÃ©nieuse.

Inspiration

La sÃ©rie Inspiration est disponible en bois laquÃ© blanc ou chÃªne et se prÃ©sente en diffÃ©rentes formes et grandeurs. Son design avant-gardiste procure Ã la salle de bains une ambiance rÃ©solument contemporaine tout en Ã©tant fonctionnelle et durable.

Balance

Comme son nom lÂindique, la sÃ©rie Balance fait lÂÃ©quilibre entre style et facilitÃ© dÂentretien, le tout Ã petit prix. Ses trois boÃ®tiers de polystyrÃ¨ne assurent une durabilitÃ© accrue et confÃ¨rent un style distinctif Ã la salle de bains.

Les armoires Evolution, Inspiration et Balance sont offertes dans les quincailleries, les grandes surfaces et les centres de rÃ©novation sous la marque Advanta de MAAX.

Ã propos de MAAX

MAAX est un chef de file nord-amÃ©ricain dans la fabrication de produits de salle de bains, dÂarmoires de cuisine et de spas primÃ©s destinÃ©s au marchÃ© rÃ©sidentiel. LÂentreprise est rÃ©solument engagÃ©e Ã offrir une expÃ©rience unique : des modÃ¨les distinctifs, innovateurs et conÃ§us avec style, de mÃªme que les meilleures pratiques de service Ã la clientÃ¨le de toute lÂindustrie. Les produits MAAX sont distribuÃ©s par le biais de grossistes en plomberie, de boutiques spÃ©cialisÃ©es et de centres de rÃ©novation. LÂentreprise compte plus de 3 700 employÃ©s rÃ©partis dans 26 usines et centres de distribution en AmÃ©rique du Nord et en Europe. Pour de plus amples renseignements, visitez www. maax. com.

Interphase systems announces virtualization exchange 2008 : educational event will be held on dec. 5 in bridgewater, n. J

2011-05-09T21:40:00.000-07:00

Interphase Systems Announces Virtualization Exchange 2008 : Educational Event Will Be Held on Dec. 5 in Bridgewater, N. J.

Interphase Systems, a leading management and technology consulting company with offices in Plymouth Meeting, Pa. and Bedminster, N. J., today announced that it will be hosting Virtualization Exchange 2008, a one day event for IT leaders of any knowledge level. Presentations will range from an introduction to virtualization basics to an opportunity for more advanced virtualization enthusiasts to hear about some of the latest technology topics and tools, including capacity planning, environment management, and business continuity. The event will be held on Friday, Dec. 5th at the Bridgewater Marriott in Bridgewater, N. J.

PLYMOUTH MEETING, Pa. (PRWEB) November 18, 2008

The Virtualization Exchange will cover topics ranging from basic server consolidation to desktop virtualization, disaster recovery solutions, and other advanced topics. Attendees can select between two tracks, "Virtualization 101" and "Virtualization 201," depending on their interests and experience. The Virtualization 101 track will focus on the foundations of virtualization concepts and technologies, while Virtualization 201 sessions will discuss advanced topics and tools.

"Virtualization was recently chosen by Gartner as one of the top 10 strategic technologies for 2009," said John Biglin, CEO of Interphase Systems, Inc. "As virtualization continues to gain momentum as a strategic solution for improved system performance, reliability, and disaster recovery, we observed a need for an educational event that would benefit both beginners and those already working with the technology. We invite IT departments, business leaders, and anyone interested in learning about the benefits of virtualization to come to our event and take advantage of the expertise that our presenters and our sponsors will be sharing. This event, with its two-track educational sessions and limited number of sponsors, is one of the first of its kind, and we look forward to continuing to help businesses further develop their virtualization strategies."

Featured sponsors of the event include VMWare, Dell, Exagrid, and others. For more information on the event, or to register, please visit www. vexchange08.com or contact Interphase Systems at 610-276-5500.

ABOUT INTERPHASE SYSTEMS

Interphase Systems, Inc. is a leading management and technology consulting organization offering architecture, strategy and implementation services. With offices in Plymouth Meeting, Pa. and Bedminster, N. J., Interphase, a Microsoft Gold Certified Partner, helps clients in the healthcare, pharmaceutical, financial services, and other industries maximize the benefits of their investments in technology and IT operations by providing innovative analysis, design, and solutions to meet customer needs. With three unique practice areas, Interphase specializes in all aspects of compliance and corporate governance, enterprise infrastructure and virtualization, and strategy services. For more information, please visit us online at www. interphasesystems. com.

PRESS RESOURCES

Press contact: Jessica Hirsch, Jessica@GregoryFCA. com

Interphase Systems Web site: http://www. interphasesytems. com (http://www. interphasesytems. com)

Association for manufacturing excellence conference to feature e-kanban

2011-05-09T10:49:00.000-07:00

Association for Manufacturing Excellence Conference to Feature e-Kanban

E-Kanban to feature at Association for Manufacturing Excellence Conference.

Durham, NC (PRWEB) September 21, 2005

According to Matthew Marotta, President of Datacraft Solutions, ÂIf American manufacturers labor costs were free, administrative costs would still make them the high cost competitor.Â Joining Marotta at the AME Boston 2005 Annual Conference is Kevin Sumstine, former director of Corporate Purchasing, Planning, and Logistics for dj Orthopedics. The two Lean manufacturing leaders will address, ÂBest of Breed Lean Electronic Supply Chain Best Practices.Â

This presentation will highlight the latest technology for utilizing electronic kanban within the factory floor as well as with customers and suppliers. Electronic kanban systems combined with unique scheduling tools, dramatically reduces inventory levels, increases turns, enhances supplier/customer relationships and improves the accuracy of manufacturing schedules. This presentation focuses on implementations of these systems at a number of lean and non-lean companies and will show the dramatic results obtained.

Datacraft SolutionsÂ mission is to be the Lean Manufacturer's indispensable partner in building trusted and efficient inventory replenishment networks. Marotta clearly states, ÂWhere the right amount of defect free product is delivered to the right place at the right time in the right quantity at the lowest possible cost.Â

The Association for Manufacturing Excellence (AME) is facilitating communities of like minded companies who are dedicated to implementing Best Practices within their Kanban / Consumption based replenishment process. Datacraft Solutions provides a best of breed kanban automation system via the web with services focused around Kiazen events that enable our partners of all sizes to gain a global competitive advantage when implementing a mission critical process within their organization.

Sumstine has a professional experience has been in Manufacturing, Purchasing and Planning functions within both Pharmaceutical and Medical Device Industries. He has had responsibilities for Continuous Improvement Programs targeting operational improvement activities, company-wide cost savings programs and supply chain management enhancements.

For more information about the Association for Manufacturing (AME) Excellence Boston conference visit http://ame. org/Events/2005/Boston/ (http://ame. org/Events/2005/Boston/)

# # #

Legalview developing cranial implant information portal detailing the recall of stryker cranial implant kits

2011-05-09T06:31:00.000-07:00

LegalView Developing Cranial Implant Information Portal Detailing the Recall of Stryker Cranial Implant Kits

LegalView recently created a new information portal detailing the recall of approximately 322 cranial implant kits that were implanted in patients suffering from face, jaw and cranium injuries. The kits have been recalled due to controversy on the sterility of the implants.

Denver, CO (PRWEB) January 19, 2009

LegalView. info, the number one source for anything and everything legal on the Web, is launching a new information portal for individuals who may have been affected by the Stryker Corporation recall of nearly 322 Custom Cranial Implant Kits, which were recalled "because sterility cannot be assured," according to a the Food and Drug Administration (FDA). The cranial implant kits are used to correct face, jaw and cranium defects. The FDA considers the recall a Class I recall meaning that there is a high likeliness that a cranial implant patient could face severe injuries or even fatality if the issue is not addressed immediately.

Patients who have received the implants are advised to seek medical attention immediately as well as to contact a cranial implant recall lawyer (http://cranial-implant. legalview. info) who can offer a free legal consultation as to the details surrounding a possible cranial implant lawsuit (http://cranial-implant. legalview. info), which could offer a return in monetary funds as compensation for victims of the defective kits. Such a return of money could provide a cranial implant victim with the appropriate resources needed to seek a new alternative to the recalled kits as well as to receive money likely needed to undergo not only physical but mental treatments for the stress endured because of the cranial implant recall (http://cranial-implant. legalview. info).

Cranial implant kits often are provided for a rare population that suffers from skull defects. According to The International Journal of Medical Robotics and Computer Assisted Surgery, "skull defects usually create aesthetic and functional disturbances to the patient." The journal noted that cranial implants can become difficult to implement because of the potential anatomical location, which is why it becomes even more dangerous and accompanied by an extensive degree of difficulty for a patient to have a cranial implant kit recalled. Patients should consider discussing their situation and construct potential litigation involving the Stryker cranial implant recall (http://cranial-implant. legalview. info).

LegalView also offers a multitude of other legal topics ranging from the cranial implant recall to the latest in Fosamax and Avandia dangers as well as the peanut butter recall that has caused five deaths so far among Americans.

Both Fosamax and Avandia are prescription drugs, however, each treats a different medical issue, but both have been associated with severe side effects among patients. Fosamax is an osteoporosis drug used to treat individuals who have suffered from bone density losses including postmenopausal women. However, in January, two medical journals informed patients of severe potential Fosamax side effects (http://fosamax. legalview. info) including the onset of jaw bone die off and the development of esophageal cancer.

Avandia, which is used to treat type 2 diabetes through the regulation of insulin levels has similarly caused the onset of osteoporosis among patients as well as an increased risk of bone fractures among women and the development of heart failure among many patients. Those who consume Avandia are encouraged to speak with their physician regarding the prescription of Avandia as well as to discuss the potential for an Avandia lawsuit (http://avandia. legalview. info/avandia-lawsuit. aspx) with an experienced pharmaceutical attorney.

Additionally, LegalView has recently updated its peanut butter recall (http://peanut-butter. legalview. info) information portal with news of the increased risk of salmonella poisonings among consumers from the recent rash of tainted peanut butter. To learn more about the dangers associated with consumption of the peanut butter, visit http://peanut-butter. legalview. info (http://peanut-butter. legalview. info)].

About LegalView:  
LegalView. com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView. com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www. LegalView. com.

###

Matrix marketing group appoints vice president of strategic development

2011-05-08T06:11:00.000-07:00

Matrix Marketing Group Appoints Vice President of Strategic Development

FORT COLLINS, Colo. Â February 20, 2003 Â Matrix Marketing Group Inc. today announced the appointment of Clark Renfro to the position of vice president, strategic development. With more than 14 years of marketing, sales, and product development experience with both start-up and established marketing companies, Renfro will be responsible for business development activities at Matrix Marketing Group.

(PRWEB) February 22, 2003

"ClarkÂs depth of experience and proven track record makes him a strong addition to our team,Â said George Schildge, president of Matrix Marketing Group. ÂHe has helped drive innovative marketing services to market leadership and has a clear customer vision. We are delighted to have him join us in this pivotal role to help us continue to deliver the services that our customers need to inspire innovations, growth, and profitability in the high-tech and professional services marketplace.Â

Renfro, who will report directly to Schildge, previously served as director, business development for The Hibbert Group, a leading provider of direct marketing services for the high technology and pharmaceutical industry. He has also held senior positions in product marketing, marketing, sales, and international positions for International Verifact, U. S. Bancorp and IBM.

"In today's economy, companies recognize that delivering compelling proven services and customer value are critical to increasing market share and improving bottom line results," said Renfro. "Matrix Marketing Group has the paramount marketing solution and a proven track record of delivering customer value. I am excited to join the Matrix Marketing Group team to help build their market leadership."

Renfro holds a B. S. from Kansas State University, Manhattan, KS and M. S. from University of Colorado, Denver, Colorado.

About Matrix Marketing Group

Matrix Marketing Group, Inc. provides sales and marketing outsourcing, consulting and training solutions to help improve and deliver superior growth and profit performance. Matrix Marketing Group helps its clients stimulate growth through a comprehensive approach to business-to-business sales and marketing that covers strategic issues, tactics, and organizational choices. The services include business-to-business marketing, marketing strategy, branding, marketing organization and capability building, marketing spend effectiveness, and sales and channel management.

The company can be reached at 970-224-9708, info@mmg-us. com, or at www. mmg-us. com.

Pharm-olam international adds additional offices in latin america

2011-05-07T20:56:00.000-07:00

Pharm-Olam International Adds Additional Offices in Latin America

Pharm-Olam International Ltd., a multi-national CRO to pharmaceutical, biotechnology, and medical device industries will expand its capabilities in Latin America.

HOUSTON, TX (PRWEB) June 17, 2006

Pharm-Olam International Ltd., a multi-national CRO to pharmaceutical, biotechnology, and medical device industries will expand its capabilities in Latin America by opening local offices in São Paulo, Brazil and Buenos Aires, Argentina scheduled to open in September 2006.

"From our previous experience conducting trials in these countries, we know that these areas offer great opportunities for finding treatment naïve patients, and having local offices there will improve the efficiency of Pharm-Olam's global trial logistics", said Iain Gordon, Director of Global Business Development. "Pharm-Olam has experience conducting trials throughout Latin America, where we have strong relationships with local physicians and an impressive network of sites, including some of the largest medical centers in the region."

Pharm-Olam established a local office in Mexico City in 2002, and with the additional offices in São Paulo and Buenos Aires, the company will now have a local presence in the three most populated metro areas in Latin America with an estimated combined population of over 50 million people. With some of the largest patient populations in the world, these areas offer sponsors great opportunities in patient recruitment and trial logistics.

Pharm-Olam's Latin American operations are overseen by Dr. Jorge Fiuza, who has over 15 years of clinical trial management experience in the region.

For further information about Pharm-Olam please contact Iain Gordon.

###

Substance abuse relapse prevention study gets high praise from review board

2011-05-05T05:27:00.000-07:00

Substance Abuse Relapse Prevention Study Gets High Praise From Review Board

ÂOne of the best things thatÂs happened to us, in these past 18 months, was finding Â right in our own back yard -- Liberty Institutional Review Board, IncÂÂ said, Bob Sewak, President of Neuro Acoustic Research Corp (NARC), after receiving the IRBÂs approval for the companyÂs seminal study on their substance abuse relapse prevention system.

DELRAY BEACH, FL (PRWEB) April 29, 2004 -

Â ÂOne of the best things thatÂs happened to us, in these past 18 months, was finding Â right in our own back yard -- Liberty Institutional Review Board, IncÂÂ said, Bob Sewak, President of Neuro Acoustic Research Corp (NARC), after receiving the IRBÂs approval for the companyÂs seminal study on their substance abuse relapse prevention system.

In a continuing effort to produce the best possible scientific and statistically significant research, the team at this small, private Florida-based firm has wrestled with the daunting task of meeting the same high government and ethical standards as those imposed on larger, publicly financed educational and institutional research organizations. And, when one considers: a) that all of their funding has been raised privately, and b) their modality, though proving to be extremely effective, is -- by present standards -- novel and (definitely) atypicalÂ making their accomplishments to date, even more noteworthy.

So, when word was received of the Liberty BoardÂs approval, for this pivotal study, there were feelings of joy and relief, as well as a great sense of accomplishment. However, it wasnÂt until several days later, when, along with the arrival of the documents, came comments from members of the BoardÂ that, to many, proved even more meaningful. A array of unsolicited descriptions, bordering on the extreme, were offeredÂ ÂexcitingÂ, ÂintriguingÂ, ÂunprecedentedÂ and Âground-breakingÂ, were contained. Ecstatic with the approval and bowled-over by the praise, Sewak offered: ÂÂ weÂve been beating this drum for over 14 years now, and finally we can say that there are some people Â people that matter Â who are beginning to pay attention and realizing that what weÂre doing is worthwhile and deserves recognition and acknowledgementÂ.

For the past 14 years, the Neuro Acoustic Research Corp. (NARC) team has lead the way in scientific research and development in the field of acoustic technology. Clearing new paths in the field of psychoneuroimmunology and establishing bio-technological entry points in wide spectrum of diverse treatment areas (i. e. pain, sleep disorders, movement disorders, addiction, human performance enhancement, etc.), NARC is committed to a continued pursuit of new and innovative uses for the science and the art of acoustic technology. One example is the innovative neuro-pathways recovery system -- a unique protocol, designed to address one of the most critical factors in substance abuse and addiction recovery Â Relapse Prevention Â utilizing an effective, safe, non-pharmacological, non-invasive, non-addictive, efficient and simple process. Acknowledged as possibly the Âonly relapse prevention tool ever createdÂ, this fascinating system is both complimentary and compatible with all forms of addiction treatment in use today.

To learn more about NARC and its neuro-pathways recovery system Â or any of their other research, developments and work, you are invited to visit them at their website at: www. neuro-pathways. com or contact them directly at: 1-561-243-0296

Pistolstar boosts password security and enhances self-service experience with web set password global 7

2011-05-05T03:08:00.000-07:00

PistolStar Boosts Password Security and Enhances Self-Service Experience with Web Set Password Global 7

Web Set Password Allows End-Users to Access Lotus Applications from Notes Clients By Authenticating with Their Password for Windows, Microsoft Active Directory, Novell eDirectory, or Sun ONE LDAP, Facilitating Password Reset/Recovery of Their Windows Password and the Lotus Notes ID

Nashua, NH (PRWEB) April 15, 2005

PistolStar, Inc., a leading password management solutions provider to companies using IBM Lotus technology, today announces Web Set Password Global 7, the latest upgrade of its single sign-on, password synchronization, and self-service password management solution. Web Set Password Global 7 enhances password security and simplifies and secures the authentication process, offering over 36 features not available in Domino R5, 6 and 6.x, including:

Web single sign-on Â Creating convenience and saving login time; Browser-based multi-password synchronization (Windows, HTTP, and LDAP passwords, and Notes ID files) Â Allowing faster, smoother access; Independent and secure self-service password management and reset from any Web browser Â Reducing the large amount of Help Desk calls for password resets; and Access to Lotus applications from the Lotus Notes clients by authenticating with the Windows or directory password (Microsoft Active Directory, Novell eDirectory and Sun ONE LDAP) Â Enabling recovery of the Lotus Notes ID password.

Web Set Password Delivers Noticeable Benefits Plus Immediate Return on Investment Companies implementing Web Set Password reap benefits that are felt across their enterprise Â by IT administrators, end-users and senior management.

For administrators, Web Set Password addresses specific problems and challenges, such as enabling secure access to corporate intranets and extranets, and protecting applications and content from illegal usage. Web Set Password also helps IT achieve security "best practices" Â functionality such as password quality, history, expiration, 3-strikes and last login Â through its ability to define password rules and numerous password preferences.

For end-users, Web Set Password provides self-service functionality that allows them to securely manage and reset their passwords directly from a Web browser, and without Help Desk intervention. The Challenge Question and Answer feature allows end-users to create customized challenge questions to recover passwords without Help Desk assistance and without creating potential security breaches from having the administrator email or phone the password.

For senior management, Web Set Password helps with executing enterprise security initiatives and regulatory compliance by enforcing strong password policies to authenticate end-users who have access to sensitive or confidential information. Web Set Password also meets corporate objectives by enabling end-users and IT to diminish downtime and increase productivity.

Web Set Password provides tremendous cost-savings in two critical ways:

1. By sharply reducing Help Desk calls, enabling IT to allocate fewer resources for managing passwords; and

2. By heading off potential security breaches caused by hackers, poor password quality, and other issues that can arise in the password authentication and management process.

As a result, companies can realize a significant and immediate return on investment (ROI).

Addressing CustomersÂ Critical Password Security and Management Concerns ÂCustomers tell us their greatest concerns today are protecting corporate data from hackers, providing end-users with secure and simple access to systems, and ensuring regulatory compliance,Â said Thomas Hoey, president and CEO, PistolStar, Inc. ÂWith every product upgrade, we respond to customersÂ concerns by adding functionality that will further reduce ITÂs workload, enhance the self-service password experience for end-users, and address the security and compliance objectives of corporate management.Â

Web Set PasswordÂs Top Password Authentication & Management Features

Features that are new with Web Set Password Global 7 include:

Self-service password reset/recovery for the Notes ID Â Eliminating password synchronization of the Notes ID and allowing organizations to end the time-intensive password maintenance and recovery tasks for the Notes ID. More simplified password synchronization Â Allowing end-users to have only one password to commit to memory, decreasing the likelihood they will write it down and become a target for internal network intruders. Forced SSL connection Â Ensuring end-user credentials are submitted when an SSL connection is present, but reverting back to normal http:// (http://) protocol after logon. Web Set PasswordÂs SSL Support sends end-userÂs credentials encrypted to the Domino server, increasing security. Extended storage of login information Â Allowing more detailed login information to be recorded and sent to the Web Set Password Database Prevention of similar password use Â Disallowing the use of similar passwords when end-users make password resets Confirmation requirement for self-registration Â Emailing end-users a link to a confirmation page for self-registration. On this page, end-users are prompted for their email address, which effects the creation of the Person document in the Domino Directory. The Self-Registration Utility enables end-users to create their own user accounts without administrator involvement Easier and more organized user interface Â Simplifying usability and the self-service experience for the end-user. Web Set Password enables customization of UI screens without Domino Designer. Advanced security of Preferences document Â Adding two functions: A password-type field for the "LDAP Administrator Password" in the LDAP Synchronization section; and the "Edit Preferences" role, a requirement for editing the Web Set Password Preferences document.

Other top features and their benefits include:

Password History Â Administrators can maintain password history, including a configurable history limit, by setting how many times an end-user must choose a new password before they can reuse an old one. This prevents end-users from repeatedly using the same password. Password Strikeout and Strike Event Functionality Â Administrators can set number of logon attempts and easily restore password lockout. Strikeouts can be logged to a database, preventing ÂdictionaryÂ attacks and identifying accounts that have been denied server access. Password Quality Â Administrators can check password quality on both the client and server sides and configure fully customizable password ÂstrengthÂ rules. Web Set Password offers 11 ÂstrengthÂ rules, while Domino only allows two options for password strength. Help Desk Manager Â Help Desk personnel with less security clearance and skills to perform tasks normally handled by an administrator can manage end-user passwords without full access to Web Set PasswordÂs configuration data and the Domino Directory. Random Password Email Functionality Â Administrators can generate random passwords to be automatically emailed to new users. This feature serves as an administrative time-saver as well as a security element because the administrator never sees the password that is emailed. Hide Previously Used Passwords Â Administrators can stop Internet Explorer Auto Complete from showing a list of previously used password entries via the dropdown menu, preventing internal intruders from accessing passwords. Dictionary Search of Unacceptable Passwords Â Administrators can specify words that would be easily guessed by potential intruders, preventing end-users from selecting them as passwords. Storage of ÂSet PasswordÂ and ÂLast LoginÂ Date and Time Â Administrators can track the date and time a user last set their HTTP password, enabling them to audit and troubleshoot. Support for Hub and Spoke Topology in Real Time Â Prevents replication conflicts and subsequent Help Desk calls by notifying end-users when their passwords are out of synch. All reads and writes occur on the hub server regardless of where login is executed. All password changes are made in real time.

Web Set Password Global 7 is also available in an abridged version Â Web Set Password Deluxe 7 Â to better meet the needs of PistolStarÂs diverse customer base.

System Requirements

Web Set Password Global 7 is a server-side solution that integrates seamlessly with IBM Lotus technology and doesnÂt require end-user setup. Web Set Password supports iSeries, IBM AIX 5.1 and higher, Linux, Sun Solaris UltraSPARC, and Microsoft Windows Server 2003 and Windows NT, 2000, and XP.

About PistolStar, Inc.

PistolStar provides Password Plug-Ins, a comprehensive set of secure password authentication and management solutions that offer tremendous business payback Â increased productivity, improved efficiencies and security Âbest practicesÂ Â delivering an immediate return on investment. End-users, IT administrators and corporate management equally benefit from these solutions, experiencing remarkable ease and convenience with managing passwords and gaining secure and trouble-free access to enterprise-wide information and intranets, directories and extranets.

PistolStarÂs products integrate with LDAP directories such as Microsoft Active Directory, Sun ONE LDAP, and Novell eDirectory, as well as IBM Lotus technology. PistolStar sells its products to Global 2000 companies and organizations across multiple vertical industries, including automotive, chemicals, consumer products, finance/banking, government, healthcare, manufacturing, advertising and media, communications, pharmaceuticals, and retail.

To learn what hundreds of enterprise customers have already discovered, visit the PistolStar Website at www. pistolstar. com.

# # #

Research and markets: must-have essential reading Âdrug and market development journalÂ

2011-05-04T14:23:00.000-07:00

Research and Markets: Must-Have Essential Reading ÂDrug and Market Development JournalÂ.

(PRWEB) October 19, 2004

This Journal helps make sense of the glut of information thrown at you every day regarding the biotech and pharmaceutical industries by providing an objective analysis of how industry developments may affect your organization.

This Journal offers the most timely and comprehensive coverage of the drug development life cycle - from the science to the market - the information your company needs to seize opportunities and remain competitive in today's evolving marketplace.

Drug & Market Development supplies key market intelligence and analysis necessary to:

Make smart R&D and marketing decisions Find lucrative product niches Create dynamic strategies

Each month, Drug & Market Development presents the best information available on topics that matter most to biotechnology and pharmaceutical professionals.

Regularly Featured in Drug & Market Development:

Therapeutic & Market Updates

Cancer Angiogenesis Â· Cancer Vaccines Â· Immunotherapy Â· Localized Cancers Â· Malignant Melanoma Â· Stem Cell Therapy Â· And more...

Cardiovascular & Blood Blood Substitutes Â· Drug-Eluting Stents Â· Dyslipidemia Â· Stroke Â· Thrombosis Â· And more...

Inflammation & Infection Asthma and Allergies Â· HIV/AIDS Â· Pneumonia Â· Psoriasis Â· Rheumatoid Arthritis Â· And more...

Nervous System Alzheimer's Disease Â· Depression and Anxiety Â· Migraine Â· Multiple Sclerosis Â· And more...

Strategic Issues Due Diligence Â· Global Marketing Â· Partnering Â· Reimbursement Â· And more...

Technology Reviews Pharmacogenomics Â· Protein Kinases Â· Protein & Peptide Drug Delivery Â· Systems Biology Â· And more...

International Developments CROs in Europe Â· EU Regulations Â· Genetics Â· And more...

For a complete index of this report click on http://www. researchandmarkets. com/reports/225266 (http://www. researchandmarkets. com/reports/225266)

About Research and Markets Ltd.

Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets. com, their range of reports or their value-added services, visit their web site at http://www. researchandmarkets. com (http://www. researchandmarkets. com) or mailto:press@researchandmarkets. com

A "healthy" company - geritrex celebrates its 30 year anniversary with new rebranding effort and expanding distribution channels

2011-05-03T07:42:00.000-07:00

A "Healthy" Company - Geritrex Celebrates Its 30 Year Anniversary with New Rebranding Effort and Expanding Distribution Channels

Leading healthcare manufacturer introduces new product packaging and e-commerce feature to company Web site - www. geritrex. com.

Mount Vernon, NY (PRWEB) February 18, 2009

The Geritrex Corporation, a privately held pharmaceutical company that offers affordable, high-quality healthcare products, is now celebrating its 30th year in business. Founded by CEO and registered pharmacist Anthony Madaio, Geritrex has grown from a mid-Atlantic regional manufacturing firm to a prominent national industry leader in the over-the-counter (OTC) goods marketplace.

"Many Americans today are concerned over the fate of the pharmaceutical industry due to the looming patent expirations on branded medicinal products, however, I believe strongly that many of the smaller healthcare manufacturers - in particular the OTC producers - will hold steady during this economic downturn," said Geritrex's president Anthony Madaio. "Our company continues to remain strong and prosperous because we are continuously working very hard to develop, manufacture and market quality, value-added products while satisfying our customers' budgetary needs."

To help maintain Geritrex's competitive edge in the future, the company has recently redesigned its logo and product packaging to help refresh the brand and reinforce its market position. The company's Web site, www. geritrex. com, now features a retail element to allow consumers to make online purchases. Geritrex also plans to launch new healthcare products into the marketplace during the first quarter of 2009, including MIN-O-EAR™, an effective ear wax softener that will be priced about 50 percent less than similar products.

For 30 years, the Geritrex Corporation has been developing and producing a proprietary healthcare line, private label medical products and generic equivalents of brand name over-the-counter health items. The company's affordable, high-quality healthcare products are currently being distributed to hospitals, long-term care facilities and other institutions and there are plans to expand into the retail market this year. To learn more about the company's current offerings, please visit www. geritrex. com.

###

Research and markets - lack of necessary research resources can lead to the failure of pharmaceutical brand teams to complete their most important tasks

2011-05-02T01:07:00.000-07:00

Research And Markets - Lack Of Necessary Research Resources Can Lead To The Failure Of Pharmaceutical Brand Teams To Complete Their Most Important Tasks

Research and Markets (researchandmarkets. com/reports/c9391) has announced the addition of Pharmaceutical Market Research: Decision Support for Brand Growth to their offering.

(PRWEB) November 18, 2004

Market research is such an integral part of the strategic process for pharmaceutical brand teams that few major decisions are made without some support data. At the same time, market research teams often lack the necessary resources to accomplish some of their most important tasks during product development. This study highlights common resource gaps in pharmaceutical market research groups, along with identifying tactics to elevate the strategic impact of this very important function.

Research and Markets (http://www. researchandmarkets. com/reports/c9391 (http://www. researchandmarkets. com/reports/c9391)) has announced the addition of Pharmaceutical Market Research: Decision Support for Brand Growth to their offering.

The most successful market research teams maintain a keen awareness of industry trends at all times. To truly impact brand strategy, these market research teams get involved from the outset and help position products well ahead of Launch. By combining solid activity planning and adequate resources, market research groups can often be the driving factor in major go/no-go decisions.

Several components contribute to a strong market research plan:

Structure & Investment Â Average market research spending remained the same over the last three years, but companies have favoured higher early-stage investments. Strategy Development Â Market research strategy development begins with overall brand goals. Research groups must function as part of the brand team every step of the way. Activity Coordination Â Even companies with low market research budgets can compete with large products if they know how to coordinate their activities.

The companies mentioned in this report are as follows:

Alcon Labs AstraZeneca Aventis Pasteur Bayer Biopedal Bristol-Myers Squibb Eli Lilly EMD Pharmaceuticals Merck KGaA Schering AG Novartis Pfizer Procter and Gamble Pharmaceuticals Roche Sanofi-Aventis Schering-Plough Schwarz Pharma Theratechnologies Wyeth

For more information visit http://www. researchandmarkets. com/reports/c9391 (http://www. researchandmarkets. com/reports/c9391)

Laura Wood

Senior Manager

Research and Markets

Press@researchandmarkets. com

Fax: +353 1 4100 980

###

Bill s.3: another homeland security scandal? Parents are watching, says naa

2011-05-01T23:46:00.000-07:00

Bill S.3: Another Homeland Security Scandal? Parents Are Watching, Says NAA

New Frist/Gregg Bill May Contain Vaccine Language that Once Again Coddles Big Pharma

Washington, DC (PRWEB) January 30, 2005

Are Senators Judd Gregg and Bill Frist at it again? In a press release issued from Senator GreggÂs office Monday, a new bill, S3, will reportedly deal with vaccine compensation, says the National Autism Association. However, the details surrounding that part of the bill remain absent.

In a section entitled "Litigation Reform," the S3 bill, "Requires the Secretary and the Attorney General of the US to make recommendations to Congress regarding the necessary modifications to federal programs and rules regarding litigation involving vaccines." And because several Senate leaders have expressed that topping the agenda are "Frivolous Lawsuits" and "Medical Malpractice Reform," it is likely S3 will contain similar language of past legislation:

In May, 2002, Senator Frist introduced legislation that protected drug companies from vaccine-related lawsuits. Parents acted and the bill died. In November 2002, a provision which would prohibit lawsuits against Eli Lilly, the maker of mercury-based Thimerosal used in vaccines, was tip-toed into the Homeland Security Bill causing a ÂwhodunitÂ scandal. Parents and legislators had the provision repealed. In March, 2003, Senator Frist introduced the same legislative language as part of the BioShield Bill. The provision was removed after parents rallied in DC. In April, 2003, Senators Frist and Gregg worked with Senator Chris Dodd on a compromise to revamp the National Vaccine Injury Compensation Program. When the compromise leaned too much in the favor of the children, Frist and Gregg pulled out. In February, 2004, Senator Frist introduced the Healthy Women and Healthy Babies Access to Care which prohibited lawsuits against any FDA-approved product or device including mercury-containing immunoglobulin products given to pregnant women.

For years, these two Senators have introduced legislation under the guise of protecting drug companies from frivolous lawsuits. Parents say it's simply a shameful attempt to keep their pharma friends happy. "My child has rights," says parent Laura Bono, Durham, NC, whose child was injured by mercury in vaccines. "His rights continue to be jeopardized by those looking out more for American pharma than American families."

A block on civil court cases would hurt more than a childÂs rights. Several Thimerosal lawsuits have moved forward in civil court. Trials begin this year. Blocking these lawsuits would interfere with already successful efforts to see what drug companies knew about the harmful effects of mercury in vaccines. "It would be criminal to try and stop parents from learning valuable information about the cause of their childÂs illness," says Rita Shreffler, parent from Nixa, Missouri and secretary of the National Autism Association.

Bono agrees. "Vioxx caused heart attacks and strokes. Harmful effects of SSRIs were swept under the rug. Thimerosal causes autism. The system is broken. In my opinion, Frist and Gregg continue to create an escape route for drug companies that have no incentive to put health before profit."

The National Autism Association is currently launching a campaign to inundate law-makers with letters requesting to keep their childÂs rights intact.

To learn more, visit www. NationalAutism. org.

# # #

Profiles of the top 10 global companies in bioinformatics

2011-05-01T04:33:00.000-07:00

Profiles of the Top 10 Global Companies in Bioinformatics

Research and Markets has announced the addition of Industry Insight - Global Bioinformatics to their offering.

Dublin (PRWEB) June 22, 2006

Research and Markets (http://www. researchandmarkets. com/reports/c38438 (http://www. researchandmarkets. com/reports/c38438)) has announced the addition of Industry Insight - Global Bioinformatics to their offering.

The report includes an exhaustive analysis of bioinformatics focusing on issues such as technology, regulations, manpower, major players, major markets, etc. The report has been divided into eleven chapters. The report gives an introduction to global bio-informatics industry and various applications of bioinformatics in sectors like biotechnology, pharmaceuticals, medicine, agriculture, etc. It describes the growth drivers, issues and challenges, technology-related issues like integrating biotechnological database etc in detail.

Profiles of top 10 global companies in bioinformatics are covered to provide better understanding about their strategies, services, etc. The report presents the analysts’ views of the future of bioinformatics industry and its impact on medical, biotechnology, pharmaceuticals, R&D and agriculture industries. It also focuses on the Indian scenario over the global bioinformatics industry.

Key Topics Covered Include:

Industry Overview Applications of Bioinformatics, Growth Drivers Critical success Factors Major players Regulatory aspects Issues and Challenges Technology Mergers and Acquisitions

Companies Mentioned:

Accelrys DNAstar Compuge Celera Genomics IBM Life Sciences Solutions Incyte Genomics Lion Bioscience Structural Bioinformatics Gene Codes Corporation Beyond Genomics 3rd Millennium, Inc, Biobase Biological Databases Biomax Informatics Ag, Biotools Incorporated Inforsense Proteome Systems Scinova Technologies Ocimum Biosolutions Inc. Data Unlimited International, Inc. (DUII),

For more information visit http://www. researchandmarkets. com/reports/c38438 (http://www. researchandmarkets. com/reports/c38438)

Laura Wood

Senior Manager

Research and Markets

Fax: +353 1 4100 980

###

New service provides first real change to discount prescription drug card model in 15 years

2011-05-01T00:41:00.000-07:00

New Service Provides First Real Change to Discount Prescription Drug Card Model in 15 Years

Healthcare Reform may have muted effect on high cost of prescription drugs, but one Florida company has added a new twist to an old idea that could save up to 90% off some prescription drugs

Sarasota, FL (PRWEB) December 29, 2009

Healthcare reform will do little to reverse the upward trend in prescription drug prices which have doubled in 10 years, according to the Agency for Healthcare Research and Quality. Controlling runaway costs through process change and application development is what Genuity Group (http://www. GenuityGroup. com) of Sarasota, FL does best and it is not waiting for reform to change things.

The company's new online resource -- called BetterRxCard (http://www. BetterRxCard. com)- provides a fresh take on the old discount prescription drug card programs with several new features designed to help more consumers save more money on more drugs at more pharmacies.

The BetterRxCard reduces the cost of expensive drugs for the uninsured, underinsured and --for the first time in 15 years-- insured consumers with high co-pays.

"BetterRxCard provides two ways to beat the high cost of drugs. First, it is a free discount prescription drug card program supported by most U. S. pharmacies (http://betterrxcard. com/Features/participating-pharmacies. html) providing up to 70% off the cost of generic drugs (http://betterrxcard. com/Features/drug-discounts. html)," said David Smith, director of Product Marketing at Genuity Group.

"Second, consumers may elect to use Genuity's EquivaMeds service which reduces costs on many brand name drugs taken for chronic conditions. This is especially important now since healthcare reform does not address increasing prescription drug costs," he said.

Several reports seemed to suggest that the healthcare reform bill will fall short of meaningful prescription drug price reform. A report by Reuters said that the Obama administration was moving forward on drug reimportation as a separate way to lower drug costs. Meanwhile, the Generic Pharmaceutical Association claimed on its website that healthcare reform would drive Medicare patients to higher cost drugs.

Discount prescription drug cards, which originated in the early 1990s, help reduce costs on generic drugs, but discounts on costly brand name drugs have been disappointing for uninsured and underinsured.

EquivaMeds works using a distinctive database of medication classes and costs that represent the various medications physicians can prescribe for similar conditions. This patent-pending process identifies many more options and savings opportunities than the typical brand-to-generic comparison methods and is the first advanced price control tool provided with a discount drug card program in 15 years. Some substitutes saved consumers up to 90% and last year the average consumer saved $893.

Another innovation announced was the mobile pharmacy application, initially designed for the Apple iPhone. The tool provides a search capability with mapping, address, phone and directions for all 59,617 pharmacies in the BetterRxCard pharmacy network including Wal-Mart, CVS, Walgreens, Target and Rite-Aid.

Other features of the service include deep drug discounts of up to 70%, printable and pre-activated cards, and the ability to use the card for many pet medications.

The free BetterRxCard is available nationwide today. For a limited time, Genuity Group is providing a 75% discount off the one-time fee of $19.95 for EquivaMeds and a savings guarantee of at least $120. To take advantage of this special offer, users can visit the site to download a BetterRxCard free discount prescription drug card (http://betterrxcard. com/Print-a-Card. aspx).

# # #

Winchester business system wins mds pharma services global contract leading contract research organization chooses parasale for crm

2011-04-30T15:12:00.000-07:00

Winchester Business System Wins MDS Pharma Services Global Contract Leading Contract Research Organization Chooses paraSALE for CRM

Winchester Business Systems, Inc., recently announced that MDS Pharma Services, a leading global contract research organization (CRO), recently signed a global license agreement to implement paraSALE, Winchester Business SystemsÂ unparalleled customer relationship management, sales information and marketing system. ParaSALE has been deployed in all U. S., Canadian, and European offices.

(PRWEB) February 2, 2002

Winchester Business System Wins

MDS Pharma Services Global Contract

Leading Contract Research Organization Chooses paraSALE for CRM

WINCHESTER, MA. ÂWinchester Business Systems, Inc., recently announced that MDS Pharma Services, a leading global contract research organization (CRO), recently signed a global license agreement to implement paraSALE, Winchester Business SystemsÂ unparalleled customer relationship management, sales information and marketing system. ParaSALE has been deployed in all U. S., Canadian, and European offices.

ParaSALE Âs CRM enterprise technology solution creates a repository for all information about MDS Pharma Services client relationships worldwide. ParaSALE aggregates vital information about MDSÂ prospects and clients to provide enhanced business among offices, divisions, and product lines. ParaSALE also generates and tracks proposals, manages marketing campaigns, analyzes lead generation, and automates sales forecasting.

"Our key objectives were to offer a useful tool to business development managers working directly with clients, provide a high level of flexibility in analyzing our relationships with our clients, and allow us to respond to our clients' needs more rapidly," said Jeff Spence, Sr. Vice President, MDS Pharma Services. "With paraSALE in the hands of our business development, marketing, and customer support groups, we will be able to completely integrate our operations and provide unparalleled service, efficiency, and rapid turnaround to our clients worldwide."

"After evaluating several alternatives, only Winchester Business Systems offered the mission critical combination of expertise in technology and workflow processes," stated John Capicchioni, Vice President for Global Confined Clinical/Generics, MDS Pharma Services. "ParaSALE is flexible enough to allow us to meet our internal needs as well as those of our clients whose with the goal rapid drug discovery and development."

" MDS Pharma Services has taken a leading position by recognizing the value of integrating customer information across locations and lines of business, forming an end-to-end solution for managing important opportunities, and providing executive management with tools to analyze how to can better serve their clients. The implementation of an integrated customer information database will permit MDS Pharma Services to continue offering more competitive services to its customers."

About Winchester Business Systems

Founded in 1993, Winchester Business Systems, Inc. (www. wbsnet. com.) is a leader in providing software business solutions to the pharmaceutical and biopharmaceutical industries. As a Premier Business Partner for Lotus/IBM, WBS combines its knowledge of the industry, clinical practices with the application of Domino technology to these areas. WinchesterÂs clients include Bayer Corporation, Pfizer, Biogen, Sanofi-Synthelabo, Johnson & Johnson, BioTransplant, sigma-Tau Pharmaceuticals, Abt Clinical Trials Assoc., and Novartis.

About MDS Pharma Services

MDS Pharma Services (www. mdsintl. com), a division of MDS Inc, offers a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With facilities in over 17 countries, the company applies advanced scientific and technological expertise to each stage of the drug discovery and development process: discovery, preclinical, early clinical research (phases I-IIa), bioanalytical, global clinical research (phases IIb-IV), and central lab.

MDS Inc., an international health and life sciences company, focuses is on using science to advance health and to fight disease by providing laboratory testing, imaging agents for nuclear medicine testing, sterilization systems for medical and consumer products, research services to speed discovery and development of new drugs, therapy systems for planning and delivery of cancer treatment, analytical instruments to assist in the development of new drugs, and medical/surgical supplies.

Contact: Nancy Sarles

Winchester Business Systems

Ph: 781-631-6416

Fax: 781-631-2537

Nsarles@mediaone. net

Know where your inventory is - at all times

2011-04-30T12:34:00.000-07:00

Know Where Your Inventory is - At All Times

Barcoding Inc. displays RFID Active Shelf System at next Week's NRF Show in the Javits Center: Booth 1463

Baltimore, MD (PRWEB) January 11, 2007

Barcoding Inc., the nationally recognized leader in automated data-capture solutions, will display its RFID Active Shelf inventory track system. This RFID shelving system is an affordable way of conducting continuous inventory counts in retail stores, stockrooms, pharmacies, libraries, and warehouses.

How it Works:

A single RFID reader is combined with an array of antennas placed within the shelves to create inventory zones. Zones can be divided by racks, shelves, or segments within each shelf. The zones are continuously monitored by the system so you know the actual status of your retail inventory at all times.

The RFID antennas within each zone monitor RFID signals from the tags that are placed on or embedded in your products. The antennas send identifying information through our patent-pending hybrid multiplexer which then transmits the data to a central RFID reader. This reader connects to your database through either a hard-wired connection or through a wireless infrastructure. Inventory levels are then available to you via a web interface or an XML feed from the system.

Active Shelf can be connected to external devices at the edge of each shelf, such as a light or a sensor. These devices can be used to detect motion near a shelf and have the inventory level checked immediately, or if an item is found in the wrong location, a light can alert workers that something is out of place.

Active Shelf can read both High-Frequency (HF) and Ultra-High Frequency (UHF) RFID tags. As RFID standards evolve, your investment in the system is protected because you can switch to different frequencies and tag formats.

Attendees of NRF wishing to see and test out this new technology should stop by booth 1463 during this week's show at the Javits Center.

About Barcoding Inc.

Barcoding Inc., the nationally recognized leader in data-capture solutions, helps business and government organizations deploy supply chain technology, including bar code scanners, wireless terminals, mobile computers, RFID systems, and related software. Clients include manufacturing, distribution, healthcare and warehousing companies, as well as state, local and federal agencies. Based in Baltimore, Maryland, Barcoding Inc. has offices in Colorado, Connecticut, Illinois, Florida, Georgia, Massachusetts, Michigan, New York, Pennsylvania, Texas, and Virginia.

For further information about Barcoding Inc., please contact David Shapiro at 1.888.860.7226 x109 or visit www. barcoding. com.

###

Smartbrief, inc. Announces addition of job listings to popular daily newsletters for executives and top level professionals

2011-04-29T13:15:00.000-07:00

SmartBrief, Inc. Announces Addition of Job Listings to Popular Daily Newsletters for Executives and Top Level Professionals

SmartBrief, Inc. announced today the addition of job listings to its popular online daily newsletters in the following industries: Aerospace, Cable and Broadband, Construction, Education, Food service, Gay & Lesbian Leadership, Health Information Technology, Interactive Advertising, Regulatory / Medical Affairs, Retail, Retail Pharmacy and Wholesale Distribution.

Washington, DC (PRWEB) October 18, 2007

Washington DC-based SmartBrief, Inc. announced today the addition of job listings to its popular online daily newsletters in the following industries: Aerospace, Cable and Broadband, Construction, Education, Food service, Gay & Lesbian Leadership, Health Information Technology, Interactive Advertising, Regulatory / Medical Affairs, Retail, Retail Pharmacy and Wholesale Distribution.

The addition of job listings to the daily informative news briefs expands both the range and depth of services previously offered by the industry-leading site to executives and employers. The company also announced that it will soon launch job listings in additional newsletters focused on the business and Healthcare industries.

SmartBrief has become the leading publisher in customized e-mail newsletters and maintains partnerships with leading trade associations, professional societies and corporations. More than 1 million professionals in 18 industries rely on SmartBrief every day to save them time and keep them informed of essential industry news.

Unlike other online job services, SmartBrief offers an alternative to the typical job search for both candidates and recruiters. SmartBrief. com job listings help solve two of the biggest concerns in the online recruiting industry: anonymity and the need for passive job seekers.

Anonymity - One of the major concerns for Job seekers, both passive and active, remains the importance of staying anonymous during their job search. SmartBrief's job listings allow jobseekers to anonymously search jobs while reading industry news in their daily newsletters. Potential candidates have the ability to learn of open positions before they even begin their job search without anyone knowing they are in the market for a new career. Interested candidates reply to positions that fit their background and skill levels.

Passive Job Seekers - SmartBrief job listings helps employers and recruiters get their job openings in front of potential job seekers not typically listed on job boards or being called by recruiters. Many of these job seekers are not actively looking for a new position but are simply reading industry news. SmartBrief readers are interested in learning more advancing their knowledge of the industry as well as their career.

In addition to its superior job services, Smartbrief. com also provides a wealth of industry news, knowledge, and up-to-date information covering a wide range of industries.

To request interviews or learn more about SmartBrief Job and SmartBrief. com, please visit www. smartbrief. com/industryjobs/ (http://www. smartbrief. com/industryjobs/) or call Laurie Pollak at 202-737-5500 ext 248.

Contact:
Laurie Pollak
Http://www. smartbrief. com/industryjobs/ (http://www. smartbrief. com/industryjobs/)
Phone: 202-737-5500 ext 248
Jobhelp(at)smartbrief. com

###

Bluemile lights new albany's fiber network

2011-04-29T10:47:00.000-07:00

Bluemile lights New Albany's fiber network

The Village of New Albany’s fiber network now has access to over 180 carriers nationwide.

Columbus, OH (PRWEB) August 18, 2010

Three years ago, New Albany was a non-winning finalist for a major central Ohio economic development project. That’s when community development leaders realized the need for New Albany to build its own fiber network to attract new jobs to the community.

Fast forward to today when combined efforts with American Electric Power (AEP) and Bluemile have made New Albany a destination community for technology based companies throughout the country because of New Albany’s 96-strand fiber network that is self-healing and robust. These attributes contribute to a reliable and affordable network that provides access to more than 180 service providers nationwide.

“The Bluemile network team is extremely excited about the technology and services we've rolled out for New Albany," stated Chris Kane, Director of Network Engineering for Bluemile. "By leveraging Cisco's REP¹ and DWDM² technologies we can provide a menu of options and fast deployments. The simplicity and efficiency the design lends to high availability and fast failover. ”

New Albany’s fiber network allows prospective companies to maintain relationships with existing service providers no matter where they are located. As a result, New Albany is making a national name for itself, even beating out cities like Atlanta and San Antonio for high tech companies and mission critical facilities.

"We are honored and excited to help the Village of New Albany support their local businesses,” states John McKenna, Vice President of Enterprise Sales for Bluemile. “The Blue Albany™ Network is helping New Albany attract new businesses by offering companies a way to lower operational expenses for technology and to preserve capital. New Albany does a tremendous job with economic development by offering their businesses the amenities they need to be successful.”

In the last two years alone, Motorists, Nationwide and TJX (the parent company of TJ Maxx), all Fortune 500 companies, have committed to New Albany because of its technology infrastructure. Additionally, PharmaForce is bringing 200 jobs to New Albany through expanded operations and Aetna, a New Albany mainstay for more than a decade, is doing the same.

“I’m thrilled with what we’ve been able to accomplish here in New Albany, and it wouldn’t have been possible without our partnership with Bluemile,” said Jennifer Chrysler, New Albany’s Community Development Director. "They have been vital to New Albany’s success."

ABOUT BLUEMILE

Bluemile is an established leading-edge provider in cloud services, wholesale voice, colocation and data technology solutions. With an optical and IP National Network powered by Cisco, a Sonus powered Voice Network, an enterprise-grade fully owned and operated tier 3 datacenter, and a best of breed vBlock cloud infrastructure, Bluemile has become one of the fastest growing companies in the industry. Bluemile specializes in the products and services that power the most successful companies and service providers worldwide.

Please visit us at:
Http://www. bluemilecloud. com (http://www. bluemilecloud. com)

The Bluemile Team
Http://bluemilecloud. com/about/executive-bio. php (http://bluemilecloud. com/about/executive-bio. php)

Bluemile Videos
Http://bluemilecloud. com/about/video-series. php (http://bluemilecloud. com/about/video-series. php)

Social
Http://www. facebook. com/bluemilecloud (http://www. facebook. com/bluemilecloud)
Http://www. twitter. com/bluemilecloud (http://www. twitter. com/bluemilecloud)
Http://www. linkedin. com/companies/bluemile-inc (http://www. linkedin. com/companies/bluemile-inc).

Additional Contacts:

Stawn Kaufman
Bluemile Inc.
614-410-2501

Jennifer Chrysler, Community Development Director
Village of New Albany
614-855-3913

Rod Brown, Director Mission Critical Facilities
Nationwide Mutual Insurance

Bill Ebbing, President
The New Albany Company
614-939-8000

This release may contain forward-looking statements regarding future events that involve risks and uncertainties. Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual future events or results. Any forward-looking statements represent Bluemile's views only as of today and should not be relied upon as representing Bluemile's views as of any subsequent date. While Bluemile may elect to update forward-looking statements at some point, Bluemile specifically disclaims any obligation to do so, except as required by law.

Bluemile™, bCloud™ and Blue Albany™ are registered trademarks of Bluemile, Inc. All other company and product names may be trademarks of the respective companies with which they are associated.

¹Resilient Ethernet Protocol
²Dense Wave Division Multiplexing

###

New fiber supplement - psyllium and inulin blend for maximum health benefits

2011-04-29T06:29:00.000-07:00

New Fiber Supplement - Psyllium and Inulin Blend for Maximum Health Benefits

Konsyl announces Balance Orange Flavor Fiber and Prebiotic Blend; a NEW specially formulated blend with two fiber sources that promote and support daily digestive health.

Easton, MD (PRWEB) February 24, 2007

Konsyl Pharmaceuticals, Inc., a leading producer of high quality, all natural fiber supplements for improving intestinal health, is proud to announce Konsyl® Balance Orange Flavor. Konsyl® Balance is a blend of two popular natural fiber sources, psyllium and inulin.

Natural psyllium fiber has been recognized as the "Best Choice" for those who need fiber for medical reasons. Studies have proven psyllium's cholesterol lowering benefits.

Inulin is the ingredient found in Fibersure®* and is also a soluble vegetable fiber. Inulin is a popular fiber alternative with its prebiotic properties. Inulin increases the activity of the beneficial bacteria in the gut, by acting as a "food" for the good bacteria ("probiotics") in your digestive system. This is why inulin is called a "prebiotic".

Konsyl Balance Orange Flavor offers a great combination of psyllium fiber for normal elimination and cleansing in the digestive tract, plus inulin fiber for a healthy balance of intestinal flora. The refreshing Orange Flavored powder is reasonably priced at $.26 cents per dose in a 50-dose container. This product is available online at www. addfiber. com.

*Fibersure is a registered trademark of Procter & Gamble.

About Konsyl Pharmaceuticals, Inc.

Konsyl Pharmaceuticals, Inc. produces high quality, all natural fiber supplements and digestive aids for improved intestinal and digestive health. Konsyl products address a variety of digestive issues, such as constipation, hemorrhoids, diarrhea, IBS and diverticulosis. For over 45 years, doctors have recommended 100% natural Konsyl products as a soluble fiber supplement for patients of all ages. The high fiber content of Konsyl products helps consumers to achieve dependable digestive health. Konsyl products are available in fine pharmacies and chain stores throughout the United States. For more information on Konsyl Pharmaceuticals, Inc. or its complete line of products, contact a company representative at 800-356-6795, or visit the company's website at www. konsyl. com.

# # #

A c labels bought by the mercian labels group

2011-04-29T02:38:00.000-07:00

A C Labels bought by the Mercian Labels Group

Barcode labelling specialists A C Labels have been acquired by the Mercian Labels Group in an assets and goodwill deal, securing the long term supply of variable data barcode labels and the highly regarded A C Labels brand.

(PRWeb UK) April 3, 2010

Barcode labelling specialists A C Labels (http://www. aclabels. co. uk/) have been acquired by the Mercian Labels Group (http://www. mercianlabels. com/) in an assets and goodwill deal, securing the long term supply of variable data barcode labels and the highly regarded A C Labels brand.

“A C Labels has a fantastic reputation in the marketplace as a market leader in complex variable information labelling.” said Dr Adrian Steele, Managing Director of Mercian Labels, adding “We are establishing a new operation in Derby specifically to serve this demand, and are delighted with both the support shown from the client base for the acquisition, and also the opportunity to acquire the brand of A C Labels. This new subsidiary of the Mercian Labels Group complements our other speciality companies in manufacturing tamper evident security labels (http://www. securitylabels. com/), Label Lock security seals (http://www. labellock. com/) and short run digital, hotfoil and flexographic labelling (http://www. selfadhesivelabels. com/).”

The new company will continue to manufacture complex constructions of self adhesive labels inlcuding variable data and barcodes, serving the medical, pharma and logistics marketplaces, and is now involved in ensuring a seamless transition for existing customers of AC Labels and to secure and expand the prospects of the business in Derby.

# # #

Fall enrollment largest in history; also record freshman class

2011-04-28T05:25:00.000-07:00

Fall Enrollment Largest In History; Also Record Freshman Class

Southern Illinois University Edwardsville] has reached the largest overall enrollment in the history of the school at 13,940, breaking the previous high of 13,700 recorded in 1970. The record enrollment numbers were released on the heels of U. S.News & World Report ranking SIUE as one of the "Top Up-And-Coming Schools" in the nation, fifth among Midwest master's granting institutions and among 77 schools from all degree categories throughout the country.

Edwardsville, IL (Vocus) September 10, 2009

Edwardsville, Ill. -- Southern Illinois University Edwardsville (http://www. siue. edu/) has reached the largest overall enrollment in the history of the school at 13,940, breaking the previous high of 13,700 recorded in 1970. The record enrollment numbers were released on the heels of U. S.News & World Report ranking SIUE as one of the "Top Up-And-Coming Schools" in the nation, fifth among Midwest master's granting institutions and among 77 schools from all degree categories throughout the country.

In the "Top Up-And-Coming Schools" category, SIUE was cited in U. S. News by its peers and reported as an "up and coming school firmly focused on improving the job they're doing today." All the rankings are in the magazine's Best Colleges of 2010 issue that hit newsstands last week.

SIUE Provost Paul Ferguson released the fall numbers today, which include undergraduate, graduate and professional schools. The new freshman class of 1,940 is up from 1,922, representing the largest group of new freshmen ever. The figures represent the fifth consecutive year of growth in new freshmen enrolled at SIUE.

"We continue to attract new students who are coming to SIUE as a first-choice, first-tier institution in Illinois," Ferguson said. He also noted "this national recognition from our peers and national associations strongly supports the commitment of SIUE to continuous quality improvement and academic innovation in all of our academic programs, and is a wonderful affirmation of the excellence of our faculty, staff and students."

For the fourth consecutive year, SIUE has been ranked among the Top 15 public universities in the Midwest-Master's category. SIUE also continues to be ranked by U. S. News in the top one-third of all public and private Midwestern master's level universities.

According to Scott Belobrajdic, SIUE's assistant vice chancellor for Enrollment Management, this is the second consecutive year of overall enrollment growth at the University including a 2 percent increase in returning undergraduates over last year and a 12 percent increase in graduate school enrollment. Applications to SIUE undergraduate and graduate school programs reached 15,373 this year. That is 16 percent more than last year and a 21 percent increase over fall 2007.

"We believe we are seeing some early returns on increased undergraduate retention efforts and several graduate programs are seeing the benefits of very intentional program modifications," Belobrajdic said. "Overall, the growth this year has been balanced but the growth in the graduate school has been impressive."

"We worked very hard to control the growth of the freshman class this year," he said. "Faced with an 18 percent surge in freshman applications the University had to stick to published deadlines and try to anticipate any possible negative enrollment impact from the economy," Belobrajdic said. "We were inundated with a record number of federal financial aid applications for new and returning students so we knew interest in SIUE was high, but we did not know how the economy would factor into the enrollment picture."

Southern Illinois University Edwardsville is a nationally recognized public university offering a broad choice of degrees and programs ranging from career-oriented fields of study to the essential, more traditional, liberal arts. At SIUE we offer 44 baccalaureate degrees, 13 post-baccalaureate certificates, 47 master's degrees, 11 post - master's certificates, two first-professional degrees, and one post-first professional certificate. Known for an emphasis in health science education (http://www. siue. edu/), SIUE offers a nursing school (http://www. siue. edu/), pharmacy school (http://www. siue. edu/) and dental school (http://www. siue. edu/). Additionally undergraduate and graduate degrees and certificates are available in engineering programs (http://www. siue. edu/), business programs, elementary education programs and secondary education programs.

SIUE offers the advantages of a small, liberal arts college with the low tuition rates of a state university. Our emphasis on undergraduate education, complemented by faculty research, creates practical applications for student learning. Located in the second most populated area of the state, this Illinois university (http://www. siue. edu/) draws students from all 102 Illinois counties, 42 states and 50 nations.

One of 12 Illinois colleges and universities (http://www. siue. edu/), SIUE is located on 2,600 acres of rolling hills and woodlands in Edwardsville, just 25 miles from St. Louis, a major metropolitan area. Proximity to the St. Louis area enhances SIUE's energy and vitality. The campus is easily accessed from several major interstates, while the city of Edwardsville offers ample opportunity for jobs, entertainment, shopping and fun.

###

“Great two-way communication” dorset police praise solcara support

2011-04-26T17:55:00.000-07:00

“Great Two-Way Communication” Dorset Police praise Solcara Support

Solcara PressBureau users at Dorset Police have praised Solcara, the market leading software solution provider, for its excellent level of support.

(PRWEB) June 14, 2006

Solcara PressBureau users at Dorset Police have praised Solcara, the market leading software solution provider, for its excellent level of support.

This comes after an upgrade to the latest version of Solcara PressBureau, a move that not only enhanced the existing functionality of the system but also offered many new features and benefits.

An essential link between the police and the press, Dorset Police’s busy media department is responsible for maintaining and promoting the reputation of the police force. Advising staff at all levels on media issues, the innovative police department receives 12, 500 calls a year and saw the benefits of Solcara PressBureau a year ago, went it first went live with PressBureau version 3.2.

Solcara PressBureau has proven to be a vital tool at Dorset Police for capturing and sharing information, ensuring that the right information reaches the right people at the right time. Version 4 offers Dorset Police even more for its Media Relations department, where internal and external communications are a high priority.

As such an integral part of the Media Relations department, good communication between Dorset and Solcara was essential during the PressBureau upgrade. Solcara takes pride in its high level of customer support, and such praise confirms the company is hitting the mark in this field.

“With enhanced reporting abilities, Solcara PressBureau version 4 has an incorporated and centralised homepage and the ability to create news releases from within the application. That has made us even more efficient than ever before.” said Paul Breakwell, Head of the Media and Corporate Communication Department at Dorset Police.

“There is excellent two-way communication between us and Solcara,” continued Mr Breakwell. “PressBureau is extremely useful because it gives us access to the current situation and we are even more effective with the solution. We work even more efficiently now. The support that Solcara offered during and after the upgrade has been second to none. We are very pleased with both the current upgrade and the Solcara team,” added Mr Breakwell.

Charlie O’Rourke, Sales Director at Solcara, commented, “Solcara PressBureau is already the de facto standard for press offices nationwide. To be known also for our first rate support is a wonderful compliment for the company and a reward for the hard work and dedication the team have for every customer. We are delighted Dorset Police is seeing real returns on its investment and we look forward to maintaining and exceeding its software expectations.”

About Dorset Police

The Media and Corporate Communication Department is based centrally at Dorset Police’s Winfrith Headquarters, near Wareham. From dealing with the day-to-day media enquiries to managing the media interest in cases of serious crime and major incidents, the work of the media relations office is very varied. The department also includes the photography, video and graphics units.

The Media and Corporate Communication Department looks after the reputation of the Force and promotes the positive work of officers and support staff. Responsibilities include the production of the Annual Report and the annual Policing Plan. It also produces many corporate documents and maintains a good relationship with the local media and departments and divisions across the Force.

Promoting the Force Corporate Communications Strategy, from which all other communication strategies should flow, is an important element of the PR section's work.

The department works in liaison with the Police Authority and provides support and advice on promoting sponsorship agreements.

About Solcara

Solcara dramatically increases the value of an organisation’s information.

We do this by providing web based software and solutions that connect people to information that matters. With Solcara you spend less time searching for information and more time putting information to work.

Our software enables users to capture, store, share and re-use unstructured and structured information regardless of its format, type or location. By improving access to this information we enable our clients to drive efficiency and productivity gains through knowledge intensive business processes in order to significantly impact the bottom line.

Solcara is one of the UK’s fastest growing and most innovative software companies. We service the needs of clients across many sectors including government, professional services, pharmaceuticals and the media.

###

Healthcare solutions and mitchell international announce specialty network services for auto casualty market

2011-04-22T04:21:00.000-07:00

Healthcare Solutions And Mitchell International Announce Specialty Network Services For Auto Casualty Market

Through a strategic partnership, Healthcare Solutions and Mitchell International have developed a new approach to medical cost management that includes enhanced capabilities for managing pharmacy, diagnostic imaging and other ancillary healthcare costs for auto injury claims.

(Vocus/PRWEB) April 13, 2009

Atlanta (Vocus) April 13, 2009 -- Healthcare Solutions and Mitchell International announced today a new specialty network solution for the auto casualty market. Through a strategic partnership, Healthcare Solutions and Mitchell International have developed a new approach to medical cost management that includes enhanced capabilities for managing pharmacy, diagnostic imaging and other ancillary healthcare costs for auto injury claims.

The solution integrates Healthcare Solutions’ specialty networks into Decision Point®, Mitchell International’s leading bill review application for the auto industry, to provide deep discounts on covered services and increased visibility into medical dollars associated with claims. For carriers utilizing Decision Point, the solution can be seamlessly deployed with little to no impact on a carrier’s technology resources.

“Total medical expenses are rising faster than the rate of medical care inflation, fueled by increases in the number of pharmacy claims, the fastest growing component of healthcare costs, and diagnostic imaging services with increasing utilization and soaring treatment costs,” said Dave Torrence, senior vice president of Mitchell International. “Integration of Healthcare Solutions’ specialty networks into Mitchell International’s bill review process provides carriers discounts ranging between 25-35% over traditional re-pricing methods, and 75% better program use, due to seamless automation within Decision Point.”

In addition to substantial discounts, the program also provides improved operational efficiency and enhanced policyholder value and satisfaction. Policyholder value is increased through ease of access at over 50,000 retail pharmacy locations nationwide, the elimination of out of pocket expenses and maximized policy limits.
The program reduces the volume of reimbursement checks written due to prospective management of bills and payment to a single vendor through Decision Point. It also reduces the number of paper bills manually entered into the system, eliminating keying errors and payment mistakes.

The integrated solution includes a prospective pharmacy program that yields discounts approximating 30% through a combination of improved management of drug utilization and compliance, the application of industry-standard treatment protocols and network discounts substantially deeper than traditional re-pricing methods that utilize Medi-Span® or Red Book® to only review bills after the expense has been incurred by the policyholder.

Additional ancillary healthcare services included in the program consist of diagnostic imaging, home healthcare and durable medical equipment and supplies. Inclusion of specialty networks into Decision Point increases the number of bills managed through in-network providers and provides discounts averaging 25% below typical charges without disrupting the bill review process. Preliminary analyses indicate that inclusion of specialty network services within Decision Point adds 75 – 80% in additional program usage.

“The comprehensive specialty network solution provides for significant improvement in loss costs related to pharmacy and other ancillary healthcare services, reduces claims administrative burden for carriers and enhances policyholder satisfaction,” said David A. George, chief executive officer of Healthcare Solutions. “Integration of specialty networks within Decision Point provides a best in class solution for customers.”

For more information about specialty network services offered by Mitchell and Healthcare Solutions, contact Kevin Gitre, Sr. Vice President of Sales for Mitchell Medical at 858-368-8030, or Kim Plotkin, Vice President of Sales for Healthcare Solutions at 303-916-6685.

About Healthcare Solutions
Healthcare Solutions, Inc. is the parent company of Cypress Care and Procura Management. Through its affiliated companies, Healthcare Solutions serves as a health service company delivering integrated solutions to the property and casualty markets, specializing in workers’ compensation and auto liability/PIP. The company’s customers include insurer carriers, third party administrators (TPAs), managed care organizations (MCOs), government agencies and self-insured employers. Utilizing market-leading technology, Healthcare Solutions delivers demonstrated benefits and savings complemented by deep industry expertise. For more information, please visit http://www. healthcaresolutions. com.

About Mitchell International
Mitchell International, Inc. (http://www. mitchell. com) provides the Insurance P&C market with a variety of technology, database and service solutions with one goal in mind –enable our clients to process their automotive medical claims in a timely, accurate and fair manner. Mitchell International has a 20 year track record of delivering high-quality products and services to auto insurance carriers, service providers and TPAs, allowing them to audit and evaluate first and third-party provider and hospital bills. Mitchell International currently serves many of the top automobile and workers compensation P&C companies and is a leading provider of information, workflow, and performance management solutions to the automotive insurance claims industry, also serving carriers, collision repair facilities, and other commercial participants in the physical damage and automobile and workers compensation related medical claims markets.

###

88% of gps in the uk prefer physical exercise or diet as the treatment for metabolic syndrome

2011-04-21T18:06:00.000-07:00

88% of GPs in the UK Prefer Physical Exercise or Diet as the Treatment for Metabolic Syndrome

Research and Markets (http://www. researchandmarkets. com/reports/c32025 ) has announced the addition of Barriers to Effective Management of Metabolic Syndrome to their offering.

Dublin, Ireland (PRWEB) March 16, 2006

Research and Markets (http://www. researchandmarkets. com/reports/c32025 (http://www. researchandmarkets. com/reports/c32025)) has announced the addition of Barriers to Effective Management of Metabolic Syndrome to their offering.

Business Implications

Sedentary lifestyles and a steady increase in obesity have contributed to rapid growth in the prevalence of metabolic syndrome in many developed nations. We estimate that, in 2003, almost 123 million people had metabolic syndrome in the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan. This population is projected to grow to 137 million in 2013. We forecast that the market for metabolic syndrome therapies will increase from $9.7 billion in 2003 to $12.8 billion in 2013. The market has enormous untapped potential, especially in Europe, but several major barriers (e. g., a lack of consensus on the definition of the disease, underdiagnosis, poor management, difficulties in the licensing of new therapies, reimbursement restrictions) have constrained growth.

General practitioners (GPs) in Europe favor the use of lifestyle modifications in the treatment of metabolic syndrome. One survey found that 88% of GPs in the United Kingdom and 69% in France identified physical exercise or diet as a preferred treatment for this disorder. More than 70% of GPs in the United Kingdom also favored treatment of cholesterol or triglycerides, hypertension, overweight, or all factors, and 60% favored the use of oral antidiabetics in the management of metabolic syndrome. French GPs were markedly less inclined to use these therapeutic options. Moreover, GPs in the United Kingdom described an average of 4.7 of these options as preferred courses of action, compared with an average of just 2.0 for French GPs.

Physicians in the United States identify controlling hypertension and elevated low-density lipoprotein (LDL) cholesterol as top clinical

Priorities owing to the well-characterized cardiovascular risk associated with these abnormalities and the availability of effective agents that can regulate them. Common first-line therapy includes oral antidiabetic agents, antihypertensive agents, and statins to control each of these components. Physicians attach less importance to elevated triglycerides, low high-density lipoprotein (HDL) cholesterol, and obesity, likely because the connection between these disorders and elevated cardiovascular risk is less clear and because therapeutic options are limited.

Achieving a consensus definition of metabolic syndrome would increase detection rates, stimulate the development of drugs targeted at metabolic syndrome, and improve the reimbursement climate for drugs prescribed for this indication. Recent convergence in definitions suggests that a consensus may be within reach, but two very influential associations have challenged the validity of the concept of metabolic syndrome. If other organizations support this view, and the medical profession responds to such advice, the concept of metabolic syndrome as a distinct disease could fall out of favor.

Some of the most widely prescribed drugs for constituents of the metabolic syndrome (e. g., metformin, glibenclamide, simvastatin, lovastatin, pravastatin, ramipril, amlodipine) are off-patent in Europe, and many other agents will lose patent protection in the next five to ten years. As a result, the European market for metabolic syndrome therapies is becoming increasingly genericized. With one or more oral antidiabetics, statins, and antihypertensives available in generic form in most of Europe, physicians can manag most of the symptoms of metabolic syndrome without prescribing branded medicines.

We forecast that the market for metabolic syndrome therapies will increase from $9.7 billion in 2003 to $12.8 billion in 2013. This market has enormous untapped potential, especially in Europe, but several major barriers (e. g., a lack of consensus on the definition of the disease, underdiagnosis, poor management, difficulties in the licensing of new therapies, reimbursement restrictions) have constrained growth.

In this Decision Resources report, we consider the problems resulting from the lack of a consensus definition of metabolic syndrome. We then examine how limited knowledge and inadequate screening have contributed to underdiagnosis of the disease. We review therapeutic options and assess the reimbursement environment for metabolic syndrome therapeutics. Further, we analyze the challenges that face drugs in development for this disorder and the consequences of a renewed debate over the validity of metabolic syndrome as a distinct disease. We conclude with an assessment of the outlook and implications for the pharmaceutical industry.

For more information visit http://www. researchandmarkets. com/reports/c32025 (http://www. researchandmarkets. com/reports/c32025)

Laura Wood

Senior Manager

Research and Markets

Fax: +353 1 4100 980

# # #

Fullscope, microsolutions collaborate to form fullscope scandinavia a/s

2011-04-20T22:20:00.000-07:00

Fullscope, Microsolutions Collaborate to Form Fullscope Scandinavia A/S

First Customer: Hempel A/S for 250 Users Now, Potential for 1,000 Users

Atlanta, GA and Horsens, Denmark (PRWEB) September 3, 2008

Fullscope, Inc., and Microsolutions A/S, both Microsoft Gold Certified Partners that focus on selling and implementing Microsoft Dynamics® AX enterprise resource planning (ERP) solutions, today announced their collaboration to form Fullscope Scandinavia A/S, a joint venture to better serve European partners and international customers in process industries (food, beverage, chemicals, life sciences and pharmaceuticals).

The arrangement gives Fullscope a local presence to better support the European resellers of Process Industries for Microsoft Dynamics AX, a solution that Fullscope develops for Microsoft as part of its industry program. The Process modules are certified and supported by Microsoft and are available worldwide to Microsoft Dynamics AX industry partners from the Microsoft price list. Fullscope assists in training and enabling the worldwide reseller channel.

"Fullscope has several North American customers with international sites, and this relationship will allow us to provide excellent customer service to all of our global customers," said John Scandar, executive vice president and co-founder of Fullscope. "Microsolutions is a strong Microsoft partner with a long history in the ERP industry and specifically with Microsoft Dynamics AX. The company, its management team and associates are an ideal fit for Fullscope and our first partnership of this type in Europe."

"Fullscope Scandinavia, Fullscope and Microsolutions bring a wealth of combined knowledge and experience to the table for both end users and partners. It's a an exciting situation for everyone: customers, partners and Microsoft," said Flemming Lund, CEO, Microsolutions, and co-founder of Fullscope Scandinavia.

Fullscope Scandinavia recently secured its first client, Hempel A/S, who will implement Microsoft Dynamics AX and Process Industries for Microsoft Dynamics AX across all of its European offices over the next three years. For additional details, see the July 30, 2008, press release, "Hempel A/S to Implement Microsoft Dynamics AX."

Microsolutions was founded in 2004 and is a highly recognized Microsoft Dynamics AX partner. The company is known for its many competencies, in-depth business knowledge and close partnership with Microsoft. For more information, visit http://www. microsolutions. dk (http://www. microsolutions. dk).

About Fullscope:
The 2007 and 2008 Microsoft Dynamics AX Partner of the Year, Fullscope offers deep domain expertise for companies with process, discrete and hybrid manufacturing operations. The company develops and supports Process Industries for Microsoft Dynamics AX; offers a Certified for Microsoft Dynamics solution for Microsoft Dynamics AX for High Tech; and is one of the largest Microsoft Dynamics AX resellers in the United States and Canada. For more information, visit http://www. fullscope. com (http://www. fullscope. com).

Product or service names mentioned herein may be the trademarks of their respective owners.

###

Select safety sales adds the new speakman se-4300 series to their eyewash station product line

2011-04-20T14:10:00.000-07:00

Select Safety Sales Adds the New Speakman SE-4300 Series to their Eyewash Station Product Line

Select Safety Sales adds the Speakman SE 4300 Series to their Eyewash Station Safety Product Line. Eyewash Stations are required by OSHA in industrial settings where workers are exposed to caustic chemicals. This series includes new features for workers safety and protection.

Clark, NJ (PRWEB) December 14, 2010

Select Safety Sales, LLC has added the Speakman SE 4300Series to its Eyewash Station Product Line. This series of gravity fed portable eyewash stations is the first of its kind to include an optional drench hose that can be used for spot body flushing in addition to its eyewash capabilities. The spot flushing can be used while the eyewash is in use. The unit also includes a 20 gallon tank which allows for longer flushing than most stations. Within the 4300 series is the SE-4350 heated eyewash which has all of the features of the SE-4300 but includes a heating component that will protect the unit from freezing in cold, harsh environments.

Eyewash Stations are an integral safety component in industries where workers are exposed to caustic chemicals. OSHA requires the use of emergency eyewash stations and showers and stipulates: “Where the eyes or body of any person may be exposed to injurious corrosive materials, suitable facilities for quick drenching or flushing the eyes and body shall be provided within the work area for immediate emergency use” {29 CFR 1910.151 (c). The ANSI/ISEA Z358.1-2009 standard guides industry in the proper selection and installation of the equipment in order to meet OSHA’s requirements. Industries and Government that usually require the use of eyewash stations are Manufacturing, Construction, Automotive, Military, Healthcare, Pharmaceutical, Colleges and Agriculture.

There are several types of eyewash stations that can be installed in a facility or jobsite. Plumbed units are connected directly to the water supply in a facility and Gravity-fed eyewashes are portable units that can be easily moved around to be close to the hazard. One type of portable eyewash station is a self contained unit that is filled with potable water and a preservative that is added at the facility or job site; while another type contains a sealed cartridge with a preservative added by the manufacturer. The SE-4300 Series uses tap water mixed with a preservative as the flushing fluid. An added benefit of a portable unit is the flexibility of its relocation which is especially convenient on a temporary job site. The fluid can be removed and the unit can be easily moved to another location. Some facilities have the need for emergency showersand an eyewash combination, because workers are exposed to large amounts of chemicals and the whole body of the worker is at risk. The SE-4300 series can be used in addition to these showers or in places where a shower installation is not feasible. The drench hose is available in case of a splash that sprays outside the eyes. The SE-4320 includes the drench hose on the 4300 series is an added safety feature on the unit though the drench hose is not ANSI compliant on its own.

It’s important to review Emergency Eyewash Requirementswhen purchasing an eyewash station or emergency shower for the industrial workplace. The guidelines set by the ANSI Standards, provide for a safer workplace for employees on the job. In order to be ANSI compliant, an eyewash station must provide a full fifteen minutes of continuous flushing with tepid water between 60 and 100 F in addition to the valves of the unit staying open without the use of the hands. Speakman’s SE-4300 series goes beyond the 15 minute requirement because of its larger tank. The heated unit provides for the tepid temperature required even in a colder work environment.

Select Safety Sales is a global distributor of eyewash stations, emergency showers and safety supplies and equipment. ”We work closely with our manufacturers so that we have the opportunity to offer our customers the newest innovative designs to keep their workplace safe and OSHA compliant” states Matthew Kane, a Managing Member of Select Safety Sales. The company was founded in 2005 as a small woman owned business. Select was awarded a GSA contract in 2009 which allows its products to be sold to the Federal Government at preset pricing in addition to its commercial base of customers

For additional information please contact:
Matthew Kane
Select Safety Sales, LLC
Http://www. selectsafetysales. com

# # #

Briefing paper: severe acute respiratory syndrome (sars) preliminary implications on the economy and disease overview

2011-04-20T13:11:00.000-07:00

Briefing Paper: Severe Acute Respiratory Syndrome (SARS) Preliminary Implications on the Economy and Disease Overview

The purpose of this briefing is to give the reader a current overview of SARS, a baseline of information about the disease and some economic implications to build upon.

(PRWEB) April 25, 2003

SARS Briefing Paper

Author: Peter Lytle, Managing Partner

The Business Development Group www. bdgpartners. com

Contact information: plytle@bdgpartners. com or 952-473-3831

Permission to use granted.

4/22/03

Briefing Paper: Severe Acute Respiratory Syndrome (SARS) Preliminary

Implications on the Economy and Disease Overview

The purpose of this briefing is to give the reader a current overview of SARS, a baseline of information about the disease and some economic implications to build upon. As the First World War came to an end, we entered a period of global travel; and with that travel, began the first global pandemic. By the end of the pandemic, over 20 million people lay dead. Since that time, we have experienced a variety of related diseases. Some are as dangerous, some with the potential to do as much damage: Aids, Hantavirus, avian flu, variants of CJD and CWD, West Nile, Ebola, Indian plague, smallpox, Legionaries disease and many other varied bacterial and viral infections. On an average, the world is subjected to a new biological threat from Mother Nature every 6 to 10 years. Man-made biological threats can be developed ad hoc: Anthrax and Smallpox.

Severe Acute Respiratory Syndrome or SARS has not received all the attention in the US media that it has in other countries perhaps due to the war. Perhaps because we are all complacent, thinking the ability to manage these diseases is commonplace. SARS has not yet been proven to be a mega disease, but it may be on the verge of becoming one. If SARS were to go unchecked in the world and mimic the problems created in China, Hong Kong or Toronto, we could see a significant impact on our economic marketplace and healthcare system.

What is SARS?

SARS is a respiratory illness believed to be caused by the coronavirus. In some cases, it is being referred to as Atypical Pneumonia because of its close resemblance to pneumonia. The criteria for SARS are: temperature of 100.5 degrees or more, one or more clinical findings of respiratory illness (i. e. cough, shortness of breath, difficulty breathing, hypoxia, or radiographic findings of either pneumonia or acute respiratory distress syndrome), travel to an area with documented or suspected community transmission of SARS, and/or close contact within 10 days of onset of symptoms with either a person with a respiratory illness who traveled to a SARS area or a person known to be a suspect SARS case. In a limited number of cases individuals also had diarrhea.

What is the origin or SARS?

A small group of scientists believes that SARS may have come from farm animals. Bi Shengli, of the Chinese Center for Disease Control and Prevention in Beijing, stated that the earliest victims in Guangdong were chefs or bird vendors in contact with chickens, ducks, pigeons and owls. This theory is yet to be proven. The current theory is that SARS is a new coronavirus; similar to the family of coronavirus that causes the common cold and mild to moderate upper-respiratory illness in humans. When viewed under a microscope, they have a halo or crown-like appearance. Some researchers think this strain of coronavirus identified may also be similar to a virus that is far more serious and found in animals where it is associated with respiratory, gastrointestinal, liver and neurological disease, but recent genetic testing has not identified this as the case. In several cases of SARS, metapneumovirs has been isolated; the role in the pathogenesis in SARS remains unclear. Scientists recently sequenced the corona virus found in numerous SARS patients and believe it is new. One of the concerning things about this virus is its ability to mutate rapidly. As one scientist state Âthis is a virus looking for the perfect host or transmission vehicleÂ. The coronavirus identified is currently considered the primary cause of SARS, according to a briefing by World Health Organization on April 17, 2003. Other potential viruses may still yet be identified that may interact with the disease as it progresses however.

SARS is believed to have originated in or around the Guangdong province of China in November of 2002 or before. From there it spread to a single hotel in Hong Kong, called the Metropole, then certain hospital clusters involving seriously ill patients. Guests on the 9th, 11th, & 14th, floors of the Metropole Hotel were exposed. International travelers from these floors spread the disease to another five countries; the disease is now in 26 countries. In February of 2003 it appeared in North America for the first time.

What is the incubation period for SARS?

Typically it is 2 through 10 days. The illness begins generally with an onset of fever of 100.4Âº or more. The fever is often associated with chills and/or rigors and might be accompanied by other symptoms including headache, malaise and myalgia. After 3 through 7 days, a lower-respiratory phase begins with the onset of a dry, nonproductive cough or dyspnea. In 10% to 20% of cases the respiratory illness is severe enough to require incubation and mechanical support.

What is the mortality rate?

This is an extremely aggressive disease. In countries where it was originally established, 1 in 20 are believed to be dying. The CDC estimates the mortality rate at about 3.5%, which is similar to other respiratory diseases. Other organizations such as Health Canada have placed the death rate at 4% to 9%. Hospitals in China have experienced up to a 25% mortality rate. It is too early to tell the actual mortality rate and it will likely be different in each country.

At the present time (4/21/03), there are 3,947 cases worldwide, there have been 229 deaths and 1,1935 recoveries. Two hundred twenty eight suspected cases have been reported in the US in 35 states, with no deaths to date. Cases studies before 4/5/03 indicated 94% of the individuals had traveled within 10 days before the onset of illness to the areas listed in the CDC SARS case areas. For more information on case areas, please go to www. cdc. gov and access the SARS page.

What is the risk of exposure?

SARS appears to be spread primarily by direct contact with moisture droplets or body fluids expelled by a SARS carrier. The World Health Organization (WHO) believes, however, that other factors may be involved. Several hundred residents of a housing complex in Hong Kong (Amoy Gardens) some of which are now leaving quarantine and being tracked; may have been infected with SARS even though they did not have direct contact with a SARS carrier. Research into transmission by cockroaches is being conducted in connection with this location. Thirteen labs around the world are currently researching SARS, how it is transmitted and related questions.

It is also becoming evident, according to the CDC and other health organizations, that some individuals may be more infectious than others. An April 4th teleconference, by the CDC and WHO, referred to the possibility of super carriers (individuals that are able to spread the disease greater than others).

According to Dr. Gerberding of the CDC, in one hospital in Hanoi, 56% of the health care worker population that came in contact with a SARS patient came down with the disease. In Toronto, where the disease has had a significant impact on hospitals and health care, 180 paramedics have been quarantined in their homes, three were hospitalized with symptoms after potential exposure to SARS infected individuals.

There appears to be a dramatic difference in the mortality of the disease depending on when it is detected. The US has experienced no deaths and a number of recoveries based on aggressive disease management, while Mainland China has experienced 1,457 reported cases and 65 deaths as of April 16, 2003. Actual numbers will turn out to be much higher. It appears that the government of China has under reported suspected case of SARS to prevent panic and economic damage to their industrial sector.

Dr Gerberding of the CDC believes this is a significant and serious threat to world health and one that needs immediate and vigilant attention. ÂWe recognize this as an epidemic thatÂs evolving differently.Â In transcripts from the CDC, Dr. Gerberding and Dr James Hughes, of the National Center for Infectious Diseases, have stated their concern about SARS. ÂThe potential for infecting large numbers of people is very great.Â The WHO said outbreaks in most parts of the world are currently under control but still spreading in China and Hong Kong. Other health organizations remain highly cautious and suggest this virus could still break away.

At the present time, many individuals that have been exposed to SARS have recovered or are in recovery. Early medical attention is critical. If you believe you have SARS you should contact local health authorities immediately and try to limit contact with other individuals if possible until you have been instructed on the best course of action.

Does the coronavirus live outside of the human body?

The virus appears to live about 3 hours outside the human body. Similar viruses have the capacity to live from 1 hour to 6 days outside the body. There are some very limited concerns that if dried, it may become airborne and still remain potent or maybe hosted by animals or in sewage or related environments. Research on other transmission methods is ongoing. Most research to this date indicates a human host is still the primary methods for transmission and the virus does not live well outside of a host. A great deal of attention is being given to ÂAirport transmissionÂ. Air passengers may be at some risk. Airplanes do filter air and only passengers in close contact to a SARS carriers or having touched perhaps a lavatory item etc. are believed to be at significant risk. The question is still being studied however and the answers may be months away. At which point a SARS carrier is infectious and can pass the disease on is still under debate.

Are there any tests developed to detect SARS?

SARS identification testing is under development. Currently a PCR test is being evaluated. Dr James Hughes has noted two CDC tests that look promising; one is an indirect fluorescent antibody test and the other is an Allose test. Both tests require the disease to have some time to establish itself in the human body.

Is there any known treatment for SARS?

At this time there is no known treatment for SARS; anti-viral drugs, antibiotics and steroids alone have not responded well. An article in the Financial Times on April 2, 2003 indicated that Hong Kong government health officials indicated some success with a treatment of cocktails of anti-viral drugs and steroids to modulate the extreme response by the patientÂs immune system. Ahang Wenkang, health minister for China believes they have found a combination of Western and Chinese medicine that works but no details are provided. There are vaccines used in animals to manage coronavirus so there may be an opportunity to expand this into human subjects in the future. No specific drugs to date including Ribavirin have demonstrated effectiveness in control of the disease. Mechanical ventilators are being used with acute patients. One concern facing many countries including the US is the lack of this equipment in the event of a major outbreak of SARS. It is estimate the US has fewer than 20,000 of these units available and during the peak of the Flu season most are in use, the question remains which patients would get the access to this equipment. With the genetic code now available for the SARS coronavirus a vaccine can be developed. This is a process that can take years, however and there is a lack of production capabilities for vaccines in the US at the present time.

Prevention of the disease is based on keeping away from direct contact with potentially infected individuals. Recommendations are to practice basic hygiene, washing hands frequently, and avoid areas where the disease is spreading. The use of surgical masks is having limited impact unless the mask is worn by an infected individual to reduce the droplets spread by the nose or mouth. Masks that are sealed and rated N-95, used in conjunction with eye protection and rubber gloves are suggested for individuals in close contact with infected individuals. N-95 masks are currently on back order many months by producers and may not be available should a large outbreak occur in the US or Europe. Most masks have a limited period of value (24 hours or less) once used. Improper use of the mask may also not prevent the disease from coming in contact with the mouth or nose. It is believed that a variety of disinfectants are successful at destroying the virus; chlorine-based disinfectants are listed in a number of health organizationÂs information articles. There is, however, no disinfectant that is currently registered or approved for SARS by any government organization at this time.

Should I travel overseas?

The CDC and WHO have travel advisories out for much of Asia. Check the CDC website. Toronto is also being noted as a travel caution area. In short, if you donÂt need to travel at this time, donÂt. Video conferencing is up 50% for Asia. According to the Center for Infectious Disease Research & Policy, individuals that are in the US who have not traveled to an infected area have very little risk of becoming infected with SARS. This suggests that staying home may mean staying safe. In some areas of the US Asian and their business are being avoided. There is no indication that Asians in the US are any more likely to have SARS than anyone who has traveled anywhere would. In fact the Asian community may have a higher awareness of the disease than other cultural groups.

Travel advisories are currently recommending restricted travel to: Mainland China (especially the Guangdong province), Vietnam (primarily Hanoi), Singapore, Hong Kong, Taiwan, Shanix and some organizations have placed a watch on Toronto, Canada. If a traveler acquires SARS in some of these countries they may not be admitted to hospitals but instead be directed to isolation clinics if they exist. Do not expect to find housing in hotels during the course of the disease. Most airlines will not allow SARS patientÂs reservations until the disease is proven to be gone and the patient fully recovered. Some countries are no longer allowing air passengers from case countries to disembark, and it is possible that a traveler could find himself or herself stranded for weeks or months if caught in an epidemic location.

Depending on the time line for this disease (3 to 10 years), the original countries where the disease has run its course may become safer to visit or do business in than countries where the disease has yet to penetrate 70% of the population, assuming a vaccine has hot been found. This is called the Jack-in Âthe-box theory. After the outbreak of food poisoning at Jack in the Box, it cleaned up its act and became one of AmericaÂs safest eating establishments.

Could SARS be similar to other respiratory or flu-like diseases?

Nobody knows. In the 1998 Â 99 flu season there were, according to the CDC, 20,000 flu associated deaths nationwide with 80 million doses of vaccine given to the public. The vaccine was between 70%-80% effective in preventing the flu among healthy adults. This could suggest that a similar disease, for which no vaccine exists, could have a devastating effect on any population that is not prepared. If SARS turns out to be an airborne disease, it will likely be considered more aggressive and could mimic the flu. Direct-contact diseases tend to spread slower allowing for health controls. The use of quarantine procedures may help control SARS. Most countries are utilizing quarantine procedures with SARS suspects but have not with used it with the flu, suggesting a lower risk rate for healthy individuals in developed countries.

Economic Impact of SARS

SARS currently has the greatest economic impact on Asian countries and businesses closely related to those countries. Among the industries currently being affected: Airlines, Asian and some Canadian (Toronto) convention and tourist business and local retail business, travel-related business and production of materials in China. By example, when Qantas Airlines issued the regionÂs first pneumonia-related profit warning two weeks ago, Merrill Lynch cut their estimates on earning by 19%. Cathay Pacific, which is based in Hong Kong, saw its shares drop by 18% and Singapore Airlines dropped by 14% as a result of SARS concerns by investors. KLM, the Dutch Airline, said that it feared the rapid spread of SARS was having a greater impact on the airline industry than the war in Iraq according to a report in the April 3rd edition of the Financial Times. As of April 16, 2003 some of the biggest Asian airlines said they had travel drop offs of up to 70% on flights to Hong Kong. Goldman Sachs analysis, Noboru Nakajima, believes that the disease will be significant in affecting all travel. Concerns by the cruise line industry of a potential SARS outbreak, has also created a major debate on how to manage the problem if it occurs and how to screen customers to reduce the threat.

Hong Kong is not a large producer of material goods anymore; on a global basis 70% of its revenues are generated by services. Services are driven by manpower. SARS is a tremendous threat to any Hong Kong based business. Already most schools are closed. Parents are staying home and away from restaurants, retail locations, cinema, and entertainment complexes. The HSBC Bank and other banks have shut down locations and canceled meeting and overseas travel. A number of embassies have closed and families sent home. Should SARS reach the US or Europe as it has in Asia, panic and over reaction will likely appear. With the war coming to an end CNN, Fox and other news media may look at SARS as the next big news item and set off a similar panic to that created Hong Kong.

In an effort to contain the damage done to its travel industry, China claims the disease is nearing control. The WHO, on the other hand, has now listed all of Mainland China under a travel advisory. Most health organizations believe that China has lost control of the virus. Manufacturing facilities in the Guangdong province are experiencing shortages of employees as non-dormitory workers stay home or are subject to quarantine. Concern by overseas buyers, that production will lag or their customers may reject goods produced in the Guangdong province, is creating a complex series of global discussion on finding supplemental suppliers before the next holiday season. China has become the supplier to the world in a variety of consumer goods and any unchecked spread of SARS in China will impact companies from Nike to Wal-Mart. China with its large electronics industry could also be subject to considerable damage. Wal-Mart has already asked its Asian travelers from case countries to go into a self-quarantine for 10 days before returning to work. Products shipped from China are considered safe due to the time it takes for them to reach US shore and should not be impacted directly according to the WHO. The workers that produce these products and those companies that have offices in China are at the greatest risk according to a recent article in Business Week.

If SARS spreads in the Western countries, the cost of health care could rise significantly. SARS is a very intensive disease to manage because it requires isolation of the patient; health care costs could increase 2 to 3 fold with a significant outbreak. The loss of workers for up to 30 to 60 days will also impact the productivity of countries and companies. Retail sales could fall significantly as they have in Hong Kong where it was reported by the Hong Kong Retail Management Association and Financial Times that retail sales are down by 50% since the outbreak of SARS with a potential 5% to 10% decline in property value estimated by Merrill Lynch

The Department of Defense is currently supplying support to the CDC in identification of the virus and in identification for means of infection. SARS could have a dire impact on our defense program and the war in Iraq. If troops in Korea became infected, we would see further destabilization of the region. The cost to the government for increased defense spending to make up for infected troops could have a longer-term impact on the recession.

At the present time there is no reason to believe that SARS is related to terrorism, so the positive side is less fear in the population. SARS is too complex and uncontrolled to use as a terrorist weapon, if it did come from a lab it would be more likely to have been the result of a lab accident where the virus was being use to create a vaccine. SARS may have more impact in some countries than others. Companies that purchase items from overseas or are related to the overseas travel industry (primarily Asia) could see longer-term financial issues. Companies in some sectors of the health care industry might see increases in revenue especially if they are in manufacturing of products like surgical masks, etc. Grants for funding research into SARS could benefit Universities and some pharmaceutical firms. SARS could help Internet commerce; catalog companies and delivery companies and digital movies grow as customer stay away from the crowds.

Companies, like Disney, could be hurt as consumers stay away from crowds this summer. Travel to Los Angeles and/or Hawaii could be down as visitors shy away from areas where there are large numbers of Asian travelers. If the disease is tracked to certain bird populations, breeders of these birds may be hurt by the additional cost of disinfecting or loss of consumer confidence in purchasing these products due to fear factors. The disease, at this time, is unlikely to have a significant impact outside of China and some Asian countries as long as the WHO is able to maintain the outbreak, but it should be monitored. Companies that are already in difficult shape and somehow related to any key areas mentioned, should be monitored closely as their survival may be directly related to the events of SARS management by world health organizations over the next several years. Events change quickly with biological diseases. Data is often conflicted. You are advised to watch a site like Center for Infectious Disease Research and Policy (www. cidrap. umn. edu/ (http://www. cidrap. umn. edu/)) or other contacts listed below for frequent updates on this disease.

References & Sources*:

Hong Kong Dept of Health www. info. gov. hk/dh/ap. htm (http://www. info. gov. hk/dh/ap. htm )
Singapore Ministry of Health http://app. moh. gov. sg/ (http://app. moh. gov. sg/)
Health Canada www. hc-sc. gc. ca/english/protection/warnings/sars/index. html (http://www. hc-sc. gc. ca/english/protection/warnings/sars/index. html )
Center for Infectious Disease Research & Policy www. cidrap. umn. edu/ (http://www. cidrap. umn. edu/ )
Center for Disease Control & Prevention www. cdc. gov/ (http://www. cdc. gov/) or www. cdc. gov/ncidod/SARS/ (http://www. cdc. gov/ncidod/SARS/ )
World Health Organization www. who. int/en/ (http://www. who. int/en/ )
Morbidity and Mortality Weekly http://www. cdc. gov/mmwr (http://www. cdc. gov/mmwr) /

Communicable Disease Surveillance & Response www. who. int/csr/en/ (http://www. who. int/csr/en/ )
Financial Times www. ft. com

Business Week, Time, Newsweek

*Some site addresses are subject to periodic change.

Nike and Wal-Mart, Jack in the Box are protected trademarks of Nike Corporations, Wal-Mart Corporation, Jack in the Box, Corp.

Trademarks apply to all other names and logos Information in this briefing may be subject to change. Data in various sources may be conflicting. Decision concerning SARS or its impact should not be made on this briefing but should come from the readerÂs own research

Protecting your baby: a new, non-mercury basal thermometer for trying-to-conceive women

2011-04-17T21:39:00.000-07:00

Protecting Your Baby: A New, Non-Mercury Basal Thermometer for Trying-to-Conceive Women

A new product to add to the list of recent fertility innovations, the Fairhaven Health Mercury-Free Glass Basal Thermometer is an environmentally-friendly alternative to hazardous mercury thermometers. This safe, accurate mercury-free glass basal thermometer has both doctors and moms-to-be smiling.

Seattle (PRWEB) August 24, 2005

Over the past few years, a number of innovative "trying-to-conceive" products have hit the shelves of pharmacies and online fertility shops. Just to name a few, the ovulation microscope, fertility supplements like FertilAid, and even ovulation-predicting software have enriched the fertility landscape, making trying to conceive a baby much, much easier.

This week's release of a new fertility product, the Fairhaven Health Non-Mercury Basal Thermometer, marks an exciting milestone in preconception products: A safe, ultra-accurate, and healthy alternative to old mercury thermometers. Call it a "green product" or just call it smart science, the Fairhaven Health glass basal is a non-mercury basal thermometer that offers all the accuracy and ease-of-use of traditional thermometers, but without the environmental danger and health hazards that mercury poses to families, pregnant mothers, and developing babies.

Millions of women use basal thermometers daily to "fertility chart", or predict when they are most fertile. Now, couples deaming of having children no longer need to worry about their glass thermometers breaking - or the hazards of mercury in the home. This is especially true during pregnancy when you need to avoid toxins or household hazardous wastes.

As the EPA indicates, "for fetuses, infants, and children, the primary health effect of methylmercury is impaired neurological development. Methylmercury exposure in the womb can adversely affect a baby's growing brain and nervous system." Home exposures can occur, according to the EPA, when products that contain elemental mercury break and release mercury to the air, particularly in warm or poorly-ventilated indoor spaces. Now, many states are pulling standard mercury thermometers from the shelves due to concerns regarding toxicity, fetal health, and family safely.

The Solution: A Mercury-Free Glass Basal Thermometer

As an alternative to mercury thermometers, the Fairhaven Health Glass Basal Thermometer is just as accurate and family-friendly. Containing an environmentally-safe liquid alloy, the Fairhaven Health thermometer is completely non-toxic; in the event it breaks, it can simply be cleaned up with warm water. Better yet, the non-mercury glass basal thermometer is ultra-accurate, exceeding standards for accuracy. Using a non-toxic alloy instead of mercury, the Fairhaven Health glass basal thermometer is capable of measuring the slightest temperature increases, particularly important when you are fertility charting.

As a quick introduction for the unitiated, a basal thermometer is a highly accurate thermometer designed to measure your resting temperature (after several hours of sleep). Women who are "TTC" (or trying-to-conceive) use a basal thermometer the first thing in the morning, before getting up or moving around in bed. To chart fertility, simply record your basal temperature daily in your ovulation calendar or fertility chart.

Sometime around the middle of your cycle, you will notice that your basal body temperature has suddenly increased. This increase of temperature is caused by hormonal changes that "heat the body up" to make a more "fertile home" for a baby. By monitoring when your basal temperature increases, you will know the exact date of ovulation, or peak fertility. Over time, you will see patterns of this temperature increase that allow you to predict ovulation and increase your odds of conceiving!

Using the new Fairhaven Health glass basal thermometer, you have all the accuracy of a mercury thermometer, but without the dangers to health and family (especially if you are pregnant or trying to conceive a baby). Also convenient, it even comes with a handy no-break carrying case that actually serves to magnify the result. Just slip the thermometer into the carrying case and get a precise close up view of the exact basal temperature. Retailing for around just $15, this mercury-free thermometer is just a better basal, plain and simple.

About Fairhaven Health, LLC

Fairhaven Health (http://www. fairhavenhealth. com (http://www. fairhavenhealth. com)) is a provider of preconception and fertility products like FertilAid for Women and Men, and Fertile Focus (See our basal at http://www. fairhavenhealth. com (http://www. fairhavenhealth. com)).

# # #

Alert: bloomberg to gather healthcare experts in chicago, april 27th

2011-04-17T08:50:00.000-07:00

Alert: Bloomberg to Gather Healthcare Experts in Chicago, April 27th

The Bloomberg Health & America Briefing will convene a live audience of 100 top representatives from government, medical schools, insurance companies, pharmaceutical firms, corporate boards and investment funds for a discussion about how to expand healthcare while controlling costs.

New York, NY (PRWEB) March 11, 2010

The Bloomberg Health & America Briefing (http://www. bloomberglink. com), to be held April 27th at the University of Chicago Gleacher Center, will feature a full day of sessions on the most timely and important questions facing the healthcare industry's key stakeholders. The goal is to examine the central challenges involved in implementing health-care reform -- controlling costs while improving quality -- and the impact that effort will have on industry, through the eyes of the experts on this issue.

No matter the outcome of the efforts underway in Congress, health-care reform is a top priority in the U. S. The effects of a health-care overhaul are staggering, not just for the insured, but for corporations, investors, governments and the medical industry as a whole.

The format will be a series of live, on-stage interviews designed to get to the core of the issues and elicit new, actionable information for those whose livelihoods most depend on the outcome of the health-care debate.

Award-winning Bloomberg journalists and other experts will conduct one-on-one interviews with leaders including:
Eric E. Whitaker, MD, MPH, Executive Vice President, Strategic Affiliations and, Associate Dean, Community-Based Research, The University of Chicago Medical Center J. James Rohack, M. D., President, American Medical Association (AMA) Darrell G. Kirch, M. D., President and CEO, Association of American Medical Colleges (AAMC) Maureen Bisognano, Executive Vice President and Chief Operating Officer, Institute for Healthcare Improvement (IHI) David T. Brooks, Chief Executive Officer, Providence Regional Medical Center Everett Jon R. Cohen, M. D., Senior Vice President and Chief Medical Officer, Quest Diagnostics Bill Conroy, CEO and President, Initiate, an IBM Company Les Funtleyder, MPH, Healthcare Strategist, Miller Tabak + Co., LLC The Bloomberg Health & America Briefing (http://www. bloomberglink. com) is a production of Bloomberg LINK, organizer of summits, briefings and events. For information on sponsoring, attending or speaking at the Bloomberg Cities & Debt Briefing or any other Bloomberg LINK event, visit http://www. bloomberglink. com (http://www. bloomberglink. com)] or call (212) 647-6530.

###

Chinese herbal formula helps overcome flu & cough

2011-04-16T16:47:00.000-07:00

Chinese Herbal Formula Helps Overcome Flu & Cough

HERBALmax(www. herbal-max. com), announces the availability of an effective, maximum strength herbal product to combat Flu and Cough.

(PRWEB) November 16, 2004

With flu season just around the corner, the award winning Chinese Herbal Pharmacologist, Doctor Lihua Zhang (www. herbal-max. com), announces the availability of an effective, maximum strength herbal product to combat Flu and Cough. It is appropriately called HERBALmaxÂ Flu, Cold & Cough formula. Clinical study has shown that 77% of persons who began taking the herbal formula soon after experiencing symptoms reported recovery by the next day. 89.5% of persons recovered within 1-4 days after taking the Flu, Cold & Cough formula. Because the herbs used in the formula are carefully selected from tens of thousands of Chinese herbs for its safety, it can be taken by all ages. Some herbs in the formula were used to stop the SARS outbreak in late 2002 and early 2003 in China.

The success of the formula is due to two factors:

1) Dr. ZhangÂs extensive knowledge and formulation of the product backed by 23 years of herbal research and clinical success experiences; and

2) Concentrates of effective Chinese herbs known for their herbal antibacterial and antiviral ingredients focusing on the respiratory system.

HERBALmaxÂÂ Flu, Cold & Cough formula has been shown in clinical studies to significantly shorten the duration of flu and cough. From September 2002 to April 2003, a series of 83 patients reporting symptoms of flu and cough were studied with results showing that the Flu, Cold & Cough formula appeared to aid recovery from flu and cough symptoms typically within 1 to 4 days.

Influenza (the flu) is characterized by the abrupt onset of upper respiratory symptoms such as fever, cough, headache, body aches and variable nasal symptoms. Fever typically lasts three to five days, but can persist up to a week or more. Cough symptoms often remain beyond the end of the acute illness. Sometimes, a post-viral cough may persist for up to eight weeks. Influenza Â also is known to be a deadly disease that can disguise itself in variety of different forms. Flu and its complications commonly known as bronchitis and pneumonia was the seventh leading cause of death in the USA in 1999 and 2000. The flu and cough are respiratory illnesses caused by different viruses with similar symptoms. People 65+ years and children 6-23 months of age, pregnant women, and people with chronic medical conditions are at high risk of complications from influenza.

Antibiotics treat bacteria and are usually not effective for treating viruses like influenza and accompanying cough. Some of the drugs available for the flu only treat certain viruses, and each flu around is caused by different viruses. One such drug, Tamiflu (oseltamivir), can only be taken within 2 days of first signs of symptoms. It cannot be taken by infants less than one year old and may cause side effects. Last month, The Lancet, a British medical journal, published a study of children with influenza treated with oseltamivir and conducted by an international team of researchers. Results showed that nearly 20% of patients treated with the drug produced mutant drug-resistant viruses as soon as four days after treatment.

Because HERBALmaxÂ Flu, Cold & cough formula can very quickly stop the flu and cough at the beginning; it is a good product to keep on hand to protect against the flu. It is also very strong against the flu and cough at its peak. After taking this formula, most people would feel better on the next day.

HERBALmaxÂ Flu, Cold & Cough formula is sold in bottles containing 60 capsules at www. herbal-max. com or by phone at 310-234-9689, it is priced at $19.95. HERBALmaxÂ line includes other specially formulated herbal products for high blood pressure, liver, skin allergies, heart, acne, high cholesterol, mood & fatigue, male impotence, menopause, and inflammation.

For more information please contact HERBALmax at:

(310)234-9689

2330 Westwood Blvd, Suite 106

Los Angeles, CA 90064

# # #

Denmark is the second largest biotech nation in northern europe

2011-04-14T16:42:00.000-07:00

Denmark is the Second Largest Biotech Nation in Northern Europe

Research and Markets (http://www. researchandmarkets. com) has announced the addition of Guide to the Danish Biotech Industry 2004 to their offering.

(PRWEB) October 1, 2004

Total revenues of the Danish Biotech Market amounted to 43 billion DKK in 2002. That makes Denmark the second largest biotech nation in Northern Europe.

"Guide to the Danish Biotech Industry 2004" is a unique CD product that contains a searchable database of more than 150 Danish biotech companies. We have divided the Danish biotech industry into 16 different industry segments, such as

-Medical Device

-Diagnostics

-Pharmaceuticals/Therapeutics etc.

Depending on size and maturity each company is described with contact details, management and board, financial data and a short company profile. Through a direct link to the company website, you can do further independent research on each company.

This CD is an attractive source of information about Danish biotech companies not found anywhere else. Whether you are an international biotech or pharma company, venture capitalist, consultant or governmental agency you will find this CD useful to locate M&A candidates, collaboration partners, competitors etc.

This searchable database of 159 companies includes the following search functions:

-Free text search in all data

-Specific search; location, industry segment etc.

-Review companies by industry segment, city, science park etc.

-Send a colleague. Any company profile can be forwarded by email from inside the application.

-Through direct link to company web page from inside the application you can make further investigation to any company of interest.

-Send emails directly from the CD.

For a complete index of this report click on http://www. researchandmarkets. com/reports/42561 (http://www. researchandmarkets. com/reports/42561)

About Research and Markets Ltd.

At the annual seabiotics conference larry thompson announced that distributors who purchase 2 identical cases of alkyl-transfactor, neurofactor, seasation activator, or replenisher at their normal discount will get the 3rd identical case at 70% off list price! This offer is valid from october 1, 2004 through november 1, 2004. Any seabiotics wholesale or ibp distributor can receive this discount. For more information see tom philo's seabiotics site at <a href="http://business. Seabiotics. Com/taphilo" onclick="linkclick(this. Href)">http://business. Seabiotics. Com/taphilo</a>

2011-04-12T14:36:00.000-07:00

At the annual SeaBiotics conference Larry Thompson announced that distributors who purchase 2 identical cases of Alkyl-Transfactor, Neurofactor, Seasation Activator, or Replenisher at their normal discount will get the 3rd identical case at 70% off list price! This offer is valid from October 1, 2004 through November 1, 2004. Any SeaBiotics wholesale or IBP distributor can receive this discount. For more information see Tom Philo's SeaBiotics site at http://business. seabiotics. com/taphilo

At the annual International SeaBiotics Conference in Dallas, Texas that Authorized SeaBiotics Distributor Tom Philo - http://business. seabiotics. com/taphilo - attended over the weekend of September 24-26, 2004, this special purchasing option was announced along with other changes in the SeaBiotics line.

(PRWEB) October 3, 2004 -

SeaBiotics, a company that is the leader in the manufacturing of high quality deep water shark liver oil from their plant in Norway, held their annual conference in Dallas, Texas over the weekend of September 24-26.

During the conference Larry Thompson (one of the two original founders of Herbal Life back in 1980 and one of the partners in SeaBiotics) made numerous announcements concerning the SeaBiotics company.

In the skin care product line Larry announced that the SeaTox product would be renamed to Seasation Activator. SeaTox had as a slogan "Facial Muscle Activator" so the company renamed it to be Seasation Activator. The Seasation product used the slogan "Facial Rejuvenator" but now it is called "Seasation Replenisher" since it helps skin replenish its natural oils.

A new web site just for the two facial skin care line items was announced also. For Tom Philo the new site's web address (URL) is:

Http://www. seasation. com/taphilo (http://www. seasation. com/taphilo)

The company's lead product - Alkyl-Transfactor - a proprietary blend of shark liver oil along with Omega-3 and other food supplements, first arrived from the Norway factory on September 15, 2003. Mr. Thompson announced a special month long promotion that allows distributors who purchase two cases of the same product at their normal discount to purchase a third case at 70% off the list price. This offer is only valid for SeaBiotics distributors who are either a Wholesale Consultant (WC) or an Independent Business Partner (IBP).

The quantity in a case varies by the product being purchased.

Going to http://business. seabiotics. com/taphilo (http://business. seabiotics. com/taphilo) allows anyone to purchase these highly refined shark based oil food supplements as well as the items in the skin care line one bottle at a time or in case lots. The same site enables a person to join as a distributor and recieive higher discounts off the list price. A distributorship enables them to earn direct sales income as well as royalty income at the IBP level if they wish to sell the products.

All the products are manufactured in Norway under the European Pharmaceutical Protocols that drug manufacturers are required to use. The SeaBiotics Alkyl-Transfactor and Neurofactor is classified as a food product per FDA rules but to ensure the purity of the ingredients, it is manufactured under the more stringent Pharmaceutical Protocols.

All products are continuously tested to see if any contaminants exist at the parts per BILLION level. The latest change to manufacturing that was recently implemented was the use of a molecular distillation process. This increases the purity since now the finished products can be tested to ensure no contaminates exist down to parts per TRILLION.

To learn more about this health food product that helps the body fight symptoms of many common ailments -- fatigue, sore joints, arthritis, lupus, fibromyalgia, allergies, and many others -- by balancing out the bodies immune system naturally to go to:

Tom Philo's SeaBiotics Web Site

Http://business. seabiotics. com/taphilo (http://business. seabiotics. com/taphilo)

On the site there are recorded audio from Doctor Haimes, Doctor Weston, Olav Sandes (Mfg) and Larry Thompson along with product information, compensation plan, nutrition facts and much more. People can also use their phone to call in to hear this information on the Sea Bridge Recorded Info Line at 512-703-8084.

Alkyl-Transfactor and Neurofactor are considered food products by the American FDA. No claims are made or can be made, implied, inferred, or construed concerning any of these products as to their ability to cure any disease or condition. The American Heart Association as well as others have and are allowed to claim that they have seen that using the ingredients included in the SeaBiotics products have helped.

AHA Report, November 1, 2002 stated that omega-3 has the benefits of:

Decreased risk of sudden death

Decreased blood clotting

Decreased triglyceride levels

Decreased growth of arterial plaque

Improve arterial health

Lower blood pressure

Authorized SeaBiotics Distributor

Tom Philo

1310 SW Hillcroft Avenue

Portland, Oregon 97225-5728

503-350-3744

Http://business. seabiotics. com/taphilo (http://business. seabiotics. com/taphilo)
Http://www. seasation. com/taphilo (http://www. seasation. com/taphilo)

# # #

"Miracle" tapping technique eft found to help stress, anxiety, depression, trauma and pain in reduced timescales. Workshops now offered

2011-04-12T08:46:00.000-07:00

"Miracle" Tapping Technique EFT Found to Help Stress, Anxiety, Depression, Trauma and Pain in Reduced Timescales. Workshops Now Offered

An intriguing and promising new treatment for many conditions including stress, trauma, anxiety, depression, anger and even physical issues such as back pain, is to be taught for self-help in a workshop format by practitioner couple Tamara and Peter Donn in London and abroad. This treatment – sometimes known as EFT, or “Tapping”, is receiving wide acclaim, spreading rapidly by word of mouth by individuals experiencing rapid shifts in their mental, emotional and physical conditions. Whilst not effective for everyone, the majority experience deep shifts in a short space of time, and it is not uncommon for individuals to experience the “miracle” of having years of back pain, or a complete past trauma disappear in one session.

(PRWEB) June 26, 2010

For so long people have been looking for quick solutions for their stress, anxiety, depression, anger and other negative emotional states. Large numbers of people are using pharmaceutical and recreational drugs, and even mild addictive substances such as tobacco, alcohol and chocolate to cover up deeper anxieties. Others use food to fill a deeper state of emptiness. The problem with turning to these methods of unconscious stress relief is that they are purely symptomatic. Underlying patterns remain firmly in place and will continue to drive behaviour.

All this is now set to change with the use of a remarkable method known as Emotional Freedom techniques (EFT), also sometimes known as Tapping. It involves tapping a small set of acupuncture points whilst focussing on an upsetting feeling or memory, and the effects are often dramatic. People are finding the negative emotions associated with past traumas suddenly dissolving in front of their eyes. Others are focussing on physical pain whilst tapping and finding that too is dissolving, sometimes permanently. In fact well-known British Hypnotist Paul McKenna is using the “Tapping Technique” in his work to help people in the fields of stress, weight loss and phobias, and it has been deployed in Rwanda and Kosovo to great effect treating Post-Traumatic Stress Disorder (PTSD).

It all started back in the 1980’s when clinical psychologist Roger Callahan was working with a lady with a very severe water phobia. She worked with various therapists for 6 years with negligible improvement. One day Roger noticed that she felt the anxiety in her stomach and suggested she tap gently under her eye – the location of the start of the stomach acupuncture meridian. She did this and the whole phobia disappeared in a matter of minutes. It was a revelation and lead to the development of a new treatment called Thought Field Therapy (TFT). This, in turn, lead to a whole set of spin-off techniques, all of which used this technique of “Tapping” to release negative emotional states in time scales that were unheard of. EFT (Emotional Freedom Techniques) was one of those, that was particularly easy to learn – even for children.

Hertfordshire-based therapist Peter Donn first came across this technique back in 2003 when he was working as a software developer. He had been the creative mind behind a software product, and his managers were looking to buy the product from the company and create a new start-up – without including him. He says: “I felt so angry, so much injustice. And for two days it didn’t go away. A friend told me about EFT and I had a session the next day. The anger and all the other negative feelings completely dissolved. It was such a relief. Despite my calmness I still knew what they were doing was unreasonable, and I took appropriate action. However, more than that I had discovered an extraordinary technique which had such a rapid effect on emotional states. It was a eureka moment and I knew I wanted to share it with others”.

Peter subsequently trained in both EFT and TFT and started treating people professionally. “People were coming to me having had counselling or psychotherapy for a lifetime and experiencing little significant shift”, he said. “Yet after a few sessions of EFT they were experiencing major changes in their emotional states and seeing life differently”.

Despite practitioners and individuals getting significant results on a daily basis, mainstream health providers are yet to adopt EFT widely. Biologist Dawson Church (author of “The Genie in Your Genes”) has spearheaded a drive to prove its effectiveness on a large variety of conditions, both emotional and physical. Initial results are very promising. One piece of research on the use of TFT with PTSD showed it to be significantly more effective than Cognitive Behaviour Therapy (CBT) – the NHS’s current treatment-of-choice for PTSD. A summary of research to date can be found here (http://www. eftuniverse. com/index. php? option=com_content&view=article&id=18&Itemid=21).

Not satisfied with working only one-to-one, Peter then started offering one-day EFT workshops (http://www. london-eft. co. uk) in Hertfordshire, UK, together with his practitioner wife Tamara Donn, UK, teaching lay people and professionals alike. “Amazingly, in one day you can learn all the basics”, he says. “ Literally, in that day, people can learn effectively to start releasing traumas, fears, anger and other issues, as well as learn to use it to help physicals issues. It’s not effective for all people all of the time, but the majority respond very well. In the last workshop in June 2010, most of the participants experienced close to a 100% release in a specific trauma they were working on. And we had roughly an average 50% drop in pain levels when we were working on physical issues – including back and neck pain and headaches. The biggest problem people have is accepting that it works as well as it does. They say “It is just too easy”!”

Radio 2 co-presenter (with Steve Wright) and author Janey Lee Grace attended the EFT Level 1 workshop in February and was amazed. As she writes in her blog (http://janeyleegrace. blogspot. com/2010/02/tapping-away-eft-styleya-convert. html) “EFT is powerful, I left the one day course feeling totally inspired and motivated with a whole host of skills and tools to use in everyday life”. At this same workshop, she had worked with a lady who hated eating and had never eaten at the table with others. This cleared within 30 minutes. A month later she said she hadn't stopped eating and was able to eat with others now. She also said an OCD-style obsession with germs had also strangely disappeared!

At a workshop in March 2010 Peter was doing a trauma release demo on one lady. As the trauma lifted she suddenly said "My back pain's gone"! She explained that she had had 18 years of back pain and needed a painkiller every day. A week later she told me she hadn't needed a painkiller since, and the pain was still gone. Another participant at this workshop said 12 years of back and neck stiffness had disappeared (and remained gone three months later).

EFT can be integrated into any niche area of interest. Tamara's interest in the field of birth and pregnancy resulted in the offering of the UK's first EFT training for Birth Professionals, where the participants experienced their new skills helping pregnant women release fears and past traumas. "It was truly empowering to be able to help so deeply", remarked one Hertfordshire-based midwife. Tamara also runs other empowering workshops for women. See her site www. womantomother. co. uk (http://www. womantomother. co. uk).

Tamara and Peter’s company EFT Training Herts is now expanding to run workshops in central London and abroad. The next workshop in London is on Friday 3rd September and in Hertfordshire on Friday 2nd Juloy 2010. They are also running a one-week EFT training holiday in Turkey in October 2010 where you get to go beyond the basics. He says: “It will be a roughly 50:50 mix between holiday and training, with plenty of practical experience, lots of personal healing, and you will take back a technique you can use for the rest of your life”. To book go to their web site below or call 01923 260 050. Individuals can additionally train to become EFT practitioners.

EFT Training Herts is pleased to offer a free EFT Tapping Manual to readers on their web site so they can try out the technique for themselves.

As well as offering workshops, one-to-one sessions are available in London, Hertfordshire or by phone or Skype all over the world.

For further information on consultations and workshops see http://www. london-eft. co. uk (http://www. london-eft. co. uk). Tamara has her own site: http://www. eftforwomen. co. uk (http://www. eftforwomen. co. uk). You can also see their Facebook fan page (http://www. facebook. com/pages/EFT-Tapping/136997692982638).

# # #

Creation and funding of content is focus of first internet content syndication conference

2011-04-12T07:48:00.000-07:00

Creation and Funding of Content Is Focus of First Internet Content Syndication Conference

Editing Error, Please See Revisions Below

New York, NY (Vocus) October 30, 2009

Due to an editing error, a recent press release recapping the 2009 ICSC Summit misstated the company name for Joanna Breen. Her correct company name is TouchStorm not Touchstone/Howdini.

NEW YORK, Oct. 26, 2009 -- Original content is key for marketers to build relationships with their customers, and Internet syndication is an effective system for creating, funding and delivering it to them.

These were some of the key points made by panelists at the first annual conference of the Internet Content Syndication Council, held on October 20. Over 200 attendees listened to industry leaders discussing various aspects of Internet content syndication -- including its role in advertisers’ marketing strategies, the business models of several industry players, and the need to track and control content.

Andrew Susman, chairman of the ICSC and president of Studio One Networks, provided an industry overview in his opening remarks. The Internet has been expanding so fast that fragmenting audiences are unable to generate sufficient revenue needed to support the creation of original content. Defining Internet content syndication as “the controlled placement of the same content on multiple partnering Internet destinations,” he stated that syndication provides an important solution to the content crisis.

Syndication is based on a simple principle, noted Susman: “What one can’t afford, many can by pooling their resources.” One key elements of Internet syndication, he said, is controlled placement, or giving the content to Web sites to use as their own rather than linking back to an originating site. The other is partnering destinations, or the establishment of a mutual relationship that ensures that the Web sites receiving the content give value back to the content producer. The result is a system that benefits all stakeholders because it aggregates large targeted audiences for advertisers, gives Web sites access to high-quality content they could not otherwise afford, and remunerates the content producer.

In the first panel, “Using Content to Adapt to the Post-Advertising Age,” several major advertisers acknowledged that technology has changed the relationship between marketers and their customers. Gary Spangler of DuPont said that customers are distrustful of traditional advertising, which he said is a “push,” an interruptive method. He said that it can be used to invite people into a relationship if it is “permission-based, opt-in, targeted and niche-based.”

Dave Mechlin, formerly with Ogilvy & Mather and now with a digital startup, agreed that “digital is a whole new way to establish and maintain brand relationships.” He said it allows marketers to listen to what their customers are saying about their brands -- which is important in, for example, selecting search keywords.

The panel, which was moderated by Brian Morrissey of Adweek, agreed that “content is still king,” noting that a blog that isn’t frequently updated is useless. Getting branded content right can be a challenge, said Jack Mason of IBM, especially as the tools (Twitter, etc.) are constantly changing. But used properly, it can allow marketers to control at least some aspects of their message. In a remark that was echoed more than once throughout the day, he said that by creating branded content, a marketer can “own the relationship with the customer rather than renting it,” as traditional advertising is known to “rent” it.

Syndication can be an effective way of delivering a brand’s content to customers. “In the ‘90s, IBM had thousands of pages of great content, but no one went to it,” said Mason. “So we have moved from ‘If we build it they will come’ to ‘How do we move the content to people?’ by placing it on other Web sites where it can be found.”

Following the panel, Bill Harvey, president of research firm TRA Inc., presented data showing how carefully targeting audiences and tailoring messages specifically to them can dramatically increase the ROI of the advertising. TRA has panels for TV measurement as well as supermarket and pharmacy purchases, with a smaller combined single-source panel that matches advertising and content exposure with purchase behavior. He said TRA plans to add an online panel shortly. Citing data from television viewing, he said TRA had found a 60-1 ratio of improvement in ROI for a social marketing approach over a traditional hard-sell. In his formulation, “subtle brand media/creative” approaches -- such as True Sponsorship, creative integration, social media and cause marketing -- are needed to overcome consumer resistance to traditional ad messages and to break through clutter.

“Making Money When Information Wants to Be Free” was the second panel, moderated by former Mediaweek Editor Bill Gloede. The panelists were representatives of three companies who use a licensing, rather than advertiser-supported, business model. Dan McKillen of HealthDay news service, which syndicates medical news and information to newspapers and Web sites, said that newspapers use the service because “we’re a lower-cost source of content than what they could generate themselves.”

Gloede prodded the panelists to discuss how they can get paid for content when “information wants to be free.” There was some debate over the meaning of the phrase. “It’s people who want to use it who want it to be free,” said McKillen, quoting Malcolm Gladwell in The New Yorker. Steve Tippie of Tribune Media Services elaborated that “once you digitize it, you can’t control its distribution” because it can be spread so easily.

Ted Mendelsohn of The Associate Press said, to general agreement, that “those who produce it need to be paid for it” in some way, whether it’s by advertisers or license fees from users. He said that every time a new medium comes about, “we have to determine how to get content properly licensed.” AP is actively tracking its content and aggressively pursuing those who do not use it properly.

Asked about the potential threat from Google, which often takes headlines but not the main body from others’ content and displays it, the panelists agreed that this was a problem. McKillen said that the Digital Copyright Act (1998), which allows this practice under Fair Use, needs to be rewritten to protect copyright holders. “We have a generation of multitasking mediaholics,” he said, memorably. Today’s teenagers are using so many entertainment/information devices simultaneously that they generally just glance at the headlines and then move on without seeking out the details in the main body. So even if Google, for example, provides a link back to HealthDay, “we can’t monetize it.”

The importance of controlling content placement was also a major topic of the next panel, “Video Syndication: Why Viral Is Not the Answer.” Moderator Corey Kronengold of Online Video Watch led several video producers and syndicators in a discussion of how to get content on the Internet and get paid for it.

Various types of video are syndicated. Damon Bethel of DBG said that brands are starting to develop professionally produced, entertaining videos that help them establish a relationship with their customers. Dave Jackson of Grab Networks said that how-to/informative videos solve a consumer need.

The panelists have several business models. Ric Camacho of Thomson Reuters said that his company displays videos on its own site and obtains license fees from its biggest customers to push the stream to them. Jackson said that Grab takes content from organizations like Reuters and expands its distribution by syndicating it to sites with whom Reuters doesn’t have relationships. Revenue can be generated by licensing, via advertising or via paid distribution. Joanna Breen of TouchStorm opined that paid distribution is essentially “just a new form of advertising.” Agreeing with others that it plays a valid role, she said that generally, paid content does not end up in the (more valuable) editorial space on Web sites -- though Bethel said that DBG does pay for placement within editorial.

Some video is advertiser-supported, although as Breen said, “the vast majority of Internet video is not monetizable, at least by advertisers.” This echoed a comment from the first panel, in which Jack Mason noted that “there [is] a lot of dross -- most Internet videos are viewed less than 100 times.”

Nonetheless, advertising does work on video. Some of the panelists discussed engagement measures, such as the number of users who watch a video all the way through. Jackson said “you must syndicate with control. You have to know what is happening with your content and how it is used.” He said syndication means control -- “syndication is not viral.”

A floor questioner asked about ad formats, specifically the 30-second pre-roll, suggesting that too often marketers just put up a network ad as the easy way out and that it could be inappropriate in front of a two - to three-minute video. Jackson said he thought a 30-second pre-roll might be too long for a ninety-second video, adding that “15 seconds are more acceptable, and eight seconds are possible.”

The final panel was “Citizen Journalism vs. Professionally Produced Content” and was billed as a debate between Carolyn Bekkedahl of Mochila and Mark Ranalli of Helium Inc. Mochila supplies professionally produced premium content and advertising to affinity Web sites. Helium has a stable of “writers who want to write” and offers them distribution opportunities subject to vetting by voluntary panels of peers. Moderator Bill Gloede asked, “What differentiates a professional journalist from a citizen journalist?”

“It’s the platform,” said Ranalli, noting that some of his organization’s writers had been paid writers for a local newspaper -- and hence, professional journalists -- but that working for Helium makes then citizen journalists. He said that Helium is tapping into the culture of voluntary writing, as in the case of Wikipedia. “‘Journalist’ is the wrong terminology,” observed Gloede. “It is more ‘enthusiasts.’” Ranalli agreed and said the model works well; Helium has just had its third anniversary. However, he warned, “Don’t confuse citizen journalist with investigative reporting.”

Bekkedahl said that “it’s not just who writes, but for whom: If it’s for The New York Times, then there is a brand that stands behind it.” She said that Mochila works with professionals whose work is fact-checked and indemnified, and that there is a proven market for professionally produced and branded content.

In the floor discussions that followed, a good deal of concern was expressed over where the new (i. e., investigative) journalists -- those who take an adversarial position with the powers-that-be -- will come from.

Since most media business is stressful these days, the conference closed with some stress-management advice by Dr. Sharon Melnick, a Harvard-trained psychologist and educator.

About the ICSC
Founded in October 2007, the Internet Content Syndication Council (ICSC) is a central source of information for companies actively engaged in or seeking to explore Internet content syndication. On behalf of its members, the ICSC promotes the growth of the Internet content syndication industry by improving understanding of what Internet content syndication is and how it acts as a means of revenue generation for digital publishers, a mode of marketing for advertisers and a system of quality content provision to consumers and networks alike. ICSC members include representatives from leading advertising, technology and media organizations.

For more information on the ICSC, please visit http://internetsyndication. org or contact
Michael Blumberg (212.966.7070, michael. blumberg (at) internetsyndication. org).

###

Molport announces data integration with zinc, the leading free database of chemical compounds for drug discovery research

2011-04-11T10:52:00.000-07:00

MolPort Announces Data Integration with ZINC, the Leading Free Database of Chemical Compounds for Drug Discovery Research

MolPort, global rare research chemical marketplace, has integrated with ZINC, the leading free database of chemical compounds for virtual screening, to help scientists in drug discovery to accelerate testing of potential drug candidates.

San Francisco, CA (PRWEB) May 12, 2010

Ordering large number of rare compounds for testing their potential drug activity and comparing it to computer simulations is a time consuming chore for scientists. Using MolPort’s unmatched, sophisticated chemical search portal to precisely locate commercially available compounds in its large database has already saved many projects time and money.

Today MolPort announces that its structural data has been incorporated into ZINC, the leading free database of commercially available compound structures especially processed and prepared for virtual drug screening. Thus a link has been created from ZINC to MolPort’s compound procurement module. Users of ZINC (http://zinc. docking. org (http://zinc. docking. org)) benefit from increased chemical diversity in ZINC and can now readily access MolPort's compound procurement capabilities while continuing to use their current workflow. MolPort's compound suppliers also benefit from access to the wider customer base that comes with ZINC integration.

MolPort CEO, Imants Zudans PhD, commented, "Both suppliers and customers benefit from the data integration with ZINC. Our aim is to make buying and selling very rare chemicals globally as easy as buying a book over the internet"

About MolPort
MolPort is a rare chemical compound marketplace enabling worry free centralized ordering of rare chemicals. To make the marketplace work MolPort has created a world class database of commercially available chemical compounds. The free access online search portal www. molport. com features unmatched advanced chemical structure search capabilities that are especially suited for a sophisticated and demanding user.

About ZINC
ZINC is a free database of commercially-available compounds for virtual screening. ZINC contains over 13 million purchasable compounds in ready-to-dock, 3D formats. ZINC is provided by the Shoichet Laboratory in the Department of Pharmaceutical Chemistry at the University of California, San Francisco (UCSF).

# # #

New healthrock music video teaches kids how to avoid h1n1 flu

2011-04-10T12:37:00.000-07:00

New HealthRock Music Video Teaches Kids How To Avoid H1N1 Flu

Sneeze into your sleeve, wash your hands and “keep you fingers outta your mouth and nose, cuz that the places H1N1 goes,” DocRock sings in the 30-second H1N1 Rap video. And while the lyrics and tune are catchy and fun, the message is very serious.

Denver, CO (PRWEB) November 16, 2009

“Blah, blah, H1N1 blah,” is what many children hear when their parents try to teach them how to avoid getting H1N1 flu. To cut through the blahs and get the message across, health service company CIGNA and Dr. Mache Seibel, a. k.a. DocRock, have produced a rap video teaching kids five steps they can take to avoid getting H1N1. It is available free to anyone for viewing or download on CIGNA's new YouTube channel at http://www. youtube. com/cignatv (http://www. youtube. com/cignatv).

“According to the Centers for Disease Control, H1N1 is going to sicken millions this flu season, and kids need to know how to protect themselves,” said Dr. Jeffrey Kang, chief medical officer for CIGNA. “Several studies have shown that music helps children learn better than many other forms of teaching, so DocRock’s H1N1 Rap is a powerful tool to get the message to stick with kids. This video gives the H1N1 Rap even more power.”

Dr. Seibel is a board-certified physician who teaches at the University of Massachusetts Medical School. As DocRock, he is an award-winning composer and performer of songs that help teach kids healthy behaviors through his HealthRock program.

“If you can sing about a health issue, you can talk about it, and talking about it helps change behavior. Getting kids to sing about steps to avoid H1N1 helps them follow those steps,” Dr. Seibel said. “I’m happy to team with CIGNA to get this video made so we can help kids avoid getting H1N1 and the regular seasonal flu too.”

Along with DocRock’s H1N1 Rap, people will find more health information on http://www. youtube. com/cignatv (http://www. youtube. com/cignatv) including “Healthful Tips,” lessons on how health care works, how to get the most value from a person’s health care benefits, and more. More free DocRock health songs for kids are available at CIGNA's health education website at http://www. itstimetofeelbetter. com/know_stuff/audio. html (http://www. itstimetofeelbetter. com/know_stuff/audio. html).

About CIGNA:
CIGNA (NYSE:CI), global health service company, is dedicated to helping people improve their health, well-being and sense of security. CIGNA Corporation's operating subsidiaries provide an integrated suite of medical, dental, behavioral health, pharmacy and vision care benefits, as well as group life, accident and disability insurance, to approximately 46 million people throughout the United States and around the world. To learn more about CIGNA visit http://www. cigna. com (http://www. cigna. com).

About Dr. Mache Seibel
Dr. Machelle (Mache) Seibel is Professor of Obstetrics and Gynecology and Director of the Complicated Menopause Program at the University of Massachusetts. Dr. Seibel founded HealthRock®, a health edutainment company that teaches health literacy through music and entertainment. He performs under the name DocRock™, offering chicken soup to audiences in the form of health information combined with original catchy songs that contain educational lyrics. For more on Dr. Seibel, visit http://www. healthrock. com (http://www. healthrock. com).

###

4-antibody replace paper lab notebooks with amphora's flexible patentsafe eln

2011-04-09T05:42:00.000-07:00

4-Antibody Replace Paper Lab Notebooks with Amphora's Flexible PatentSafe ELN

4-Antibody, a biopharmaceutical company located in Basel, Switzerland and Jena, Germany have implemented PatentSafe as a replacement for their traditional paper notebooks. By moving to Amphora Research Systems' PatentSafe solution not only do they create secure records for patent purposes but they also have the benefit of a searchable, sharable repository of the company's research.

Bracknell, UK (PRWEB) August 3, 2010

New research tools and methods bring benefits to researchers around the world, but also create ever increasing volumes of data that gets ever more difficult and time consuming to accommodate within the traditional paper lab notebook. 4-Antibody were looking to replace their paper based system but had some definite ideas about how any new electronic system would need to work for them. Marc van Dijk, Chief Technology Officer for 4-Antibody explained "It was very important for us that a new electronic lab notebook should not impose restrictions on us in the way that we work". 4-Antibody evaluated several possible ELNs (Electronic Lab Notebooks) and chose to implement Amphora's PatentSafe system, because according to van Dijk "Amphora seemed to offer the most flexible system which allowed us to do what we wanted to do in terms of workflow".

PatentSafe allows scientists to work with whatever software tools they find most effective and submit their work into a secure notebook system for signing and witnessing as appropriate. All the content is searchable, according to the security setting chosen by the organisation, making it easier for researchers to find related work, prepare reports and of course, reducing unnecessary rework.

4-Antibody are also using PatentSafe to manage official reports, giving date and time stamps which van Dijk and the project managers find useful. The system can also be simply integrated with other R&D applications, which was important to 4-Antibody because they plan in the future to implement these types of links. Van Dijk said that 4-Antibody aim to use PatentSafe as "one searchable database connecting all our R&D records, linking to our LIMS system" and he continued, "this will allow scientists and management to quickly see everything that is going on across R&D".

Allison Coles from Amphora commented, "PatentSafe's flexible approach allows scientists to switch to an electronic notebook without having to go through the disruption of a major shift in working practices."

PatentSafe is a direct replacement for the bound laboratory notebook. Completely discipline neutral it allows scientists to gain the benefits of electronic working methods without having to experience the upheaval of major changes in working practices. Amphora's PatentSafe solution delivers significant ROI with little disruption and at a price that can work for organisations of all sizes and types.

About Amphora Research Systems
Launched in 1996, Amphora Research Systems (http://www. amphora-research. com) is one of the world's leading suppliers of electronic laboratory notebooks. Its software products, including PatentSafe, are used around the world by large and small companies, including those in the pharmaceutical and chemical sectors. PatentSafe helps scientists to work better, collaborate easily with each other, and protect their inventions.

For further information, please contact: Allison Coles, Amphora Research Systems
Tel US: +1 800-221-3916
Tel UK: +44 (0) 845 2300160
Http://www. amphora-research. com (http://www. amphora-research. com)

About 4-Antibody AG
4-Antibody AG is a privately held Swiss Biotech company active in the area of therapeutic antibody drug development. 4-Antibody AG has developed a portfolio of powerful, proprietary antibody discovery and engineering platforms, including the Hu-PAC® and the Retrocyte Display® technologies. 4-Antibody AG owns patent families related to therapeutic antibody discovery platforms and products, including more than a dozen of granted patents worldwide. The company has 40 employees working at its headquarter in Basel, Switzerland, and its subsidiary in Jena, Germany.

# # #

Prominent physician achieves success using topical sinus medications via pulsitile irrigation

2011-04-09T04:55:00.000-07:00

Prominent Physician Achieves Success Using Topical Sinus Medications via Pulsitile Irrigation

Murray Grossan, MD (creator of the Hydro-Pulse sinus irrigation device) describes his successful treatment protocol for applying antibiotics, anti-fungals and anti-inflammatories directly into the sinus cavities using a pulsating irrigation device. This treatment has been extremely helpful for his patients who experience symptoms of sinus infections, snoring and sleep apnea. http://abclocal. go. com/kabc/story? section=news/health&id=6231390

Los Angeles, CA (PRWEB) July 31, 2008

Dr. Murray Grossan releases new information today regarding his new treatment protocol for sinus infections. Tower ENT gets many requests from doctors regarding his method of administering medications via pulsatile irrigation with the Hydro-Pulse. Dr. Murray Grossan shares his insight into this treatment protocol to provide maximum success for his patients. His method is based on the Bernoulli principle: as a liquid stream passes an opening, it creates a vacuum, which displaces the contents. Because his device uses gentle pulsatile irrigation, this effect is amplified by a steady pumping action.

The liquid reservoir of the Hydro-Pulse™ is clearly marked as to volume of liquid. To achieve maximum effect, the patient administers their medications as follows:

1. The patient fills the reservoir with 500 cc of sterile water and adds one packet (1 tsp) of Breathe-EaseXL™. (This makes a 1% modified Ringer's saline solution)
2. The patient then attaches the nasal tip to the handle and irrigates approximately 150 cc through each nostril
3. After completing the 300 cc, they stop and gently clear their nose
4. The patient then adds their ampoule of medication to the remaining 200 cc of saline and irrigates again approximately 100 cc into each nostril
5. When finished, the patient will stop and sit quietly at the sink for 10 minutes with no blowing
6. The patient is instructed to not blow their nose for the next hour

Which medications should be used? Dr. Grossan initially began with Tobramycin added to 200 cc of saline. Today he often cultures the infection and adds the appropriate medications accordingly. For fungal infections, he use antifungals (such as Amphotericin B or Itraconazole). For inflammation, he adds an anti-inflammatory (such as Mometasone or Betamethasone). "Of course, patients really appreciate this simple topical method vs. taking systemic oral antibiotics," states Dr. Grossan. "One important factor here is that the medications come in a sealed vial -- the patient just pops the top and squeezes out its contents. This is vital for many medications that are unstable and removes the need for preservatives. Note that we add Amphotericin B to saline. This is fine as long as the mix is used right away before it precipitates."

More information regarding this unique treatment protocol and a complete list of medications commonly used at Tower ENT, may be found at ASL Pharmacy (http://www. aslrx. com/when_should_I. shtml). These medications require a prescription. Information on how to acquire these medications and device may be obtained through ASL Pharmacy at 866-552-7579.

# # #

Seminar on how pharmaceutical companies can achieve unprecedented visibility into and greater command over their core processes

2011-04-09T04:33:00.000-07:00

Seminar on How Pharmaceutical Companies Can Achieve Unprecedented Visibility into and Greater Command Over their Core Processes

BusinessEdge Solutions, Inc. and Lombardi Software, Inc., present a March 1 seminar at Fiddlers Elbow Country Club, Bedminster, NJ, from 8:00 a. m. to noon. Participants will learn how they can automate processes throughout the company. Addressing opportunities in the medical, manufacturing, marketing, and sales functions, the seminar will demonstrate how BPM can help implement and enforce standard operating procedures for both internal and external participants and help companies gain real-time oversight into policy compliance and process performance metrics enterprise wide.

East Brunswick, NJ (PRWEB) February 8, 2005

In todayÂs customer centric, information-driven world, pharmaceutical enterprises are challenged to integrate workflow and information streams, reduce product development time and, in general, provide workers with the tools and methods to increase productivity. ÂDelivering Efficient, Compliant Business Processes Through Automation,Â a free half-day seminar will provide pharmaceutical managers with an understanding of how Business Process Management (BPM) is helping companies achieve unprecedented visibility into and greater command over their core processes.

Sponsored by East Brunswick, NJ-based BusinessEdge Solutions, Inc. and Austin, Texas-based Lombardi Software, Inc., the March 1 seminar will be held at Fiddlers Elbow Country Club, Bedminster, NJ, from 8:00 a. m. to noon. For more information, or to register for the seminar, please visit www. businessedge. com or contact Patrick Mullen at 732.213.3937.

Participants will learn how they can automate processes throughout the company. Addressing opportunities in the medical, manufacturing, marketing, and sales functions, the seminar will demonstrate how BPM can help implement and enforce standard operating procedures for both internal and external participants and help companies gain real-time oversight into policy compliance and process performance metrics enterprise wide.

ÂCompanies have previously been trapped into thinking that every business problem leads to building or modifying an existing software system,Â said Art Barrios, BusinessEdge BPM solutions partner. ÂBut BPM's process-oriented methodology looks at defining the correct process first, considers how current systems support the process, and finally provides a coordination layer which leverages existing systems while filling in process gaps where tasks had poor or no automation.Â

ÂTodayÂs organizations are demanding greater efficiencies out of their business processes than those delivered by traditional enterprise applications like ERP or CRM,Â said Phil Gilbert, executive vice-president and CTO of Lombardi Software. ÂBPM software delivers on those demands with rapid implementation, new visibility into process performance and the agility to change quickly. And organizations that have deployed BPM solutions achieve tangible business results in weeks instead of months or years.Â

About BusinessEdge Solutions, Inc.

BusinessEdge Solutions is an industry-focused consulting and integration firm that serves the life sciences, communications, financial services and insurance industries. The company drives competitive advantage for its clients by leveraging innovative, Reusable Solution Accelerators (RSAs) to reduce the time, cost and risk of client engagements. BusinessEdge is distinctive among consulting firms in that its multidisciplinary consultants each have an average of 12 years of industry experience and expertise Â most of them more. This strong knowledge and experience base is at the core of the companyÂs unwavering commitment to create vision for its clients Â and is the driver behind the company's delivery of high-impact, cutting edge solutions. BPM is one of the companyÂs many service offerings.

About Lombardi Software

Based in Austin, Texas, Lombardi Software is the developer of TeamWorksÂ®, the industry award-winning business process management (BPM) software. TeamWorks provides ongoing visibility and control of business processes, increasing the speed and flexibility with which organizations can manage their process activity and decision-making. Unlike traditional enterprise applications, TeamWorksÂ Shared Model architecture is designed to change at the pace that your business changes. TeamWorks delivers better business economics and Continuous Process Improvement, enabling our customers to achieve BPM success faster, more frequently and with better, measurable results. Lombardi SoftwareÂs customers include Pfizer, Wells Fargo, Whole Foods, Universal Music Group, Shell, Dell, and Hasbro. Lombardi is listed as a Leader in the 2004 Forrester Wave and a Visionary in GartnerÂs 2004 Magic Quadrant. Lombardi Software: BPM software that keeps pace with your business. Visit Lombardi at: www. lombardisoftware. com.

Contact:

Patrick Mullen

Director of Marketing

BusinessEdge Solutions, Inc.

1 Tower Center Blvd.

East Brunswick, NJ 08840

T: 732. 213.3937

Fax 732. 839.3600

# # #

Growth hormones direct announces legal human growth hormones for athletes

2011-04-08T05:51:00.000-07:00

Growth Hormones Direct Announces Legal Human Growth Hormones for Athletes

Growth Hormones Direct announces legal Human Growth Hormones for athletes.

Phoenix, AZ (Vocus) December 5, 2010

Growth Hormones Direct announces legal Human Growth Hormones for athletes. For decades athletes have attempted to access the potential benefits of elevated levels of Human Growth Hormone (HGH). These attempts, for the most part, have been illegal. The use of prescription grade HGH injections is carefully monitored due to possibility for severe side effects. But athletes now have the opportunity to take advantage of legal Human Growth Hormones.

Legal human Growth Hormones have no known side effects and are:
based on the science of homeopathy available without a prescription available without a doctor's office visit available orally; no injections required

The desire to incorporate HGH treatment into athletic training is based upon a few of the most popular benefits of the HGH product:

increased endurance increased strength increased lean muscle mass decreased body fat decreased recovery time increased energy levels

Dr. J. Ronald Willis of Growth Hormones Direct said, "The injection based HGH treatments were illegal because they were dangerous. They carried with them the potential for very serious health consequences; especially when used in the athletic arena because they were typically not monitored for safety and doses often rose with extended use. Luckily, these dangers should decrease as more athletes take advantage of the benefits through safer channels like legal Human Growth Hormone products."

Growth Hormones Direct urges consumers to watch 'Science…Meet Nature' as they reap the benefits of optimizing their hormone levels through proper use of the homeopathic growth hormone formula. Optimal hormone levels allow individuals to enjoy increased general health. Growth Hormones Direct is an Arizona based distributor of quality health foods, supplements, pharmaceuticals and neutraceuticals.

To get further information on Growth Hormones Direct or the benefits of the homeopathic growth hormone formula contact:

Contact: Dr. J. Ronald Willis
Company: Growth Hormones Direct
Http://www. GrowthHormonesDirect. com
Phone: 480-281-7593

# # #

Federal judge rejects sepracor, inc.'S motion to dismiss case and allows tharos laboratories, inc. (Makers of nytex®) to proceed with lawsuit against sepracor, inc. (Makers of lunesta®) on infringement of tharos butterfly

2011-04-05T13:10:00.000-07:00

Federal Judge Rejects Sepracor, Inc.'s Motion to Dismiss Case and Allows Tharos Laboratories, Inc. (makers of NYTEX®) to Proceed with Lawsuit Against Sepracor, Inc. (makers of Lunesta®) on Infringement of Tharos Butterfly

Tharos Laboratories, Inc. ("Tharos") won a key battle in an ongoing lawsuit against Sepracor, Inc. The complaint alleges that Sepracor's advertisements and website related to its Lunesta sleep product have copied several aspects of Tharos' promotional materials and intellectual property used in connection with Tharos' NYTEX® sleep aid supplement, including confusingly similar butterfly designs which cause confusion to consumers and irreparable damage to Tharos.

Salt Lake City, UT (PRWEB) March 25, 2007

Tharos Laboratories, Inc. ("Tharos") won a key battle in an ongoing lawsuit against Sepracor, Inc. ("Sepracor"). Federal Court Judge Dee Benson has sided with Tharos on proceeding with its filed lawsuit (Case No. 2:06CV00757) in federal court in Salt Lake City, Utah against Sepracor of Marlborough, MA, directed to protect Tharos' intellectual property.

Alleged in the Complaint are claims of trademark infringement, false designation of origin and dilution arising under the Lanham (Trademark) Act of 1946, violations of the Deceptive and Unfair Trade Practices Act, and common law unfair competition and trademark infringement. The complaint alleges that Sepracor's advertisements and website related to its Lunesta sleep product have copied several aspects of Tharos' promotional materials and intellectual property used in connection with Tharos' NYTEX® sleep aid supplement, including confusingly similar butterfly designs which cause confusion to consumers and irreparable damage to Tharos.

Dr. Nikos M. Linardakis, President and CEO of Tharos said, "It's about good will and trademarks. We developed the trademarked butterfly first, we had it first, and these are close to identical marks and products. We want Sepracor to stop their butterfly advertising and marketing campaign immediately." Dr. Linardakis added, "We are pleased the Court recognized the importance of this case, and are encouraged by this latest step. Since our initial request for Sepracor to cease and desist, they have not responded in the form we would like to see. For almost a year we have been fighting Sepracor's delay tactics at dealing with this issue. Our position is to protect our company's intellectual property, which include its federally registered trademarks. We are confident that Tharos will prevail on this case."

Tharos has filed an action for trademark infringement under the Lanham Act to protect Tharos' federally registered butterfly design and NYTEX® trademarks for sleep supplement products. "It's a classic 'David and Goliath' scenario," said Tharos' attorney Rakesh M. Amin, of Amin Hallihan, LLC. "In the end, Sepracor will not be allowed to trade in on the butterfly trademark and the promotional campaign that my client worked so hard to develop. We are dealing with two very similar butterfly marks which are both used in connection with sleep aid products. Tharos places great value in all of its intellectual property, and we will fight to that end to protect it," said Amin.

In an effort to prevent evidence from reaching a jury, Sepracor sought to dismiss the case. Sepracor argued that the marks are completely different. However, during the hearing on Friday, February 9, 2007, Federal Court Judge Benson rejected Sepracor's argument, stating that "These are both butterflies or something like a butterfly,…We'll take a look at it under a summary judgment standard and we will be exploring facts, which is what we do."

Tharos will protect its intellectual property to the fullest extent. In its complaint, Tharos Laboratories has claimed ownership of its federally registered NYTEX® and butterfly design trademarks. Tharos is seeking damages from Sepracor for utilizing a confusingly similar butterfly design in a marketing and advertising campaign for a similar product. Tharos has alleged and believes that Sepracor is attempting to trade off the good will Tharos has established in connection with its registered trademarks by utilizing a confusingly similar design in connection with a similar product in a similar marketplace to similar consumers. Tharos is also requesting a permanent injunctive relief under Section 34(a) of the Lanham Act. This includes the broad provision restraining Sepracor from unfairly competing with Tharos in any manner whatsoever.

Tharos is an international pharmaceutical ingredient and nutraceutical company focused on isolating, extracting, purifying and concentrating commercially standardized dosages of naturally occurring phytochemical compounds. Using a patented extraction process, high-grade phytochemicals are isolated from fruits and plants such as raspberries, blueberries, and other fruits grown by quality producers. The company's current product line includes NYTEX® sleep supplement which contains the patent-protected antioxidant PROCIDIN®. Tharos Laboratories' company motto is "Strength from Nature. Endorsed by Science."®

For company or product information contact Tharos Laboratories at 774.219.6619 or visit www. TharosLabs. com, www. BuyNYTEX. com, www. NYTEX. info and www. HeartDefense. info.

Tharos Laboratories, Inc.

6465 South 3000 East, Unit 105

Salt Lake City, UT 84121

801-944-2484

For more information contact:

Rakish M. Amin

Amin Hallihan LLC

312.466.1033

NYTEX® and PROCIDIN® are registered trademarks of Tharos Laboratories, Inc. All other names and trademarks are the property of their respective owners.

###

Chemdiv and euroscreen form strategic alliance for gpcr drug development

2011-04-03T06:02:00.000-07:00

ChemDiv and Euroscreen Form Strategic Alliance for GPCR Drug Development

ChemDiv, Inc. and Euroscreen s. a. today announced a partnership to discover and develop drug candidates targeting difficult-to-discover drug candidates for high value GPCR family chemokine targets.

San Diego, CA / Brussels, Belgium (PRWEB) July 1, 2005

ChemDiv, Inc. and Euroscreen s. a. today announced a partnership to discover and develop drug candidates targeting difficult-to-discover drug candidates for high value GPCR family chemokine targets. ChemDivÂs proprietary chemistry permits small molecule drug development for such G Protein-Coupled Receptors (GPCRs) while EuroscreenÂs expertise in GPCR assay development and testing will provide rapid screening of the ChemDivÂs Library and subsequent target validation and support to ChemDiv lead optimization. The partnership will provide preclinical and clinical candidates for partnering with shared income for the companies.

"We are very excited about the possibility of rapidly targeting the chemokine GPCRs as the focus of our collaboration," said Alexander Kiselyov, VP Global Chemistry ChemDiv. "This target-focused alliance with Euroscreen adds to our existing programs with partners to develop high value drug candidates for GPCR targets for future partnering."

ÂThis should provide our companies with a rapid opportunity to each contribute our key proprietary skills to rapidly advance important new drug candidates,Â said Dr. FranÃ§ois Roman, the Head of Drug Development R&D at Euroscreen.

For further information, please contact:

Euroscreen s. a.

Tel: +32 71 348 500

Pierre Nokin, Ph. D.

President and CEO

ChemDiv, Inc.

Tel: +1 858-794-4860

Nikolay Savchuk, Ph. D.

President

About ChemDiv Inc.

ChemDiv Incorporated (ChemDiv) is a global chemistry-driven contract research organization focused on the delivery of new scientific innovation and products and services that meet the drug discovery needs of its partners.

Drawing on a long heritage in small-molecule chemistry research as well as world class pre-clinical biology resources, ChemDiv provides partners with access to Discovery outSourceÂ a full service drug discovery capability encompassing synthetic chemistry, medicinal chemistry, pre-clinical development, diverse & focused screening libraries and global logistics.

Taking a dedicated and personal approach to collaborative research and development has proven to be a successful business model for ChemDiv over a period of 15 years. This is attested to by the formation of strategic partnerships with many of the major pharmaceutical and biotechnology companies such as Merck KgaA, Sanofi-Aventis, Astra Zeneca, Dupont, Novo Nordisk and other biopharmaceutical and crop protection, Early adoption of collaborative R&D model with top academic centers such as Johns Hopkins, Harvard, Stanford, Burnham Scripps as well as biotech partners enables ChemDiv with novel biological targets, pioneering assay systems and animal models.

Opening of the Chemical Diversity Research Institute in Moscow a facility that houses state-of-art technology expanded ChemDivÂs capability in discovery chemistry, biological screening, animal testing, bionanalytical, chemo - and bio-informatics.

ChemDiv, Inc. is a privately held company based in San Diego, CA with 400 employees in its facilities worldwide. More information can be found at www. chemdiv. com.

About Euroscreen s. a.

Euroscreen is a world leader in G-protein coupled receptors (GPCRs). The company integrates its research expertise in this area with its patented high-throughput AequoScreenÂ cellular assay platform to patent new GPCR targets and drug candidates.

The company is building a patent portfolio of GPCR targets and novel drug leads for licensing to biopharmaceutical companies, and to date has agreements with Cephalon, CyBio, EvotecOAI, GE Healthcare, ICOS, Merck & Co, Pfizer Inc, Solvay, Syngenta and UCB. Euroscreen has also established collaborations with numerous academic centers for access to licenses to help in making available its broad menu of GPCR-based products (recombinant cell lines and membrane preparations) and services (custom screening and cloning).

Euroscreen has grown significant and strong patent positions to protect many key drug targets for licensing. Such patents include CCR5, GPR7/8 involved in metabolic defects and adult-onset obesity, purinergic receptors (P2Y4, P2Y11 and P2Y13), ORL-1 and the non-GPCR SHIP2 for type II diabetes. Euroscreen is able to offer rights to companies which are developing therapeutic drugs that act through the above-mentioned key targets mode of action.

Euroscreen is a privately held company based in Brussels, Belgium with 80 employees. More information can be found at www. euroscreen. com.

# # #

Lessons in transforming brick & mortar businesses to the dot-com world

2011-04-03T00:01:00.000-07:00

Lessons in Transforming Brick & Mortar Businesses to the Dot-Com World

(PRWEB) June 23, 2000

NEWS RELEASE

Contact:

Lisa Manganiello, Outrider

541-617-5332

Lmanganiello@outrider. com

Www. outrider. com

Lessons in Transforming Brick & Mortar Businesses to the Dot-Com World

Matt Straznitskas, CEO of Outrider North America, to present a behind-the-scenes look at bringing a traditional business online at Marketing WeekÂs ÂHealth OnlineÂ Conference in Central London, Thursday, June 29th

FARMINGTON, CONNECTICUT, June 14, 2000 What does it take to successfully bring a traditional brick and mortar retailer to the dot-com world? Matt Straznitskas, CEO of Outrider North America will share his insights and industry experience in online strategy and branding at Marketing WeekÂs ÂHealth OnlineÂ conference in Central London on Thursday, June 29th.

Straznitskas will provide a behind-the-scenes look at a full-cycle online business launch based on a case study of his work with familymeds. com, the online pharmacy site for Arrow Pharmacy & Nutrition Centers. Launched in August, 1999, familymeds. com has quickly become one of the top rated pharmacy sites on the web, competing head to head with Planetrx. com and Drugstore. com.

In his presentation, Straznitskas will address issues including the importance of understanding the market environment, a strategic assessment of the business model, branding and identity development, technical design, and marketing strategy.

Straznitskas is recognized internationally as a leading web innovator and strategist, and is the author of Mastering PhotoShop 5.5 for the Web.

To register for Health Online or for more information, call 020-7970-4770.

About Outrider

Outrider is a global interactive agency providing truly integrated solutions for online business. The company has more than 250 employees and offices in 11 countries, with North American headquarters in Farmington, Connecticut, and global headquarters in London. OutriderÂs clients (U. S.) include familyMeds. com, art. com, Bridgestone-Firestone, Bank of America, Citicorp, icollector, and Warner-Lambert.

For more information, visit Outrider online at www. outrider. com, or call 860-674-9100, or fax at 8602841058.

###

Samaritan discusses r&d strategy and details robust pipeline at european biosquare partnering conference

2011-04-02T12:42:00.000-07:00

Samaritan Discusses R&D Strategy and Details Robust Pipeline at European BioSquare Partnering Conference

Samaritan Pharmaceuticals focused on two AIDS/HIV Drug Programs with One in Late-Stage Clinical Development and the highlights of Late-Stage Preclinical Programs for Alzheimer's, Adult Stem Cell and Cardiovascular drugs. Regulatory Filing for Four Innovative Drugs Anticipated Throughout 2006-2009

Las Vegas, NV (PRWEB) April 24, 2005

Pharmaceuticals Inc. (AMEX:LIV - News):

Focused on Two AIDS/HIV Drug Programs with One in Late-Stage Clinical Development Also Highlights Late-Stage Preclinical Programs for Alzheimer's, Adult Stem Cell and Cardiovascular Regulatory Filing for Four Innovative Drugs Anticipated Throughout 2006-2009..

Samaritan Pharmaceuticals Inc. (AMEX:LIV - News), a developer of innovative drugs, announced today it highlighted four innovative drugs from its robust Research and Development (R&D) program, to key pharmaceutical business development executives at the BioSquare partnering conference in Lyon, France.

Samaritan reviewed its pipeline and gave an in-depth review of its emerging commercial candidate SP-01A, an oral entry inhibitor HIV drug, expected to commence its monotherapy clinical trial next month. Samaritan, in response to an FDA request, is conducting a 10-day monotherapy trial and, with strong patient enrollment, optimistically anticipates having completed data to submit to the FDA for review within four to six months.

Dr. Janet Greeson, CEO of Samaritan, stated, "Although we are aggressive and fast track everything we can, patient enrollment is out of our hands. All we can do is hope that the various sites recruit as fast as possible so, with positive data, we can move to PIII before the end of the year."

Our robust early development pipeline is significantly advanced in terms of its innovative content. Most importantly, our discovery and early development programs are meeting the ambitious expectations of submitting at least one or two new INDs per year to lay the groundwork of having numerous drugs in clinical development for many years to come.

Samaritan expects to file three new drug applications (INDs) for new drugs -- SP-10 for HIV, SP-233 for Alzheimer's and SP-04 for Alzheimer's -- by the end of 2005 and throughout 2006, contingent on respective promising toxicology studies.

Dr. Greeson went on to say, "Samaritan is ambitiously committed to applying for at least one to two new investigational new drugs (INDs) with the FDA per year -- a major undertaking when you consider a major pharmaceutical such as Wyeth is committed to apply for three new INDs per year."

Samaritan expects these drug programs to significantly contribute to its growth and financial performance in the coming years. Samaritan Pharmaceuticals: "A Cure Is Closer Than You Think." Samaritan, a small biopharmaceutical company, is committed to winning the race to approval for its life-saving affordable drugs. Samaritan, in collaboration with Georgetown University, is advancing its proprietary compounds for AIDS, Alzheimer's, Cancer and Cardiovascular disease.

Visit our Web site at www. samaritanpharma. com.

Disclaimer he company disclaims any information that is created by an outside party and endorses only information that is communicated by its press releases, filings and Web site. This news release contains forward-looking statements that reflect management's current beliefs about the potential for its drug candidates, science and technology. However, as with any biopharmaceutical under development, there are significant risks and uncertainties in the process of development and regulatory review. There are no guarantees that products will prove to be commercially successful. For additional information about the factors that affect the company's business, please read the company's latest Form 10-K filed April 15, 2005. The company undertakes no duty to update forward-looking statements.

Contact:

Samaritan Pharmaceuticals, Inc., Las Vegas Gene Boyle, 702-735-7001

Fax: 702-737-7016 or by Email: GeneBoyle@SamaritanPharma. com

Source: Samaritan Pharmaceuticals, Inc.

# # #

Regional technology alliance selects gcs-pr for strategic counsel

2011-03-31T04:02:00.000-07:00

Regional Technology Alliance Selects GCS-PR for Strategic Counsel

GCS-PR (Gable-Cook-Schmid) has been selected by the San Diego Regional Technology Alliance to provide strategic public and media relations consulting for the industry group. The account will be led by GCS partner Jon Schmid.

(PRWEB) August 18, 2003

San Diego, CA August, 2003 -Â GCS-PR (Gable-Cook-Schmid) has been selected by the San Diego Regional Technology Alliance to provide strategic public and media relations consulting for the industry group. The account will be led by GCS partner Jon Schmid.

GCS will advise The San Diego RTA on its campaign to save the California Technology Investment Partnership grant program, which was cut from the current version of the state budget. The agency will also provide ongoing public relations and media relations consulting as part of an ongoing effort to promote the San Diego Regional Technology Alliance and the services it provides for local high technology companies.

ÂWe selected Gable-Cook-Schmid during this critical time for the RTA because of their excellence in strategic planning and their inside knowledge of media relations,Â said Tyler Orion, director of the San Diego Regional Technology Alliance. ÂAnd they are so plugged in with San Diego technology Â they have a terrific track record with several prominent local technology companies and with promoting the region as a tech capital.Â

ÂThe RTA is an example of the type of industry group that built San Diego into a technology capital and we are very pleased to be working with this top tier organization,Â said Jon Schmid, GCS partner. ÂThe CalTIP grant in particular is important and effective at commercializing technology Â the key to building a technology cluster Â and we will work to get this program reinstated into the budget for next year.Â

GCS represents companies in a broad range of industries, including financial services, biotechnology, real estate and development and technology. Some of GCS Public RelationsÂ clients include Forward Ventures, the largest Southern California venture fund focused exclusively on the life sciences, Epicyte Pharmaceuticals, The Metropolitan Transit Development Board, The La Jolla Institute for Molecular Medicine and the San Diego Film Festival.

About the RTA

The San Diego Regional Technology Alliance (www. sdrta. org) is a private non-profit corporation that promotes sustainable technology growth in the region by providing direct business assistance to entrepreneurs and high tech and biotech companies, programs to bridge the digital divide, and research and education to help shape public policy and forge effective collaborations.

About GCS-PR

GCS (Gable, Cook, Schmid) represents a new breed of public relations firms. The agency was created by seasoned public relations and former media professionals as a more effective alternative to most marketing communications models where daily contact with senior staff is rare. GCS builds customized teams of specialists with the depth and breadth of specific industry knowledge and relationships that ensure clients achieve their business and marketing goals.

GCS is the only firm in the West with two Pulitzer Prize nominees on staff; its senior team members boast an average of 20 years experience. Additional information is available at www. gcs-pr. com.

###

U. S. Army adds inxight star tree visual navigation to its hyperwave knowledge management system

2011-03-24T18:29:00.000-07:00

U. S. Army Adds Inxight Star Tree Visual Navigation to its Hyperwave Knowledge Management System

Kanda Integrates Star Tree with HyperwaveÂs Information Portal to Make Navigation Faster and More Intuitive for Users

(PRWEB) March 8, 2002

SANTA CLARA, Calif. - March 6, 2002 - The U. S. Army has improved the ability of its computer users and information analysts to quickly navigate large-scale databases with the addition of Star TreeÂ visual navigation from InxightÃ Software. Integration of Star Tree into the ArmyÂs Hyperwave IS/6 knowledge management platform was done by Kanda Software of Concord, Mass.

ÂThis is a great example of how two complementary technologies can be integrated to take the whole category to a new level,Â said Ramana Rao, InxightÂs chief technology officer. ÂHyperwave offers an extremely powerful platform for managing huge volumes of data in many different file types and formats, but the larger the knowledgebase the greater the challenge for the user to find the best possible information. Star Tree is the perfect addition to Hyperwave as it lets users navigate graphically instead of using text commands, which is more natural and has been shown to cut navigation time by more than 60 percent. In addition, the integration done by Kanda is truly seamless.Â

Star Tree is InxightÂs proven technology technique for visualizing and navigating large hierarchies of information. Users can quickly view and intuitively understand relationships by simply clicking or dragging the nodes on an interactive tree diagram. It is easy to focus on areas of interest while maintaining a sense of that area's relationship to other information in the tree. By visually communicating multiple levels of information in a single view, Star Tree users can quickly see and understand entire Web sites, information directories, catalogs, organization charts and large document collections.

The Hyperwave solution is a collaborative knowledge management system that allows the creation and access of information anywhere in the extended enterprise. The Hyperwave eKnowledge Infrastructure consists of three principal products that can be implemented as an individual or multiple solution: the eKnowledge Suite, the eKnowledge Portal and the eLearning Suite.

Together, these technologies allow users to correlate information from multiple formats such as documents, images, charts, graphs, and tables and to navigate them based on their associations to one another. Star Tree creates a visual information navigation system that will help improve the discovery and handling of extensive and constantly changing data in ArmyÂs databases. Faster and more intuitive data navigation will translate into faster and better decision making by the information analysts and other military personnel.

About Inxight:

Inxight Software, Inc., develops, markets and supports high-performance information access and content analysis software products and services. These products and services multiply the value of vast amounts of information, enabling users to organize, navigate, and analyze text to find relevant information faster, easier and more efficiently. Inxight's unrivaled products are ideal for information-intensive applications in enterprise markets including financial services, pharmaceuticals and electronic publishing. Customers include Computer Associates, Credit Suisse First Boston, Dow Jones, Factiva, Hewlett Packard, Inktomi, Internal Revenue Service, Lexis Nexis, Lotus, Oracle, Reuters, SAP, Tivoli, Verity and Xerox. Inxight has offices throughout the United States and Europe. For more information visit www. inxight. com or call 408-969-7200.

About Hyperwave

Founded in 1997, Hyperwave is a global company that provides collaborative knowledge management solutions to organizations so they can create and access information anywhere in the extended enterprise and deliver it to employees, customers and partners. Unlike point solutions, the Hyperwave eKnowledge Infrastructure is a broad, integrated knowledge management/e-learning product suite that includes content and document management, search and retrieval, workflow, collaboration and e-learning applications. It also includes a portal product, providing a single, personalized point of access to all information, integrating with other systems and enabling collaboration on projects.

Applications can be implemented as individual or multiple solutions. Moreover, Hyperwave products are highly cost effective with a proven international customer track record. Hyperwave has its headquarters in Germany with North American headquarters outside of Boston. It also has offices in New York, the UK, France, and an R&D center in Austria. Among its customers are BMW, DaimlerChrysler, McCann-Erickson, MetLife, European Commission, Havas Advertising, Bank Austria/Creditanstalt Group, Universal Music, Siemens, and the US Department of Defense. For more information visit www. hyperwave. com or call 978-392-4200.

About Kanda Software

Kanda provides custom application development and integration services for the web. They integrate the latest technology with existing enterprise information infrastructures, providing new ways to distribute and access information. The sites Kanda generates include robust Portal technology, ePublishing and eBusiness functionality. For more information, contact Terrence Rourke, Director of Marketing at Kanda at 978-371-9996 x167 or visit www. kandasoft. com.

###

Drury produces successful training for janssen launch

2011-03-22T08:54:00.000-07:00

Drury Produces Successful Training for Janssen Launch

Drury Design Dynamics just completed a comprehensive training program for the launch of Janssen PharmaceuticaÂs latest drug, Risperdal Consta, the first and only long-acting atypical antipsychotic approved by the U. S. Food and Drug Administration for the treatment of schizophrenia.

New York, NY (PRWEB) March 3, 2004

Drury Design Dynamics just completed a comprehensive training program for the launch of Janssen PharmaceuticaÂs latest product, Risperdal Consta, the first and only long-acting atypical antipsychotic approved by the U. S. Food and Drug Administration for the treatment of schizophrenia. Training for this launch was no small feat.

ÂBecause Janssen and patients needed to have Risperdal Consta immediately in the market after approval [in December], we had two regional meetings with a major training emphasis,Â said Carl Hyman, Director of Education & Training at Drury.

In the two and a half days, reps were engaged in a series of workshops that covered such topics as the new delivery system by injection and overcoming physician objections. A culminating activity involved practicing how to sell to real physicians who attended the meeting.

By the end of the meeting, Janssen reps became thorough experts on the drug, knowledgeable in selling against the competition and learned how to implement in-service training. ÂThey learned how to make giving the injection look smooth and effortless,Â said Hyman, thereby demonstrating to physicians and nurses how to properly administer the injection.

The successful results of DruryÂs training program are expected to be shown later this year through better than forecasted sales figures for Risperdal Consta.

Drury Design Dynamics, founded in 1981, is a full service communications company that specializes in the planning and production of meetings, corporate communications, training, special events and entertainment.

Early-bird discount extended for product management educational conference, the global hub for all things product management

2011-03-22T08:05:00.000-07:00

Early-Bird Discount Extended for Product Management Educational Conference, the Global Hub for All Things Product Management

Deadline extended through March 15, 2006.

Sacramento, CA (PRWEB) March 2, 2006

The Association of International Product Marketing and Management (AIPMM), the resource for all things product management, announced today that the early-bird registration discount has been extended through March 15, for the Product Management Educational Conference to be held at the Hyatt Grand Champions Golf Resort in Indian Wells, California.

The Product Management Educational Conference 2006, entitled The Way of the Product Manager, will be held Wednesday April 19, 2006 to Friday April 21, 2006. PMEC 2006 will provide learning and networking opportunities for product managers representing pharmaceutical, software, medical devices, travel & tourism, food services, financial services, and consumer goods.

PMEC 2006 is sponsored by the Association of International Product Marketing and Management (AIPMM), the resource for all things product management. The AIPMM is the only worldwide professional association dedicated to product managers, brand managers, product marketing managers and other professionals who cover the entire discipline of the product life-cycle throughout any industry.

For information or to register go to http://www. aipmm. com/pmec (http://www. aipmm. com/pmec)

About the Association of International Product Marketing and Management

The AIPMM provides value to its individual members, corporate members, and sponsors by providing training, education, certification and professional networking opportunities. Membership benefits include the national Product Management Educational Conference, regional conferences, the Career Center, peer Forums, tools, templates, publications and eligibility to enroll in the Certification Programs. The Certified Product Manager (CPM) and Certified Product Marketing Manager (CPMM) program allows individual members to demonstrate their level of expertise and provides corporate members an assurance that their product professionals are operating at peak performance. For more information on issues concerning product management and product managers go to http://www. aipmm. com (http://www. aipmm. com).

# # #

Bpg properties, ltd. Announces 2750 morris road in lansdale, pennsylvania is for sale

2011-03-21T22:29:00.000-07:00

BPG Properties, Ltd. Announces 2750 Morris Road in Lansdale, Pennsylvania is for Sale

Cushman & Wakefield of Pennsylvania Named as Listing Agent for 87-Acre R&D/Manufacturing Facility

Philadelphia, Pa. (Vocus) September 9, 2009

BPG Properties, Ltd. (BPG), one of the nation's leading private equity fund managers, has announced that 2750 Morris Road (http://www. bpgltd. com/index. asp? page=properties§ion=industrial&building=335), a 705,000 square foot highly specialized research and development/manufacturing facility in Lansdale, Pennsylvania is available for purchase. The 87-acre property is located less than five miles from the Lansdale interchange of the Northeast Extension of the Pennsylvania Turnpike (Interstate 476) in Montgomery County. The Greater Philadelphia region including Montgomery County is home to a significant number of top employers in the life sciences, pharmaceutical and biotechnology industries. In fact, 18 of the top 51 private sector employers in the region are life science companies.

"2750 Morris Road is a first class facility that offers significant infrastructure, ideal zoning classification, enhanced building systems and features," commented Joseph Nahas, vice president of BPG who is overseeing the sale of the property. "The extensive features of this state of the art manufacturing facility, combined with its location in what is one of the strongest life science regions in the United States make it ideal for research, manufacturing or distribution companies looking to expand or establish a presence in the area."

Situated adjacent to the Northeast Extension of the Pennsylvania Turnpike, 2750 Morris Road offers convenient access to the region's highly skilled workforce, residential communities and business centers via the Pennsylvania Turnpike and Routes 202 and 309. Road improvements to the Pennsylvania Turnpike have been planned and are already in process which will greatly enhance access to and from the property and the surrounding area. The property offers a secure campus setting enclosed behind a 15' berm with extensive landscaping on the perimeter and two gated entrances along Schultz and Morris Roads.

2750 Morris Road is comprised of five interconnecting buildings which include office, administrative, engineering, manufacturing and production space. This design allows for flexible occupancy scenarios which includes the ability to subdivide the building into spaces as small as 45,000 square feet and as large as 450,000 square feet

Electrical and mechanical systems at 2750 Morris Road are enhanced due to the building's original design for electronics manufacturing and include an HVAC chilled water system with 3200 tons of cooling capacity and a Class 10,000 clean room. A separate detached pump station services the site and houses five generators that are capable of supporting the entire facility and providing the transfer of continuous power without interruption.

The facility was designed and built in 1989 for Ford Electronics and Refrigeration. To date, it has been the regional manufacturing facility for the Visteon Corporation (Visteon), a global leader in the design and manufacturing of electronic control modules for the automotive industry. Visteon is moving its operations overseas and will be vacating the property as of the first quarter 2010.

BPG has named John Shelly and Gina Brennan of Cushman & Wakefield of Pennsylvania, Inc. as the sales and listing agents for the property.

About BPG Properties, Ltd.
BPG Properties, Ltd. is one of the nation's leading private equity real estate fund managers. BPG's portfolio consists of over 20 million square feet of office, retail, student housing, and industrial properties and more than 25,000 apartment units in more than 100 communities located throughout the United States. The firm is headquartered in the Philadelphia area with regional offices in Los Angeles, Chicago, Washington DC, Boston, Atlanta and Raleigh-Durham. For additional information, please visit the company's website at www. bpgltd. com.

For additional information on BPG Properties, Ltd., please contact:
Holly T. Reynolds, Vice President, at (215) 575-2363

For additional information on the property, please contact:
Joseph Nahas, Vice President, at (215) 575-2356

# # #

New protocol established by university of utah for determining adherence to niosh definition of a closed-system

2011-03-20T15:30:00.000-07:00

New Protocol Established by University of Utah for Determining Adherence to NIOSH Definition of a Closed-system

New evidence-based research for determining adherence to the NIOSH definition of a closed-system was unveiled at the ASHP Mid-year meeting by the University of Utah.

(PRWEB) January 2, 2007

New evidence-based research for determining adherence to the NIOSH definition of a closed-system was unveiled at the ASHP Mid-year meeting by the University of Utah.

Project advisor Jim Jorgenson, Administrative Director of Pharmacy Services at University of Utah Health Care, and project lead Cam Au, Pharm. D., tested 5 transfer devices by using titanium tetrachloride to determine which device prevents the escape of vapor, hence meeting the NIOSH definition of closed. Closed-system drug transfer devices are recommended by the National Institute for Occupational Safety and Health (NIOSH) for the containment of hazardous drugs.

The five devices tested were the Alaris Smart Site by Cardinal Health, Tevadaptor Vial Adaptor System by Teva Medical, Ltd., Chemo Mini-Spike Plus Dispensing Pin by B. Braun, the Chemoprotect Spike by Codan US Corporation and PhaSeal Protector 50 & Injector Leur Lock by Carmel Pharma.

Only the PhaSeal System by Carmel Pharma, prevented the release of the titanium smoke out of the closed-system drug transfer device.

Only the PhaSeal System met the definition of a closed-system drug transfer device.

“We’ve used the PhaSeal System for five years at the University of Utah,” Jorgenson said, “and the study confirms selecting it was the right choice.”

University Health Care is the only academic health care system in the Intermountain West. As part of that system, University Hospitals & Clinics offer services in more than 120 specialties and is consistently ranked as one of the country’s best hospitals by U. S. News & World Report. The system provides care for Utahns and residents of five surrounding states in a referral area encompassing more than 10 percent of the continental United States. The hospitals and clinics log more than 900,000 outpatient visits and more than 23,000 inpatient admissions each year. Its academic partners at the University of Utah School of Medicine and Colleges of Nursing, Pharmacy, and Health are internationally regarded research and teaching institutions.

With over 10 peer-reviewed, independent studies currently available, the PhaSeal System is the only clinically proven closed-system drug transfer device available today. The System consists of an Expansion Chamber that captures aerosols and vapors while equalizing the pressure in the vial, a Double membrane that ensures dry connections, and a Needle-Safe Design that enables the retrieval of all the drug from the vial.

The PhaSeal System is manufactured by Carmel Pharma ab in Gothenburg, Sweden and is distributed from its U. S. affiliate office, Carmel Pharma, Inc., in Columbus, OH. PhaSeal has been in use in the U. S. since 2000 and has been implemented in over 400 cancer centers, oncology practices, specialty pharmacies in the United States, including M. D. Anderson in Houston, TX, Texas Children’s and UCSF. If you have questions regarding the PhaSeal System or Carmel Pharma, Inc., please contact Christine Crooks, Director of Marketing at 1-866-487-9250 ext.202, or email us.

###

Md biosciences nominated for scottish annual life sciences award: most promising new life science company

2011-03-18T05:25:00.000-07:00

MD Biosciences Nominated for Scottish Annual Life Sciences Award: Most Promising New Life Science Company

Glasgow, Scotland (PRWEB) January 6, 2006

MD Biosciences has been nominated for the Scottish Enterprise Annual Life Sciences Award in the category of Most Promising New Life Science Company. MD Biosciences is one of three finalists in this category. Awards will be presented to recognize outstanding achievements of new life science companies during the Scottish Life Sciences Annual Dinner on February 9th in Edinburgh. The 2005 launch of the Inflammations Discovery Service along with cutting-edge mode of action platforms has positioned the company as a leading product and services provider for inflammations research. “Being nominated in this category is truly an honor and signifies the potential of our company, not only as seen by ourselves but also by our industry”, comments Dr. Eddie Moradian, Managing Director of MD Biosciences. This nomination also reflects MD Biosciences commitment and focus on the inflammations drug discovery market.

MD Biosciences provides researchers a unique combination of products and services. Investing time into customizing protocols to meet individual needs, along with learning and understanding clients’ objectives, hurdles and milestone requirements, enables MDB to contribute suggestions and alternatives to tackle the obstacles challenging the clients business. MDB maintains a unique position by providing flexibility in custom tailoring all procedures and offering the ability to use the same products for client’s research, allowing simultaneous in-house development while services are being out-sourced to MD Biosciences.

With laboratories and offices in Switzerland, Israel, and the United States as well as the MD Biosciences Inflammations Discovery Service in Scotland, the company has a unique team of scientists encompassing the globe and comprise inflammation specialists, pharmaco-biologists, in vitro laboratory personnel and project leaders, forming a network of contracted experts within areas of core competence.

The information in this press release should be considered accurate only as of the date of the release. MDB has no intention of updating and specifically disclaims any duty to update the information in these press releases.

# # #

Lifeclinic international to highlight health station benefits at food marketing institute supermarket pharmacy conference

2011-03-15T16:39:00.000-07:00

Lifeclinic International to Highlight Health Station Benefits at Food Marketing Institute Supermarket Pharmacy Conference

Featured at this year's conference will be Lifeclinic's continued commitment to provide state-of-the-art automated health testing technology to the general population and to encourage retail clients to utilize their blood pressure monitors and health testing stations for employee wellness.

Burtonsville, MD (PRWEB) May 1, 2008

Lifeclinic International, Inc. (http://www. lifeclinic. com), the world's leading manufacturer and distributor of automated blood pressure monitors and health testing stations (http://www. lifeclinic. com/products. aspx), will be showcasing its latest consumer healthcare technology and its corporate wellness initiative for its retail customers at the Food Marketing Institute (FMI) (http://www. fmi. org) Supermarket Pharmacy Conference, May 3 - 6, 2008, Table 51, Mandalay Bay Convention Center, Las Vegas, NV.

Within the healthcare sector, Lifeclinic is leading the industry in the development and promotion of technology that allows people to become proactive in tracking and managing their own vital-signs. "Our retailer customers (http://www. lifeclinic. com/customers. aspx) provide our blood pressure monitors to their customers as a free service, promoting self-monitoring and wellness, while also driving that consumer traffic to the retailer's pharmacy where the unit resides. However, there's an incredible opportunity to serve a population of people who are at the store almost every day - the retailer's employees," says Lifeclinic Senior Vice President, David Read. Read continues, "Workplace wellness is a critical component of any health promotion strategy and a legitimate investment in any organization. Lifeclinic is committed in providing the programs and tools to help our retail clients meet the health and wellness needs of their employees."

Lifeclinic's latest line (http://www. lifeclinic. com/lc600.aspx) of automated health testing stations offer automated blood pressure, weight, body fat and blood oxygen tests. The health station's scalability allows for the integration of additional tests, such as those for sight, hearing and bone density, from multiple manufact¬ur-ers. Peripheral input ports include IR, USB and Bluetooth for interfacing and uploading data from various personal health devices such as glucose meters and pedometers.

Consumers and employees can easily navigate through the health station's interface of test options, health information, and a database of the retailer's products, coupons and discounts, via a color LCD touch screen. Optional features include both a magnetic stripe and a barcode reader for retail loyalty card programs. The barcode reader can also generate multimedia product information, allowing consumers to retrieve tailored product information for general merchandise, HBA, OTC and Rx products.

About Lifeclinic International, Inc.
Lifeclinic was established in 1976 as Vita-Stat Medical Services, Inc. Since then, it has grown to be the world's largest supplier of commercial, automated, blood pressure monitors and health stations. Lifeclinic monitors can be found in over 30,000 pharmacies and 4,000 company and organizational wellness centers worldwide, accounting for 500 million blood pressure measure-ments annually. Lifeclinic monitors, health stations and management systems encourage individuals to take an active role in their healthcare and provide corporate management with tools to help reduce costs while simultaneously improving the health of individual employees. Lifeclinic monitors and health stations can be found throughout the United States and in many other countries worldwide.

Please visit http://www. lifeclinic. com (http://www. lifeclinic. com) for more information.

###

Added value pharmaceutical services turns to active marketing services for creative campaign & marketing services

2011-03-15T10:29:00.000-07:00

Added Value Pharmaceutical Services Turns to Active Marketing Services for Creative Campaign & Marketing Services

Long Beach - Added Value Pharmaceutical Services has turned to Active Marketing Services, better known as AMS, for help in launching their new product. Added Value Pharmaceutical Services have just launched two new flu masks for sale here in the US.

Los Angeles, CA (PRWEB) July 3, 2009

Added Value Pharmaceutical Services has turned to Active Marketing Services, better known as AMS, for help in launching their new product. Added Value Pharmaceutical Services have just launched two new flu masks for sale here in the US.

AMS has been tapped to provide strategy and deliverables in the form of online marketing to include development and integration of multiple website properties, event promotion, ads, email campaigns, public relations and more.

In accomplishing this they are utilizing their online & web creative section of the business known as Enlarge Media Group. As in past projects these two separate sectors of the business work alongside each other to integrate their web marketing and outdoor marketing campaigns which include a wide array of unique marketing tactics and newsworthy events to bolster publicity.

Added Value Pharmaceutical Services is under a larger umbrella of companies to include Aidarex Pharmaceuticals and also Industrial Pharmacy Management, LLC. Their 2 newest products are the Pasture Pharma GPU F550G Respirator Mask and the Pasture Pharma NT-V2 Respirator Mask. These masks are N95 respirators and Pasture Pharma is one of only two companies with mask the FDA has cleared for use by the general public in public health medical emergencies. These masks are available on the website www. truthaboutflu. com and with the promotional code "mask" you can even obtain a 15% discount. With the approaching flu season upon us and with the pandemic swine flu looming in the background, Added Value Pharmaceutical Services needed a company that was able to move fast in this product launch.

AMS president Chad Zaputil says "This is a very exciting project to be working on and we are eager to launch this product with some attention grabbing events at various 4th of July celebrations around Southern California." Active Marketing Services (AMS) is based out of Long Beach, California. To learn more about them visit their website at www. theamssite. com.

# # #

Obama's healthcare debate and dr. Chao's 8 herbal ounces of prevention ~by ed rampell

2011-03-12T21:58:00.000-08:00

Obama's Healthcare Debate and Dr. Chao's 8 Herbal Ounces of Prevention ~By Ed Rampell

The debate over healthcare reform dominates America's news. The effort to tame ever-increasing costs, from monthly insurance premiums to co-pays to hospital visits to pharmaceuticals, et al, and to provide coverage for those with preexisting conditions and the almost 50 million uninsured Americans, has become the centerpiece of the Obama administration's domestic program.

Claremont, CA (PRWEB) September 24, 2009

From raucous town hall meetings to Senate Finance Committee Chairman Max Baucus' suggested legislation, front page stories, headlines, op-eds, talk radio, TV talking heads, blogs and more chronicle and wrangle over proposals to reform the U. S. medical insurance system. Republicans fight Democrats, and within the President's own party, liberals vie with fiscally conservative "Blue Dogs."

To press his case Barack Obama makes innumerable campaign and media appearances - interviewed on five TV news programs on Sept. 20 alone, appearing the next night on "The Late Show With David Letterman." Meanwhile U. S. Rep. Joe Wilson interrupted the President during his address to a joint session of Congress shouting "you lie!" and "teabagger" protesters denounce Obama as a Nazi, socialist or communist hell-bent on instituting "death panels" and big government takeover of America's doctors, nurses and hospitals. The U. S.' single largest union, the AFL-CIO, for the first time ever endorses single payer, while the public option, a co-op plan, doing nothing at all and more are also bandied about as possible solutions to the current crisis, wherein America is the country with the highest healthcare costs yet the only major industrialized nation without a universal healthcare system.

Amidst all of this sound and fury, something essential to wellbeing has been overlooked, lost and forgotten in the healthcare brouhaha: prevention. One of the few commentators who hasn't neglected this all-important factor is comedian Bill Maher, the host of HBO's "Real Time." During the presidential race Maher acidly observed in the "New Rules" segment of his cable TV program, "none of the [candidates'] plans address the real problem. We won't stop being sick until we stop making ourselves sick. Because there is a point where even the most universal government health program can't help you. They can't outlaw unhealthy food or alcohol or cigarettes."

Maher added, "the government isn't your nanny." Indeed, even if Washington universally insures every American, individuals pursuing unhealthy lifestyles are still likely to get sick. As Maher pointed out: "Fifty years ago, children didn't even get Type 2 Diabetes. Now, it's an emerging epidemic. As are a long list of ailments which used to be rare, and have now been 'mainstreamed.'" (In 2004 a study published in the Journal of the American Medical Association concluded: "Higher consumption of sugar-sweetened beverages is associated with... weight gain and an increased risk for development of type 2 diabetes in women...")

In his televised rant the HBO humorist, who is a vocal critic of medicating people with manmade chemicals, asserted, "diet and exercise don't fail. A fact brought home... by a new Duke University study that showed exercise - yes, exercise - is just as effective a cure for depression as Paxil and Zoloft... You know, if Republicans can sell the idea of preemptive war, Democrats have to at least get us interested in the idea of preventive medicine."

Maher's notion is older than the United States. In 18th century colonial America Dr. Benjamin Franklin wisely noted: "An ounce of prevention is worth a pound of cure." While universal health insurance may be a worthy goal, individuals must also be active participants in their own wellness, instead of passive victims complicit in their own illnesses and diseases.

Among those who believe soda is an addictive silent killer loaded with sugar, preservatives, carbs and often caffeine responsible for much of America's obesity and diabetes epidemics is Chinese herbalist Ted Chao. Previously herbs - plants with healing properties from Mother Nature's "pharmacy" -- were consumed in tablet, pill or powder form. But drawing upon his family's herbal heritage, as well as China's 5,000-year-old medical tradition, Ted has rendered herb-based recipes into liquid form that can be consumed in eight-ounce flip top metal tab cans.

The Dr. Chao Herbal Drink Line is a healthy soft drink alternative consisting of beverages that are 100% natural and vegan, without sugar, caffeine, calories, glutens, artificial sweeteners or preservatives, and which feature a variety of health benefits. The eponymous Dr. Chao refers to Ted's illustrious ancestor, Baoyin Chao, a famous herbalist from Guizhou Province in Southwest China who, in the 1870s, was a sort of Asian Gregor Mendel or George Washington Carver.

Ted and his family, which includes three brothers and a sister, followed in his famous great-great-great-grandfather's footsteps. When Ted grew up, his family "always used the herbs for nutrition and treatment, and knew their uses very well." The family established a hospital, institute, clinic and herbal school at Guizhou, where Ted started working in 1989 when he was 24, after graduating with a master's degree from Guiyang College of Traditional Chinese Medicine in Guizhou's capital.

By 2007, Ted had come to America and was thinking how to make "the consumption of herbs more convenient for consumers." The Chinese entrepreneurial herbalist started working with the Northern California-based National Food Laboratory, which, according to its website, is "a consulting organization specializing in transforming inspiration and experience into innovative food and beverage development." Ted and the NFL looked into the best way to preserve the herb's beneficial properties while providing convenience for users. Ultimately, they hit upon the idea of liquefying the herbs, and the Dr. Chao Herbal Drink Line was born. While the actual herbs are grown in China, they are imported to the U. S.A. and are processed into soft drinks at a FDA certified beverage factory in Wisconsin that also produces V8 juice.

Doctor Chao spent years in the mountains studying the properties of herbs, applied his knowledge to a practice that included thousands of patients and compiled a sort of herbal encyclopedia. The formulas for the Dr. Chao Herbal Drink Line are derived from this manuscript, which consists of hundreds of pages of parchment, containing handwritten recipes in Chinese characters. Ted joked that if this writer read Chinese, he would not have shown the loosely bound pages to him. Like the Kentucky Colonel's "secret recipe" for Col. Sanders' "finger lickin' good" chicken (which, by the way, includes 11 herbs and spices), Ted refuses to disclose and publish the closely guarded formulations of his forebear, a sacred family text that remains a patented trade secret.

However, in an interview at the Claremont, California headquarters of the firm he is the president of, U. S. People Foods & Beverages Company (www. uspfb. com; 877-2DR CHAO), Ted revealed the recipes, properties and benefits of the Dr. Chao Herbal Drink Line. "The 'Stress Reliever' alleviates symptoms caused by stress, such as headaches, insomnia, irritability and back pain," Ted explained. "It has Cordyceps [caterpillar fungus], saffron, Fructus Momordicae [Grosvenor Momordica fruit] and Herba Hyperici Japonici [St. John's Wort]."

The "Adult Drink," Ted said, is "similar to Viagra, but in a natural way. It's designed to increase sexual health, by stimulating the healthy production of sexual hormones and glands, and combats sexual exhaustion." The herbs in this concoction include Herba Epimedii, which, in English is called, appropriately enough, Horny Goat Weed. Both the Stress Reliever and Adult Drink are carbonated.

The "Lady Drink," which, as its name suggests, is geared for females as "an herbal detox beauty drink with anti-oxidants for removing impurities from their internal systems, improving facial skin, anti-aging benefits and alleviating PMS symptoms. The Lady Drink excretes toxic substances, combats aging and enhances kidney and liver functions. It's made with Herba Leonuri [Motherwort Herb], aloe and more," the U. S.P. F.B. president stated.

According to Ted, a fifth drink called "21" will be on the market by the end of 2009 with a most practical function that could have come in handy in that popular 2009 comedy, "The Hangover": curing the effects of overdrinking. Down the road, U. S.P. F.B. plans to introduce herbal-based foods, such as "herbal ice cream, which will be as sweet as normal ice cream - but without sugar," Ted said. U. S.P. F.B. also intends to grow its own herbs here in the U. S.A. as well as to expand its distribution beyond the health and organic food stores, such as Whole Foods Market, where the Dr. Chao Herbal Drinks are currently sold.

Ted's master plan is to bring the wisdom of the East to the West, in the shape of healthy soft drinks that can replace sugary, syrupy sodas and the like. "I want to introduce herbal drinks to the whole world. When the public knows the value of herb drinks, they will love it," he insisted. Although well aware that alternative beverages are obviously not the sole solution to America's medical insurance dilemmas, the Chinese herbalist believes that by being proactive in their own wellbeing and choosing to consume healthful products, Americans can avoid pitfalls such as diabetes and obesity. "Herbs can supplement healthcare," proclaimed Ted.

This great-great-great-grandson of a venerable Chinese herbal doctor hopes that his herbal ambrosia will have an impact similar to the introduction of the ancient Chinese science of acupuncture had on healing practices in the Western world. If, as Ben Franklin observed, "An ounce of prevention is worth a pound of cure," then as far as Ted Chao is concerned, the Dr. Chao Herbal Drink Line provides eight herbal ounces of preventive healthcare per can.

Companies grapple with optimal strategies for avoiding risk in hiring independent contractors

2011-03-11T00:08:00.000-08:00

Companies Grapple with Optimal Strategies for Avoiding Risk in Hiring Independent Contractors

Albany says concern is heightened with changing legislation in U. S., globally

Mountain View, Calif. (PRWEB) March 17, 2009

A growing global contingent workforce (http://www. thealbanygroup. com/riskaudio) and changing legislation is heightening concern over worker misclassification (http://www. thealbanygroup. com/USA/landing. asp? section=85§ionTitle=Global%20Workforce%20Management), an issue increasingly discussed at industry forums.

Even companies in markets not typically worried with contract worker issues, such as the pharmaceutical industry, have sounded warnings by firing executives who’ve violated contingent worker policies. Management is increasingly asking “how do I become compliant” when hiring independent contractors (http://www. thealbanygroup. com/USA/page. asp? section=126§ionTitle=Contractor+Management%2C+Payroll+%26+Compliance).

“Companies in the U. S. are closely watching pending legislation from the new administration, and the changing regulations throughout Europe and other regions,” said Jason Posel, senior vice president of Albany, a provider of contingent worker management services operating in over 70 countries. “Globalization is prompting many firms to rethink their strategies.”

Some companies have responded conservatively, mandating all contingent and temporary workers become employees of their suppliers to steer far clear of onerous fines and penalties resulting from misclassifying contract workers. This is not always the best strategy, according to Posel. Some Western European countries are very strict in their definition and regulations of contract workers. In other countries, it’s typical for skilled workers to be independent contractors and less restrictive governmental regulations support that.

“It takes a state-by-state approach in the U. S., and globally, it’s best to combine a country-by-country with an individual approach,” added Posel.

Posel was joined by representatives of industry giants Cisco and Google at the last Contingent Workforce Strategies (CWS) Summit. A recording of the session, “Managing Independent Contractor Compliance Risk: Down the Block and Around the World,” is availably at Albany’s website, www. thealbanygroup. com/riskaudio (http://www. thealbanygroup. com/riskaudio).

Cisco System’s Randall Levinson, Global Contingent Workforce Program Manager, said a key driver of the company’s contractor compliance program is “managing around the precedents,” set by Microsoft, Fed-Ex, Time Warner and HP that dealt with legal issues between assumed employees who were actual contractors—resulting in enormous fines and penalties.

Given Cisco’s global presence, Levinson advised having the appropriate internal expert or working with a partner with a strong international presence and knowledge to guide the company on the necessary steps to ensure compliance for every employee.

“With Albany engaged to handle our Contractor Compliance Program we have streamlined our processes and had a significantly positive impact on misclassification management in the U. S. and internationally," said Levinson. “They’ve helped us institute a clear and repeatable process dealing with our contract workers.”

About Albany
Albany, http://www. thealbanygroup. com/usa (http://www. thealbanygroup. com/usa), is a global leader in contingent workforce management solutions with over 20 years of experience. With offices on six continents serving clients in 70 countries, Albany offers a variety of national and international workforce solutions, including contractor payroll, Independent Contractor compliance (http://www. thealbanygroup. com/USA/page. asp? section=323§ionTitle=Independent+Contractor+Compliance), Managed Service Provider programs, Recruitment Process Management and Consulting, and visa & migration services.

Contact:
Jason Posel
Senior Vice President
1-800-664-5508
Jason. Posel(at)thealbanygroup. com
Www. thealbanygroup. com/usa (http://www. thealbanygroup. com/usa)

This press release was distributed through eMediawire by Human Resources Marketer (HR Marketer: www. HRmarketer. com) on behalf of the company listed above.

###

Centice corporation awarded nearly $500,000 in qualified investment rebates from the irs

2011-03-10T23:07:00.000-08:00

Centice Corporation Awarded Nearly $500,000 in Qualified Investment Rebates from the IRS

For their submissions to the Qualifying Therapeutic Discovery Project Program, Centice Corporation has been awarded close to $500,000

Morrisville, N. C. (PRWEB) December 2, 2010

Centice Corporation, a pioneer in chemical verification and identification using Raman spectroscopy and computational sensor technology, was awarded nearly $500,000 in qualified investment rebates from the IRS for their two submissions to the Qualifying Therapeutic Discovery Project Program, created by the Affordable Care Act.

Credits and grants were available for projects that showed potential to produce new cost-saving therapies, create U. S. jobs, and increase U. S. competitiveness. Centice submitted work for two different projects. The first, for work on the Diagnostic Reader for cardiac biomarkers and the second for work on the company's drug verification system, PASS Rx®.

Applications for investment rebates were evaluated by the Department of Health and Human Services for their potential to produce new therapies, reduce long-term health care costs or cure cancer within 30 years.

"We are very excited to have been awarded grants from the IRS for both of the projects for which we applied," said Scott Albert, CEO. "Our team has worked hard to find new ways to help make a difference in the healthcare industry and we are pleased to receive funding to continue our efforts as we look toward impacting other markets in the future."

About Centice

Centice Corporation creates and delivers advanced technology solutions to select markets in pharmacy operations, healthcare, manufacturing and homeland security. By leveraging an expertise in applied Raman spectroscopy, computational sensors, and machine vision technology, Centice provides products and integration expertise that saves lives and protects people's lifestyles. Centice's scientists and engineering teams work with a network of partners to answer emerging business needs. Headquartered in Morrisville, N. C. and founded in 2004, the company maintains sales offices across the country and markets products direct and through distributors. More information can be found at http://www. centice. com.

# # #

Process development programme key to avecia/ zymogenetics partnership

2011-03-09T21:07:00.000-08:00

Process Development Programme Key to Avecia/ Zymogenetics Partnership

Avecia has delivered the first quantities of the recombinant version of human Factor XIII protein from its Billingham UK Advanced Biologics Centre to US based ZymoGenetics Inc. (Nasdaq: ZGEN). The delivery marks successful completion of an extensive process development programme by Avecia Biotechnology, and follow-on GMP batches are already underway.

(PRWEB) June 16, 2002

Recombinant human (rh) Factor XIII, produced in a yeast expression system, is being developed by ZymoGenetics to reduce perioperative bleeding following cardiopulmonary bypass surgery. Factor XIII, the last enzyme in the coagulation cascade, cross-links fibrin strands in a blood clot to make the clot stronger, and reduce the chance of rebleeding.

With its combined track record in microbial process development services and manufacture, AveciaÂs Biologics business was chosen by ZymoGenetics to develop a robust and scaleable process and to manufacture clinical product in compliance with current Good Manufacturing Practice (GMP).

ÂWe are extremely pleased about our partnership with Avecia and the success they have achieved in manufacturing GMP rh Factor XIII to support our clinical development activities,Â stated Bruce L. A. Carter, Ph. D., President and Chief Executive Officer of ZymoGenetics. ÂRh Factor XIII is our most advanced project for which we intend to file an investigational new drug application (IND) with the FDA in late 2002Â.

ZymoGenetics Inc., of Seattle, Washington (USA) is biopharmaceutical company focused on the discovery, development and commercialisation of protein therapeutics for the prevention or treatment of human diseases.

Avecia is a strategically focused service provider to the biotechnology and pharmaceutical industry, helping customers to commercialize new and advanced medicines through innovative process science and GMP manufacturing technology. Avecia has considerable process development experience with a wide range of micro-organisms, and has been making biologics at Billingham since 1997.

In February, the company announced a US $100m expansion programme to build one of the worldÂs most advanced facilities for manufacturing microbially-derived biologics. The investment, at Billingham, will create an additional 40,000 litres of capacity. With the first phase on stream during 2003, AveciaÂs new facility will bring integrated capacity on a single site for process development, clinical trials and large-scale manufacturing to cGMP standards.

guitarrawlings

2011-03-09T08:02:00.001-08:00

guitarrawlings

A medical ÂdavidÂ takes on a ÂgoliathÂ establishment

2011-03-09T05:34:00.000-08:00

A MEDICAL ÂDAVIDÂ TAKES ON A ÂGOLIATHÂ ESTABLISHMENT

Dr. Irving Dardik has been like David battling Goliath. He took on an establishment that would rather treat illness with drugs and operations instead of preventing it. Despite being ostracized, he never lost his passion for his belief that his theory would revolutionize life itself.

(PRWEB) May 18, 2002

From the earliest time, everything in nature has displayed rhythmic cycles. Light waves. Sound waves. Radio waves. Gravitational waves. Lunar cycles. Ocean tides. The EarthÂs seasonal temperature fluctuations and long-term Ice Ages. Animals in the wild wake, hunt and sleep. Bears hibernate and arise. And every second of our lives, our own heart valves open and close, for survival itself is based on maintaining these rhythms.

Yet when one man made this observation and postulated that we could all be healthier if we focused more on our rhythms, he was disbarred from medical practice and ridiculed in the press.

In retrospect, Dr. Irving Dardik has been like David battling Goliath. He took on an establishment that would rather treat illness with drugs and operations instead of preventing it. Despite being ostracized, he never lost his passion for his belief that his theory would revolutionize life itself.

Dr. Dardik believes that once we recognize that the rhythms of nature are real and do affect everything, we will realize that modern life has isolated us from natureÂs survival mechanisms. In the advanced technological world, we do not depend on the rhythms of the day and year to give us light, food or comfort. Instead, we have come to act as if we exist outside the natural world, putting lights on at night, ignoring the bodyÂs need for a siesta in the afternoon, forcing ourselves awake with alarm clocks.

All of these changes are very recent events in human history. Humans evolved because, in the natural world, our physiology was in synchrony with the rhythms that embraced us. This fundamental connection to nature persists in all our physiology, which changes with the time of day, month and season. Whether we choose to recognize it or not, we are rhythmic animals, embedded within the larger rhythms of the natural world and ourselves contain multiple rhythms of biology, from the rhythms of our individual cells, to larger rhythms like blood pressure and hormones, to the longer rhythms of growth, maturity and reproduction.

Like Nelson Mandela who, after being imprisoned in South Africa emerged from his cell to become a Nobel Prize winner, Dr. DardikÂs own day in the sun seems to be arriving. Today, the daily cycles of the body known as circadian rhythms are being studied throughout academia and the medical world. Ironically, much of the current focus is on how the effectiveness of pharmaceutical drugs seem to be affected by circadian rhythms. The Food & Drug Administrations online consumer publication at www. fda. gov frequently mentions the topic (more than a dozen times in the first quarter of 2002).

While much of the establishmentÂs focus is on drug uptake and such things as the time of day most heart attacks occur, Dr. DardikÂs prevented approach of getting synchronized with circadian rhythms has been embraced by The LifeWavesÂ Program which has attracted interest from Harvard to Columbia Presbyterian Hospital.

The goal of The LifeWavesÂ Program is to enhance overall health, performance and quality of life. One significant way to enhance the natural rhythms of the body is to create them ourselves. Much of our natural activity is rhythmic, from laughter to running.

In every corner of the world, people seem drawn to rhythms, creating music, dance, and art that embody rhythms. The LifeWavesÂ Program is designed to create short periods of exertion, less than one minute long, followed by complete recovery. These rhythmic cycles of exertion and recovery are performed a few times a week for between 30 - 45 minutes. The cycles are intended to help restore the individualÂs own internal cycles to what nature intended so that they can better utilize their energy to improve overall health and live happier, more productive lives.

Dr. Dardik spent 15 years developing the cyclic exercise program believes that the ability to enhance heart rate variability is the common factor associated with all healthy individuals.

Ary Goldberger, MD, of The Margaret and H. A. Rey Institute for Nonlinear Dynamics in Physiology and Medicine and Beth Israel Deaconess Medical Center/Harvard Medical School, stated that Dr. DardikÂs Ânovel cyclic protocol designed to train both the activation and recovery phases of exercise may increase vascular fitness, heart rate variability and enhance mood in healthy patients.Â

In an interview, Dr. Dardik predicts that within five years every EKG machine in use in emergency rooms and by paramedics will be equipped with a ÂCircadian Rhythm MonitorÂ and that pharmaceutical companies will determine medication dosages based upon them. He believes that all Clinical Trials will have established protocols for measuring effectiveness throughout the circadian rhythm and eventually physicians will be prescribing medication with specific instructions on time of day.

He appears to have beaten the Goliath. Even the National Institutes of Health in March 2002 held a lecture on the topic "Ideas on How Circadian Rhythm is Reciprocally Linked to Metabolism" with distinguished speakers from the University of Texas Southwestern Medical Center.

For more information on The LifeWaves Program visit http://www. lifewaves. com (http://www. lifewaves. com).

To learn more about Dr. Dardik, visit http://www. dardikinstitute. org (http://www. dardikinstitute. org) Â Â Â Â Â Â Â Â Â

Identa networking, marketing and sales efforts Â july-august 2003

2011-03-09T04:06:00.000-08:00

Identa Networking, Marketing and Sales Efforts Â July-August 2003

Identa Ltd. succeded to market and sale the new drug detectorin: RUSSIA, ROMANIA, SWEDEN, SOUTH AFRICA, ISRAEL, USA

(PRWEB) August 1, 2003

Over the next several weeks we will be holding two very important meetings with representatives from Russia and Romania. These meetings will take place in Israel on the following dates:

1.Between August 19-22 we will be meeting with representatives of the Russian company ZAO ÂMOSVNESHINFORMÂ: Mr. Romma Leybe, Chairman of the Board of Directors and Mr. Mikhail Knyazev, Deputy General Director.

2.Between August 31 and September 4 we will be meeting with Romanian Deputy Ministers of the Interior General Nicolae Berechet and General Dr. Pavel Abraham.

The Romanian delegation will be hosted by Identa, and these meetings will follow-up on the working meetings that were held between the parties in Romania in July. During the meeting, the final details will be discussed, regarding their order of products for various Romanian national authorities: police, border patrol, customs and prison administration. All of these organizations report to the Romanian Ministry of the Interior.

Our initial estimate is that the order will be large, in the order of many tens of thousands of kits.

Today Identa received an official order from CVS, a large American drugstore chain. The order is for 420 units. It is an initial trial order that provides us with an opportunity to penetrate the American market, which offers enormous potential.

In the next few days we expect to get an initial order from the CompanyÂs representative in South Africa. The following are the activities conducted by our representatives in South Africa, as outlined in the e-mail we received about two weeks ago:

"What I have done to date is set up a database of some 2500 Pharmacys whom we are systematically e-mailing with information regarding the availability of the kits. I have also set up a database of all the schools in South Africa whom we will approach next. I have had an initial meeting with the SA Police Services who appear to be interested but are saying the cost is prohibitive.

"I will continue to work on them and will show them the benefits to encourage them to purchase. I have also set up a database of the agencies who work in the substance abuse field (from Psychiatric hospitals through to counselling centres) and am also approaching them systematically. I am also compiling list of potential corporate customers such as Pick Ân Pay Supermarkets, Woolworths, etc. in order to approach their Human Resource Departments.

We are also going to do promotionals to these groups probably in our local newspapers and weekly papers, I am still trying to decide on the best approach.

I have set up a support system to be able to handle queries and give necessary advice to the potential customers in order to support and assist them where necessary."

Regards

Bobby Hamman

Initial contact was made with a professional source who has a high level of involvement in police entities in Sweden.

In Israel: In principle the Israeli army has decided to use the CompanyÂs products. The Department of Customs & VAT has decided to purchase the CompanyÂs products and will begin using them regularly as of January 2004. Discussing the final details of a contract with the SuperPharm chain Â made up of 100 stores.

Genericsweb launches generic pharmaceutical business intelligence database ‘rmf’

2011-03-08T18:10:00.000-08:00

GenericsWeb Launches Generic Pharmaceutical Business Intelligence Database ‘RMF’

GenericsWeb announces the launch of RMF (Research Master File), bringing together the generic pharmaceutical industry’s most reputable publishers to create an industry-dedicated online business intelligence portal.

Sydney, NSW (PRWEB) April 20, 2006

GenericsWeb announces the launch of RMF (Research Master File), bringing together the generic pharmaceutical industry’s most reputable publishers - including Arrowhead, Urch, Datamonitor and Espicom - to create an industry-dedicated online business intelligence portal.

Using RMF, GenericsWeb browsers can easily find vital data and analysis on companies such as Actavis, Teva, Sandoz and Dr Reddy’s; country analysis describing trends and developments in key countries; and generics industry analysis covering topics such as biogenerics, cancer, cytotoxics, and statins. All reports can then be purchased online via credit card using secure SSL technology.

Hosted on the world's only web portal dedicated to providing insight and intelligence to the generics industry, Mr Jesse Tale, Business Development Manager for GenericsWeb commented “GenericsWeb RMF will soon become renowned as the place to efficiently source business intelligence reports from a comprehensive yet relevant catalogue”. He added “RMF is a perfect partner for our ‘Pipeline Patent Intelligence’ and will firmly place GenericsWeb as the primary source of high quality, information for the generic pharmaceutical industry”.

To see RMF for yourself, please go to www. GenericsWeb. com and click on ‘RMF’ in the navigation bar.

About GenericsWeb:

GenericsWeb Pty Ltd (www. GenericsWeb. com) hosts a web portal dedicated to serving the generic pharmaceutical industry. Resources found at GenericsWeb include patent intelligence, regularly updated news and articles, careers, business intelligence, industry links and product development services. Receive our free monthly newsletter ‘INNsight’ by registering online.

###

Global language solutions offers tips for translation and regulatory compliance in the pharmaceutical and medical device industries

2011-03-08T14:10:00.000-08:00

Global Language Solutions Offers Tips for Translation and Regulatory Compliance in the Pharmaceutical and Medical Device Industries

Based on more than a decade of providing translation services to leading companies in the healthcare and life sciences industries, GLS offers several tips for translation and regulatory compliance.

NEWPORT BEACH, CA (PRWEB) April 27, 2006

If you pick up a bottle of one of your prescription medicines you'll see various types of information on it - dosage and frequency of use, storage instructions, side effects, warnings, etc. – often in more than one language. The distribution of drugs and devices across borders has done away with translating packaging and labels as a luxury or value-add and, instead, made it a highly regulated, and more often than not, required process. Based on more than a decade of providing translation services to leading companies in the healthcare and life sciences industries, GLS offers the following tips for translation and regulatory compliance:

1. Do not assume that you can use English-language labels in foreign countries. In the European Union (EU) countries, for example, several directives, including the Clinical Trials Directive, Medical Device Directive (MDD) and In-vitro Diagnostics Directive (IVDD), have specific provisions that make translation of medical labels mandatory into the language or languages of the country in which the products are being tested, distributed, or sold.

2. Consider developing medical labels for each geographic region with similar regulatory requirements. Pharmaceutical and medical device companies are increasingly developing region-specific labels or instructions instead of trying to fit all languages into one universal piece. For example, for the countries of NAFTA (United States, Canada, and Mexico), in which FDA-approved drugs can be marketed, the labels would include English, French, and Spanish languages.

3. Do not use a canned machine translation program. Errors in translating medical labeling or instructions for use could lead to regulatory and/or product/civil liability. Machine translation is not precise enough to accurately translate the highly technical terminology used in medical labels, and worse, could cause a misinterpretation of the actual meaning altogether.

4. Assign a point person within your organization for the management of all translation projects. As translation mistakes can delay product approvals and launches, managing translations becomes a critical component of the medical device and pharmaceutical global distribution process. By centralizing the translation process within your organization you will benefit from consistent quality of all translations, faster turnarounds, and reduced translation costs.

There is more to pharmaceutical and medical device packaging and label translation than replacing words with the native language. It is imperative to achieve a translation quality that moves beyond language, cultural, and regional differences, as well as meets all local and international regulatory guidelines.

About Global Language Solutions

Global Language Solutions (GLS) is a full-service translation company delivering solutions in over 100 languages to increase its clients’ multicultural and international market share. The company’s expertise includes translation of product labeling, instructions for use (IFUs),manuals, informed consent forms, protocols, advertisements, IVRS scripts, and more. For additional information, visit http://www. globallanguages. com (http://www. globallanguages. com) or call +1-949-798-1400.

Note to Editors:

The following tip sheet is a partial list. To request the entire tip sheet or for reprint permissions, please contact Melissa Gillespie at 760-522-4362 or visit www. globallanguages. com.

###

Oak ridge men arrested on drug charges

2011-03-07T21:59:00.000-08:00

Oak Ridge men arrested on drug charges

(PRWEB) July 3, 2004

Oak Ridge police arrested two men on cocaine charges Monday and Tuesday in separate incidents.

Kayvin Grate, 42, 134 S. Walker Lane, was arrested Monday for possession of cocaine, possession of drug paraphernalia, possession of Schedule III drugs and possession of Schedule IV drugs after officers searched his house.

Adrian Curb, 24, 121 Elmhurst Lane, was arrested Tuesday night for possession of crack cocaine, public intoxication and evading arrest.

Court records said Bethel Poston and other officers served a search warrant at Grate's home. Once inside, they found crack cocaine, acetaminophen 5000 mg./hydrocodone pills without a prescription, Phentermine pills without a prescription and marijuana. These pill (viz. Hydrocodone & Phentermine) are only available through a proper prescription. Online Pharmacies like www. northusapharmacy. com are reliable sources to buy them. But they are also sold unhestitantly over Internet & OTC and getting the prescription is not so difficult.

Lt. Rick Stone said Ruff saw Curb walking on Wilberforce, carrying a bottle of liquor. Curb dropped the liquor when he saw Ruff. Ruff stopped Curb and determined he was intoxicated and placed him under arrest for public intoxication and then searched him.

Stone said Ruff found crack cocaine on Curb and while officers were detaining him, he broke free and ran. Officers chased him for about a mile before catching him.

Both men have a long criminal histories in Oak Ridge. Oak Ridge police first arrested Curb in 1997 when at age 16, he shot a man in the Scarboro neighborhood. When arrested for the shooting, officers found him with about 35 crack cocaine rocks.

Source: Oakridger. com

Baron & budd named one of the nationÂs exemplary plaintiffsÂ litigation firms by the national law journal

2011-03-07T00:07:00.000-08:00

Baron & Budd Named One of the NationÂs Exemplary PlaintiffsÂ Litigation Firms by The National Law Journal

Baron & Budd, P. C. has been named to the ÂPlaintiffsÂ Hot ListÂ for the second year in a row by The National Law Journal. The ÂPlaintiffsÂ Hot List Â Results Come Before ReputationÂ (The National Law Journal, July 26, 2004) lists 20 plaintiffsÂ litigation firms in the U. S. that have done exemplary work during the past year.

DALLAS, TX (PRWEB) September 9, 2004

The firmÂs profile in the national legal publication highlighted three of its 2003 noteworthy cases, including

City of Santa Monica v. Shell Oil (Orange Co., Calif., Super. Ct. 2003): The firm secured a $312.8 million settlement from a dozen oil companies responsible for drinking water contamination caused by the gasoline additive MTBE.

Blandford v. Garlock Sealing Technologies (Cuyahoga Co., Ohio, Ct. C. P. 2003): The firm won a verdict of $6.4 million to the family of a pipe-and-steam-fitter who died of asbestos-related mesothelioma.

Ytuarte v. Quigley (El Paso Co., Texas, Ct. at Law 2004): The firm won a $5.2 million verdict for the family of a tradesman who died of asbestos-related mesothelioma.

About Baron & Budd, P. C.

Since 1977, the law firm of Baron & Budd, P. C., has championed the rights of people and communities harmed by corporate misconduct. With over 70 attorneys and offices in Texas, Illinois, Ohio, Louisiana, and New York, Baron & Budd enjoys a national reputation as a leader of the plaintiffsÂ bar. The firm represents individuals injured by asbestos, benzene, other toxic substances, and unsafe pharmaceuticals; water authorities seeking clean-up costs for drinking water contamination; securities investors defrauded by corporate wrongdoing; and consumers in class actions.

For more information, call 1-800-222-2766 or visit www. baronandbudd. com

# # #

Custom formulation - creating new products

2011-03-05T23:11:00.000-08:00

Custom Formulation - Creating New Products

Chemir Analytical Services helps innovative companies develop new formulations, reformulate existing products, create customized blends or assist with other product challenges.

St. Louis, MO (PRWEB) August 25, 2005

Chemir Analytical Services, with years of experience reverse engineering products, takes the next step with custom formulation services. Manufacturers of cosmetics, personal care products and pharmaceuticals often seek to partner with outside laboratories experienced in ingredient identification, deformulation or reformulation. Chemir Analytical Services, a non-routine independent analytical laboratory, helps innovative companies develop new formulations, reformulate existing products, create customized blends or assist with other challenges.

ÂThis is a natural sequence in our service offeringsÂ explains David Dowell, Ph. D., Vice President Â Technology of Chemir Analytical Services. ÂOur laboratory chemists have analyzed hundreds of formulated products and have been involved in numerous partnerships involving deformulation and subsequent reformulation. This has provided a wealth of experience and intuitive understanding of custom formulations. Many customers have asked us to assist with formulating new products, and we are pleased to offer an expansion of this service.Â

About Chemir Analytical Services

Chemir, founded in 1959, provides chemical analysis and testing to a wide variety of industries, using a unique combination of analytical capabilities, instrumentation, technical expertise and quality systems. Current divisions include Chemir Analytical Services, a non-routine problem solving laboratory, Chemir Analytical Services-Michigan, a research and development laboratory serving the paints, coatings, and inks industries; and Industrial Testing Laboratories, a customized mechanical and metallurgical testing facility.

David Dowell, Ph. D.

Chemir Analytical Services

2672 Metro Blvd.

Maryland Heights MO 63043

800-659-7659

Www. chemir. com

# # #

Cole-parmer presents new thermo scientific steri-cycle co2 incubators

2011-03-05T10:12:00.000-08:00

Cole-Parmer Presents New Thermo Scientific Steri-Cycle CO2 Incubators

Achieve complete contamination control with combined HEPA air filtration and sterilization cycle to maintain cleanroom-like Class 100 air quality

Vernon Hills, Ill. (Vocus/PRWEB) November 16, 2010

Cole-Parmer offers a new option for eliminating contamination, such as biological contaminants and airborne particulates, in cell culture laboratories and pharmaceutical environments. The Thermo Scientific Steri-Cycle CO2 Incubators contain an in-chamber HEPA air filtration system that filters the chamber volume every 60 seconds and reaches Class 100 air quality conditions within five minutes following a routine door opening. Plus, the incubator’s on-demand 140°C high-temperature sterilization cycle eliminates contamination from all internal surfaces―simplifying cleaning procedures.

Several programmable features make the incubators easy to operate. These include the microprocessor control of temperature and CO2 concentration, the configurable audible on/off switch, access code, filter change reminder, remote alarm contacts, and low temperature and high/low CO2 alarms. The Thermo Scientific Steri-Cycle CO2 Incubator selection includes the TC sensor model (used when temperature and relative humidity are relatively constant) and the IR sensor model (when temperature and relative humidity levels change frequently).

To view the Thermo Scientific Steri-Cycle CO2 Incubators from Cole-Parmer, visit ColeParmer. com/8182.

Cole-Parmer has been a leading global source of laboratory and industrial fluid handling products, instrumentation, equipment, and supplies since 1955. Our product lines, including popular brand names such as Masterflex®, Oakton®, and more, are sold through company-owned customer channel outlets and a strong network of international dealers. We also feature an ISO-17025-accredited metrology lab for instrument calibration and repair. Cole-Parmer responds with excellence to customer needs, and offers application expertise and technical support. For more information, contact Cole-Parmer, 625 East Bunker Court, Vernon Hills, IL 60061. In the U. S., call 800-323-4340. International customers, call 847-549-7600. Visit us at http://www. coleparmer. com.

###

Resistant hypertension & sleep apnea: common links & solutions – baroreflex failure, tracheal caudal displacement & zht?

2011-03-04T20:49:00.000-08:00

Resistant Hypertension & Sleep Apnea: Common Links & Solutions – Baroreflex Failure, Tracheal Caudal Displacement & ZHT?

Coinciding with the Latest World Research, and Searching For No-Mask, No-Surgery Alternative Solutions For Sleep Apnea, Dr. Jin Zhou, DC Is In The Seventh Year of Zhou’s Hypoxicology Therapy (ZHT) for Possible Alternative Solutions to More Medical Conditions Than Sleep Apnea, Such As Resistant Hypertension.

Hanover Park, IL (Vocus/PRWEB) January 19, 2011

Dr. Jin Zhou, DC at PainUSA. com celebrates seventh year of Zhou’s Hypoxicology Therapy (ZHT) clinical research for possible solutions to more medical conditions than sleep apnea, such as resistant hypertension, due to the same possible causes: baroreflex dysfunctions and tracheal caudal displacement (TCD), coincidentally in the wake of latest world research findings on "Difficult to Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies", published this month in the volume 2011 of International Journal of Hypertension.

With obvious and satisfactory clinical benefits from ZHT in early clinical observations for sleep apnea and anecdotal benefits for hypertension, Dr. Zhou is clinically seeking for alternative solutions to sleep apnea and hypertension that are completely supernatural and most economical.

Intriguingly, the new research this month revealed the sparring partnership relationship between resistant hypertension and obstructive sleep apnea, the implantable electrical stimulation of carotid sinus as a most innovative and promising therapy, and calling for more multidisciplinary and comprehensive alternative approaches, while Dr. Zhou’s clinical observational assessment indicated the same clinical picture completely from conservative, natural and alternatives with ZHT. Today, Dr. Zhou initiated new approaches to develop anecdotal success into a systematic clinical alternative for persistent hypertension and sleep apnea.

International Journal of Hypertension Volume 2011 (2011) published four articles on “Difficult to Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies”

Resistant Hypertension and Obstructive Sleep Apnea: The Sparring Partners
Benefits from Treatment and Control of Patients with Resistant Hypertension
Resistant Hypertension Workup and Approach to Treatment
Obesity Hypertension: The Regulatory Role of Leptin
Http://www. sage-hindawi. com/journals/ijht/2011/si. dtrh. html

“In treating patients with headache or low back pain by ZHT, patients were observed with anecdotal reports of benefits for difficult to treat hypertension and sleep apnea. After reviewing this issue of International Journal of hypertension, I realized the difficult to find opportunity for the world new challenges: conservative baroreflex and carotid receptor resetting for persistent hypertension and sleep apnea,” said Dr. Jin Zhou, the innovator of Zhou’s Hypoxicology Therapy (ZHT), who coined the word, “Hypoxicology”.

Resistant hypertension may affect up to 30% of people with high blood pressure, and hypertension is considered resistant if a person's blood pressure remains above goal despite taking three medications to lower it. High blood pressure that is under control but still requires four or more medications to treat is also considered resistant to treatment. As its name implies, resistant hypertension is difficult to treat, successful treatment of resistant hypertension requires traditional standard pharmaceutical and alternative but effective solutions, further explained, Dr. Zhou.

“Never claim for cure for any modern medical diagnosis, a natural solution with mother nature human body functions will be the most powerful protections against migraines and sleep apnea,” disclaimed Dr. Zhou.

Worldwide research in the last two or three decades discovered significant evidence suggesting a causative or accessory role of sympathetic nerve activity in the etiology of essential hypertension. The implantable use of electrical carotid baroreceptor stimulation in clinical trials is also supported by initial clinical success and increasing evidence that, in hypertension, the baroreflex undergoes a ‘‘resetting’’ that avoids baroreceptor saturation, thus preserving the reflex ability and buffer zone to cause vasodilation and decrease BP in response to an increase in its activity.
Http://files. sld. cu/hta/files/2010/04/resistant_hypertension_treatment_through_carotid_baroreceptor_stimulation. pdf

For resistant hypertension research, Dr. Zhou developed a hypothesis that trachea caudal displacement (TCD) and vocal cord dysfunction (VCD) primarily impair baroreflex function of carotid sinus, and the reversal of TCD and VCD as well as volitional resuscitation with upper airway defense reflex may reverse sleep apnea thus benefit persistent hypertension management.

In developing the new ZHT (Zhou’s Hypoxicology Therapy) alternatives for sleep apnea, Dr. Zhou, observed clinically that trachea caudal displacement (TCD) (the windpipe moving downward), resulted from diaphragm malfunction and baroreflex dysfunction, instead of weakened soft appellate as claimed by the mainstream scientists, is the main anatomical pathology for snoring, collapse of the upper airway and frequent breathing stops during the night for people with obstructive sleep apnea. In addition, as Dr. Zhou hypothesized, the dysfunction of the baroreflex, chemoreflex, metabo-reflex, mechanoreflex, psychosomato-reflex and respiration pace-making malfunction, due to psychological, environmental and anatomical causations, are primarily and intricately responsible for the obstructive and central sleep apnea development.

Clinically, ZHT employs unique breathing and reflex exercises in conjunction with chiropractic manual and therapeutic exercises to reset baroreflex and functional fitness of upper airway. ZHT is simple, natural and quick for clinical results. Under ZHT Sleep Apnea Protocol, a patient is expected to see definitive noticeable results on the first visit with increasing uvulo-palatal-pharyngeal space and diaphragm breathing; significant and satisfactory results of both anatomical and functional breathing improvements, and activities of daily living (ADL) improvements within three sessions or if not so, ZHT therapy should be discontinued.

Dr. Jin Zhou, D. C. has been a licensed chiropractic physician in Hanover Park, IL since 1991. He was a former orthopedic surgeon 23 years ago in China. Dr. Zhou is dedicated to developing a revolutionary breakthrough, an extremely simple and super natural therapy that could potentially save millions of lives and trillions of dollars without having to rely upon only medication, surgery and device. He coined the new word, “Hypoxicology”.

For more scientific information on ZHT, please visit http://SleepapneaUSA. net, or contact Dr. Jin Zhou at 630-808-7237.

For more clinical information on migraine, please visit http://PainUSA. com, or contact DR. Jin Zhou at 630-736-1646.

###

Wildly popular alternative health website counters propaganda of big pharma and the fda

2011-03-04T18:34:00.000-08:00

Wildly Popular Alternative Health Website Counters Propaganda of Big Pharma and the FDA

Readership is growing at one of the top alternative health websites thanks to uncensored articles covering modern medicine, the FDA, prescription drugs and more.

(PRWEB) August 18, 2005

Millions of readers are discovering a new online destination for information about preventing chronic disease, eliminating pain, and setting themselves free from prescription drugs for life: NewsTarget. com. Seemingly out of nowhere, NewsTarget. com has achieved unprecedented, explosive readership growth over the last six months, catapulting the site into the world's No. 3 spot for alternative health websites.

What's NewsTarget all about? It gives readers an alternative view of what's happening with modern medicine today. With regular assaults on Big Pharma, the FDA, food manufacturers, and the practices of "old school" doctors, NewsTarget gives readers an uncensored look into the ugliest corners of modern medicine... the stuff mainstream media rarely wants to report.

The site was the first, for example, to point out that one painkiller drug (Vioxx) has killed more Americans than the entire Vietnam War, if drug safety statistics from the FDA are to be believed. NewsTarget also ran a study revealing that prescription drugs have killed 16,400 percent more Americans than terrorists since 2001.

That's the kind of raw reporting served up daily at NewsTarget. "The American people are being lied to about prescription drugs," says Adams, the primary contributor to the site, who is 100 percent free of all drugs and yet has such outstanding health that he posts his blood chemistry lab results online. "NewsTarget. com is one of the few websites where people can learn the uncensored truth about this fiasco called modern medicine," he says.

Why is NewsTarget able to get to the truth about drugs? The site accepts no advertising from drug companies, food companies, vitamin manufacturers or any other health products. So advertising revenues don't control the site's content.

Visit the site at http://www. newstarget. com (http://www. newstarget. com)

###

guitarrawlings

Piribo: meeting the needs for improved diagnostic and prognostic tools for rheumatoid arthritis

New insights into the global pain market-post vioxx

Hospital performance improvement: healthcare management council partner's internal collaboration focuses on pre-sedation pain and cuts costs by decreasing use of propofol

Cyco software announces inaugural european user & reseller conference

New medical sales salary calculator helps job seekers narrow their search

Cbdm. T&#174;, the market and business intelligence company reviews the enzyme market

Visicom corp. Adds new board of advisors members

Dr’s secret to beauty online store

Tpg capital selects metricstream grc platform to boost its internal controls and compliance

Hr&#174; pharmaceuticals, inc. To showcase hr&#174; lubricating jelly and hr&#174; clini-clean at the 25th annual american academy of nurse practitioners conference in phoenix, arizona

Search engine marketing firm iprospect taps kaminski for c-level spot

Efolder's jan spring recognized by everything channel's crn magazine as one of the top 100 women in the channel

Spanning 18 countries and 41 industries, the 2006 rebrand 100™ award winners show the world how rebranding is done

New capsure™ cleanroom wiper from berkshire corporation captures and retains 42 times more contaminant particles

Ephedrine affordable to all: asthma sufferers breathe easier

World diabetes day 2003 type 1 diabetes in children &#194; same diagnosis, different prognosis

Wireless patriot polling system now available to u. S. Markets

Palo: business intelligence for openoffice. Org

Kistler-morse has just signed a contract with falcon-software's falcongrafx division for the redesign of their corporate company websites

Pharmaceutical companies are implementing new pathway-based technologies and strategies in their r&d programs

Are we poisoning our seniors?

Proactive strategic intelligence of greece and cyprus joins the global intelligence alliance, already a network of 60 professional ci companies

Unique split-architecture device coupler system doubles number of intrinsically safe (is) devices for hazardous environments

Dan atwood honored as oracle ace

Adieu aux salles de bains encombr&#195;&#169;es!

Interphase systems announces virtualization exchange 2008 : educational event will be held on dec. 5 in bridgewater, n. J

Association for manufacturing excellence conference to feature e-kanban

Legalview developing cranial implant information portal detailing the recall of stryker cranial implant kits

Matrix marketing group appoints vice president of strategic development

Pharm-olam international adds additional offices in latin america

Substance abuse relapse prevention study gets high praise from review board

Pistolstar boosts password security and enhances self-service experience with web set password global 7

Research and markets: must-have essential reading &#194;drug and market development journal&#194;

A "healthy" company - geritrex celebrates its 30 year anniversary with new rebranding effort and expanding distribution channels

Research and markets - lack of necessary research resources can lead to the failure of pharmaceutical brand teams to complete their most important tasks

Bill s.3: another homeland security scandal? Parents are watching, says naa

Profiles of the top 10 global companies in bioinformatics

New service provides first real change to discount prescription drug card model in 15 years

Winchester business system wins mds pharma services global contract leading contract research organization chooses parasale for crm

Know where your inventory is - at all times

Smartbrief, inc. Announces addition of job listings to popular daily newsletters for executives and top level professionals

Bluemile lights new albany's fiber network

New fiber supplement - psyllium and inulin blend for maximum health benefits

A c labels bought by the mercian labels group

Fall enrollment largest in history; also record freshman class

“Great two-way communication” dorset police praise solcara support

Healthcare solutions and mitchell international announce specialty network services for auto casualty market

88% of gps in the uk prefer physical exercise or diet as the treatment for metabolic syndrome

Fullscope, microsolutions collaborate to form fullscope scandinavia a/s

Select safety sales adds the new speakman se-4300 series to their eyewash station product line

Briefing paper: severe acute respiratory syndrome (sars) preliminary implications on the economy and disease overview

Protecting your baby: a new, non-mercury basal thermometer for trying-to-conceive women

Alert: bloomberg to gather healthcare experts in chicago, april 27th

Chinese herbal formula helps overcome flu & cough

Denmark is the second largest biotech nation in northern europe

"Miracle" tapping technique eft found to help stress, anxiety, depression, trauma and pain in reduced timescales. Workshops now offered

Creation and funding of content is focus of first internet content syndication conference

Molport announces data integration with zinc, the leading free database of chemical compounds for drug discovery research

New healthrock music video teaches kids how to avoid h1n1 flu

4-antibody replace paper lab notebooks with amphora's flexible patentsafe eln

Prominent physician achieves success using topical sinus medications via pulsitile irrigation

Seminar on how pharmaceutical companies can achieve unprecedented visibility into and greater command over their core processes

Growth hormones direct announces legal human growth hormones for athletes

Federal judge rejects sepracor, inc.'S motion to dismiss case and allows tharos laboratories, inc. (Makers of nytex&#174;) to proceed with lawsuit against sepracor, inc. (Makers of lunesta&#174;) on infringement of tharos butterfly

Chemdiv and euroscreen form strategic alliance for gpcr drug development

Lessons in transforming brick & mortar businesses to the dot-com world

Samaritan discusses r&d strategy and details robust pipeline at european biosquare partnering conference

Regional technology alliance selects gcs-pr for strategic counsel

U. S. Army adds inxight star tree visual navigation to its hyperwave knowledge management system

Drury produces successful training for janssen launch

Early-bird discount extended for product management educational conference, the global hub for all things product management

Bpg properties, ltd. Announces 2750 morris road in lansdale, pennsylvania is for sale

New protocol established by university of utah for determining adherence to niosh definition of a closed-system

Md biosciences nominated for scottish annual life sciences award: most promising new life science company

Lifeclinic international to highlight health station benefits at food marketing institute supermarket pharmacy conference

Added value pharmaceutical services turns to active marketing services for creative campaign & marketing services

Obama's healthcare debate and dr. Chao's 8 herbal ounces of prevention ~by ed rampell

Companies grapple with optimal strategies for avoiding risk in hiring independent contractors

Centice corporation awarded nearly $500,000 in qualified investment rebates from the irs

Cbdm. T®, the market and business intelligence company reviews the enzyme market

Hr® pharmaceuticals, inc. To showcase hr® lubricating jelly and hr® clini-clean at the 25th annual american academy of nurse practitioners conference in phoenix, arizona

World diabetes day 2003 type 1 diabetes in children Â same diagnosis, different prognosis

Adieu aux salles de bains encombrÃ©es!

Research and markets: must-have essential reading Âdrug and market development journalÂ

Federal judge rejects sepracor, inc.'S motion to dismiss case and allows tharos laboratories, inc. (Makers of nytex®) to proceed with lawsuit against sepracor, inc. (Makers of lunesta®) on infringement of tharos butterfly

A medical ÂdavidÂ takes on a ÂgoliathÂ establishment

Identa networking, marketing and sales efforts Â july-august 2003

Baron & budd named one of the nationÂs exemplary plaintiffsÂ litigation firms by the national law journal

Resistant hypertension & sleep apnea: common links & solutions – baroreflex failure, tracheal caudal displacement & zht?